Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association
Abstract
BACKGROUND: Infective endocarditis is a potentially lethal disease that has undergone major changes in both host and pathogen. The epidemiology of infective endocarditis has become more complex with today's myriad healthcare-associated factors that predispose to infection. Moreover, changes in pathogen prevalence, in particular a more common staphylococcal origin, have affected outcomes, which have not improved despite medical and surgical advances. METHODS AND RESULTS: This statement updates the 2005 iteration, both of which were developed by the American Heart Association under the auspices of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease of the Young. It includes an evidence-based system for diagnostic and treatment recommendations used by the American College of Cardiology and the American Heart Association for treatment recommendations. CONCLUSIONS: Infective endocarditis is a complex disease, and patients with this disease generally require management by a team of physicians and allied health providers with a variety of areas of expertise. The recommendations provided in this document are intended to assist in the management of this uncommon but potentially deadly infection. The clinical variability and complexity in infective endocarditis, however, dictate that these recommendations be used to support and not supplant decisions in individual patient management.
Verified 2026-10-11 · 2 references not checked yet
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
102 of 369 cited sources checked · 46 supported · 4 flagged · accuracy not yet measured
- Findingcitation
A retrospective study of 410 patients showed good agreement (72%-90%) between the Duke criteria and clinical assessment by infectious disease experts blinded to underlying infective endocarditis risk factors.
“a retrospective study of 410 patients showed good agreement (72%-90%) between the Duke criteria and clinical assessment by infectious disease experts blinded to underlying IE risk factors.39”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [39] 39. Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, Ryan T, Sexton DJ, Roussakis G, Harrell LJ, Corey GR. Infective endocar- ditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis. 1999;28:106-114. doi: 10.1086/515076. source
The Abstract describes a prospective study of 59 patients with definite infective endocarditis, not a retrospective study of 410 patients. The Definition of IE says the authors used the Duke criteria, but our copy does not report the claimed 72%–90% agreement with blinded infectious disease experts. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
Staphylococcal or fungal infective endocarditis appears to carry a high incidence rate of embolization independently of vegetation size.
“In contrast, as confirmed above by Vilacosta et al, 278 staphylococcal or fungal IE appears to carry a high incidence rate of embolization independently of vegetation size.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [278] source
The Discussion says earlier reports suggested increased embolization risk with Staphylococcus and fungi, but this study found no significant difference by microorganism. It also reports that, in staphylococcal endocarditis, large vegetations had a higher incidence of embolism. The Clinical and microbiologic data section identifies vegetation size—not microorganism—as the only independent predictor in its multivariate analysis. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
Adjustment of the Duke criteria to require a minimum of 1 major plus 1 minor criterion or 3 minor criteria as a floor to designate a case as possible infective endocarditis has been incorporated into the modified criteria to reduce the proportion of patients assigned to the possible infective endocarditis category.
“adjustment of the Duke criteria to require a minimum of 1 major plus 1 minor criterion or 3 minor criteria as a”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [24] 24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diag- nosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638. doi: 10.1086/313753. source
- Premisecitation
Daptomycin has been evaluated in the treatment of Staphylococcus aureus bacteremia and infective endocarditis in a randomized controlled trial.
“daptomycin has been evaluated in the treatment of S aureus bacteremia and IE in a randomized, controlled trial.13”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
- Findingcitation
The proportion of infective endocarditis patients undergoing surgery has increased over time to approximately 50%.
“the proportion of IE patients undergoing surgery has increased over time to reach ≈50%.1,10,11”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [1] 1. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco- Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B; AEPEI Study Group. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifi- cations: three successive population-based surveys. J Am Coll Cardiol. 2012;59:1968-1976. doi: 10.1016/j.jacc.2012.02.029. source
- cites [10] 10. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005-1013. doi: 10.1161/CIRCULATIONAHA.109.86 source
The Results report that 720 of 1,552 eligible patients with native valve endocarditis (46%) underwent early surgery, supporting the approximate 50% figure for that study group. The paper does not establish that the proportion increased over time or that the figure applies to all infective endocarditis patients. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [11] 11. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239-2247. doi: 10.1001/jama.2011.1701. source
The Results report that another study found surgery in 46% of patients with left-sided infective endocarditis and heart failure, a restricted group close to the claimed 50%. This paper reports surgery in 62% of its own patients with heart failure. Neither passage establishes that surgery rates increased over time or reached approximately 50% among infective endocarditis patients generally. (LLM, conf=0.77)
Experimental — accuracy not yet measured
- Interpretationcitation
The echocardiographic minor criterion was eliminated in the modified Duke criteria.
“Therefore, this minor criterion was eliminated in the modified Duke criteria.24”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [24] 24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diag- nosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638. doi: 10.1086/313753. source
- Premisecitation
An anti-phase I immunoglobulin G antibody titer of at least 1:800 or a single blood culture positive for Coxiella burnetii should be a major criterion in the modified Duke schema.
“Thus, an anti-phase I immunoglobulin G antibody titer ≥1:800 or a single blood culture positive for C burnetii should be a major criterion in the modified Duke schema.24”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [24] 24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diag- nosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638. doi: 10.1086/313753. source
- Premisereasoning
The modified Duke criteria recommend inclusion of Staphylococcus aureus bacteremia as a major criterion regardless of whether the infection is hospital acquired or community acquired.
“the modified Duke criteria (Tables 2 and 3) recommend the inclusion of S aureus bacteremia as a major criterion, regardless of whether the infection is hospital acquired (with or without a removable source of infection) or community acquired.24”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [24] 24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diag- nosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638. doi: 10.1086/313753. source
- Premisecitation
The curative dose of penicillin for streptococcal infections in animal models increases markedly with the number of organisms inoculated and the duration of the infection.
“For example, the curative dose of penicillin for streptococcal infections in animal models has been shown to increase markedly with the number of organisms inoculated and the duration of the infection, presumably because of the interim increase in the number of organisms in the infected host.76”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [76] 76. Eagle H. The effect of the size of the inoculum and the age of the infection on the curative dose of penicillin in experimental infections with streptococci, pneumococci, and Treponema pallidum. J Exp Med. 1949;90:595-607. source
- Findingcitation
Combination therapy with penicillin or ceftriaxone and an aminoglycoside for 2 weeks is highly effective in viridans group streptococci (VGS) IE in very select patients with uncomplicated infection.
“Combination therapy with penicillin or ceftriaxone and an aminoglycoside for 2 weeks is highly effective in viridans group streptococci (VGS) IE 90 in very select patients with uncomplicated infection.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [90] 90. Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocar- ditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis. 1995;21:1406-1410. source
- Interpretationcitation
The lower bacterial densities in right-sided vegetations may result from host defense mechanisms, including polymorphonuclear activity or platelet-derived antibacterial cationic peptides.
“Of interest, right-sided vegetations tend to have lower bacterial densities, which may result from host defense mechanisms, including polymorphonuclear activity or plateletderived antibacterial cationic peptides.90,91,93”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [90] 90. Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocar- ditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis. 1995;21:1406-1410. source
The Results describe the infected valves and organisms in this treatment study, but do not compare bacterial densities in right- and left-sided vegetations. The Discussion addresses antibiotic efficacy, not polymorphonuclear activity or platelet-derived antibacterial peptides; searches for those mechanisms found no supporting passage. Page numbers were unavailable in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [91] 91. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988;109:619-624. source
- cites [93] 93. Bayer AS, Cheng D, Yeaman MR, Corey GR, McClelland RS, Harrel LJ, Fowler VG Jr. In vitro resistance to thrombin-induced platelet microbici- dal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemother. 1998;42:3169-3172. source
The Discussion (page unavailable) describes platelet-released antimicrobial peptides as a host defense at endovascular sites and links resistance to those peptides with proliferation in cardiac vegetations. It does not report that right-sided vegetations have lower bacterial densities or address polymorphonuclear activity, so it supports only the platelet-peptide mechanism in the cited sentence. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
Certain groups of antimicrobials commonly used to treat IE, such as β-lactams and glycopeptides (and, to a lesser extent, lipopeptides such as daptomycin), are less active against highly dense bacterial populations.
“The effect of high bacterial densities on antimicrobial activity is called the inoculum effect in which certain groups of antimicrobials commonly used to treat IE such as β-lactams and glycopeptides (and, to a lesser extent, lipopeptides such as daptomycin) are less active against highly dense bacterial populations.[73][74][75]”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [73] 73. LaPlante KL, Rybak MJ. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacody- namic model. Antimicrob Agents Chemother. 2004;48:4665-4672. doi: 10.1128/AAC.48.12.4665-4672.2004. source
- cites [74] 74. Arhin FF, Sarmiento I, Parr TR Jr, Moeck G. Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus. Int J Antimicrob Agents. 2012;39:159-162. doi: 10.1016/j. ijantimicag.2011.09.017. source
- cites [75] 75. Rose WE, Leonard SN, Rossi KL, Kaatz GW, Rybak MJ. Impact of inoc- ulum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2009;53:805-807. doi: 10.1128/AAC.01009-08. source
- Premisecitation
Stationary growth-phase conditions make it less likely that bacterial cell wall-active antibiotics (β-lactams and glycopeptides) are optimally effective.
“In addition, the stationary growth-phase conditions make it less likely that bacterial cell wall-active antibiotics (β-lactams and glycopeptides) are optimally effective.[77][78][79]”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [77] 77. Lunde CS, Rexer CH, Hartouni SR, Axt S, Benton BM. Fluorescence microscopy demonstrates enhanced targeting of telavancin to the divi- sion septum of Staphylococcus aureus. Antimicrob Agents Chemother. 2010;54:2198-2200. doi: 10.1128/AAC.01609-09. source
The passage labeled Abstract (page unavailable) says glycopeptides must reach the site of active cell-wall biosynthesis to act on their targets. It does not address stationary-phase conditions, reduced antibiotic effectiveness during that phase, or β-lactams. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [78] 78. Pogliano J, Pogliano N, Silverman JA. Daptomycin-mediated reorga- nization of membrane architecture causes mislocalization of essential cell division proteins. J Bacteriol. 2012;194:4494-4504. doi: 10.1128/ JB.00011-12. source
The Introduction identifies vancomycin and oxacillin as cell wall-active antibiotics, but does not discuss their effectiveness during stationary-phase growth. A References entry mentions stationary-phase cells only in the title of a study about daptomycin. Searches for stationary-phase efficacy of β-lactams and glycopeptides found no passage addressing the claim. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [79] 79. Eng RH, Padberg FT, Smith SM, Tan EN, Cherubin CE. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother. 1991;35:1824-1828. source
- Premisecitation
An inoculum effect has been demonstrated with penicillin versus streptococci in both in vitro and animal models.
“An inoculum effect has been demonstrated with penicillin versus streptococci in both in vitro and animal models.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [76] 76. Eagle H. The effect of the size of the inoculum and the age of the infection on the curative dose of penicillin in experimental infections with streptococci, pneumococci, and Treponema pallidum. J Exp Med. 1949;90:595-607. source
The Introduction (p. 595) describes an in vitro inoculum effect for penicillin against bacteria, but does not identify those bacteria as streptococci. It says the relationship is confirmed in streptococcal infections of mice and rabbits, and the Experimental results (p. 599) report higher curative doses with larger streptococcal inocula. Thus the animal-model part is supported, but the streptococcus-specific in vitro part is not established by our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingcitation
Early investigations of 3-dimensional transesophageal echocardiography have demonstrated advantages over 2-dimensional transesophageal echocardiography to better detect and delineate vegetations and to identify infective endocarditis complications and their relationships with surrounding structures.
“early investigations 64,65 of 3D TEE have demonstrated advantages over 2-dimensional TEE (which is routinely used) to better detect and delineate vegetations and to identify IE complications and their relationships with surrounding structures.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [64] 64. Hansalia S, Biswas M, Dutta R, Hage FG, Hsiung MC, Nanda NC, Singh P, Manda J, Kesanolla SK, Wei J, Yin WH. The value of live/real time three-dimensional transesophageal echocardiography in the assessment of valvular vegetations. Echocardiography. 2009;26:1264-1273. doi: 10.1111/j.1540-8175.2009.01042.x. source
- cites [65] 65. Liu YW, Tsai WC, Lin CC, Hsu CH, Li WT, Lin LJ, Chen JH. Usefulness of real-time three-dimensional echocardiography for diagnosis of infective endocarditis. Scand Cardiovasc J. 2009;43:318-323. doi: 10.1080/14017430902737940. source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Findingcitation
Even transesophageal echocardiography may miss initial perivalvular abscesses, particularly when the study is performed early in the patient's illness.
“Even TEE may miss initial perivalvular abscesses, particularly when the study is performed early in the patient's illness.54”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [54] 54. Daniel WG, Mügge A, Martin RP, Lindert O, Hausmann D, Nonnast- Daniel B, Laas J, Lichtlen PR. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991;324:795-800. doi: 10.1056/NEJM199103213241203. source
The Transesophageal Echocardiography section (p. 2) reports that TEE detected 40 of 46 abscesses, supporting that it can miss some. The Limitations of the Study (p. 5) describes a small abscess that can be missed because of acoustic shadowing, but neither passage links missed abscesses to studies performed early in the patient's illness. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Right-sided vegetations tend to have lower bacterial densities.
“Of interest, right-sided vegetations tend to have lower bacterial densities, which may result from host defense mechanisms, including polymorphonuclear activity or plateletderived antibacterial cationic peptides.90,91,93”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [90] 90. Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocar- ditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis. 1995;21:1406-1410. source
The Results describe valve involvement and vegetations, but do not compare bacterial densities in right- and left-sided vegetations. Searches for that comparison and for the proposed host-defense mechanisms found no passage addressing either point in our copy. (LLM, conf=0.77)
Experimental — accuracy not yet measured - cites [91] 91. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988;109:619-624. source
- cites [93] 93. Bayer AS, Cheng D, Yeaman MR, Corey GR, McClelland RS, Harrel LJ, Fowler VG Jr. In vitro resistance to thrombin-induced platelet microbici- dal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemother. 1998;42:3169-3172. source
The Discussion describes platelet antimicrobial peptides as a host defense and discusses bacterial proliferation within cardiac vegetations. It does not compare bacterial densities in right-sided and left-sided vegetations; searches for that comparison found no passage in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Overall outcomes for patients with CoNS infective endocarditis and S aureus infective endocarditis are similar.
“Of interest, data suggest that the overall outcomes for patients with CoNS IE and S aureus IE are similar.137”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [137] 137. Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, Federspiel J, Athan E, Stryjewski ME, Nacinovich F, Marco F, Levine DP, Elliott TS, Fortes CQ, Tornos P, Gordon DL, Utili R, Delahaye F, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis- Prospective Cohort Study Group. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis. 2008;46:232-242. doi: 10.1086/524666. source
- Premisecitation
The increase in S aureus infective endocarditis is primarily a consequence of healthcare contact such as intravascular catheters, surgical wounds, indwelling prosthetic devices, and hemodialysis.
“This increase is primarily a consequence of healthcare contact (eg, intravascular catheters, surgical wounds, indwelling prosthetic devices, hemodialysis) 6,8,9”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [6] 6. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS; ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress [published correction appears in JAMA. 2005;294:900]. JAMA. 2005;293:3012-3021. doi: 10.1001/jama.293.24.3012. source
- cites [8] 8. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infec- tive endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463- 473. doi: 10.1001/archinternmed.2008.603. source
The ‘Changes in Microbiologic Characteristics of IE’ section attributes the shift toward S aureus IE in part to health care contact and invasive procedures, but also names intravenous drug use. It does not say health care contact is the primary cause of the increase. The Definitions section includes wound care and hemodialysis as forms of health care contact; it does not establish the full list of examples as causes of the increase. Page numbers were not available in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [9] 9. Benito N, Miró JM, de Lazzari E, Cabell CH, del Río A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, Habib G, Kamarulzaman A, Kumar AS, Nacinovich FM, Suter F, Tribouilloy C, Venugopal K, Moreno A, Fowler VG Jr; ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non- nosocomial acquisition [published correction appears in Ann Intern Med. 2010;152:480]. Ann Intern Med. 2009;150:586-594. doi: 10.7326/0003-4819-150-9-200905050-00004 source
The Discussion identifies health care contact as an important risk factor for native valve endocarditis, and the Results identify S. aureus as its most common cause in health care–associated cases. The Results also report intravascular catheters as a presumed infection source and an association with hemodialysis. The paper does not establish that health care contact is the primary cause of an increase in S. aureus endocarditis, or identify surgical wounds and indwelling prosthetic devices as causes of that increase. No page numbers were available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Increasing rates of oxacillin-resistant S aureus or MRSA isolates in hospital and community settings have complicated the treatment of S aureus infective endocarditis.
“Increasing rates of oxacillin-resistant S aureus or MRSA isolates in both hospital and community settings and the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [138] 138. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK; Vancomycin-Resistant Staphylococcus aureus Investigative Team. Infection with vancomycin-resistant Staphylococcus aureus contain- ing the vanA resistance gene. N Engl J Med. 2003;348:1342-1347. doi: 10.1056/NEJMoa025025. source
- cites [139] 139. Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC; Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. Epidemiological and microbiological char- acterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis. 2003;36:429-439. doi: 10.1086/346207. source
The Abstract (page unavailable) describes S. aureus as a cause of community-acquired and health care-associated infections, and the Clinical description study (page unavailable) lists MRSA endocarditis cases. The copy does not establish increasing MRSA rates in either setting or show that those rates complicated treatment of infective endocarditis. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
The increase in S aureus infective endocarditis is especially prevalent in North America.
“and is especially prevalent in North America.6,138,139”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [6] 6. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS; ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress [published correction appears in JAMA. 2005;294:900]. JAMA. 2005;293:3012-3021. doi: 10.1001/jama.293.24.3012. source
- cites [138] 138. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK; Vancomycin-Resistant Staphylococcus aureus Investigative Team. Infection with vancomycin-resistant Staphylococcus aureus contain- ing the vanA resistance gene. N Engl J Med. 2003;348:1342-1347. doi: 10.1056/NEJMoa025025. source
- cites [139] 139. Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC; Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. Epidemiological and microbiological char- acterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis. 2003;36:429-439. doi: 10.1086/346207. source
The Clinical description study section reports one US patient whose S. aureus bloodstream infection was complicated by endocarditis. The Discussion addresses the rarity of reduced vancomycin susceptibility, not trends in infective endocarditis. Searches for endocarditis incidence and North American prevalence found no passage establishing that S. aureus infective endocarditis is increasing or especially prevalent in North America; page numbers were unavailable in our copy. (LLM, conf=0.74)
Experimental — accuracy not yet measured
- Premisecitation
Recovery of clinical S aureus isolates partially and fully resistant to vancomycin has complicated the treatment of S aureus infective endocarditis.
“the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [138] 138. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK; Vancomycin-Resistant Staphylococcus aureus Investigative Team. Infection with vancomycin-resistant Staphylococcus aureus contain- ing the vanA resistance gene. N Engl J Med. 2003;348:1342-1347. doi: 10.1056/NEJMoa025025. source
- cites [139] 139. Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC; Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. Epidemiological and microbiological char- acterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis. 2003;36:429-439. doi: 10.1086/346207. source
The Clinical description study reports a vancomycin-intermediate S. aureus (VISA) infection complicated by endocarditis, and Table 1 describes a patient with mitral valve endocarditis who died. The paper also mentions a fully vancomycin-resistant isolate, but not in an endocarditis case; it does not establish that both forms of resistance complicated treatment of S. aureus infective endocarditis. Page numbers were not available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
In a registrational open-label multinational clinical trial comparing daptomycin monotherapy with therapy including low-dose gentamicin for the first four days, patients did equally well in either treatment arm.
“In a registrational open-label, multinational, clinical trial for the treatment of S aureus bacteremia or right-sided IE comparing the efficacy of daptomycin monotherapy with therapy that included low-dose (1 mg/kg IV every 8 hours or adjusted on the basis of renal function) gentamicin for the first 4 days, patients did equally well in either treatment arm.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
- Premisecitation
CoNS now cause a significant but relatively small proportion of native valve infective endocarditis cases.
“As noted above, in addition to their importance in PVE, CoNS now cause a significant but relatively small proportion of NVE cases. 2”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [2] 2. Correa de Sa DD, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD, Bachuwar A, Pazdernik M, Steckelberg JM, Wilson WR, Baddour LM. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota [published correction appears in Mayo Clin Proc. 2010;85:772]. Mayo Clin Proc. 2010;85:422-426. source
The Discussion (page unavailable) reports a high incidence of coagulase-negative staphylococcal endocarditis among recent cases and says native-valve cases due to these organisms deserve monitoring. It does not give the proportion of native-valve cases they cause, so the characterization of that proportion as relatively small is not established by our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
The combination of daptomycin and a beta-lactam antibiotic has been reported to be effective in treating a limited number of patients with persistent MRSA bacteremia.
“The combination of daptomycin and a β-lactam antibiotic has been reported to be effective in treating a limited number of patients with persistent MRSA bacteremia.168”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [168] source
- Premisecitation
In the multinational trial of S aureus bacteremia and right-sided infective endocarditis, daptomycin at 6 mg/kg per day was noninferior to standard therapy with vancomycin or an antistaphylococcal penicillin plus low-dose short-course gentamicin.
“In the above-noted multinational trial 13 of S aureus bacteremia and right-sided IE, this agent (at 6 mg•kg -1 •d -1 ) was noninferior to standard therapy with vancomycin or an antistaphylococcal penicillin plus low-dose, short-course gentamicin.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
- Premisecitation
In an in vitro study, the addition of trimethoprim-sulfamethoxazole to daptomycin was rapidly bactericidal for a daptomycin-nonsusceptible strain compared with daptomycin monotherapy.
“In an in vitro study, 167 the addition of trimethoprim-sulfamethoxazole to daptomycin was rapidly bactericidal for a daptomycin-nonsusceptible strain compared with daptomycin monotherapy.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [167] 167. Steed ME, Vidaillac C, Rybak MJ. Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations. Antimicrob Agents Chemother. 2010;54:5187-5192. doi: 10.1128/ AAC.00536-10. 168 source
- Study design and conductown data
The small number of patients with left-sided infective endocarditis enrolled in the trial prevented meaningful conclusions on the comparative efficacy of daptomycin in this infection.
“Importantly, the small number (n=18; 9 in each arm) of patients with left-sided IE enrolled in the trial prevented meaningful conclusions on the comparative efficacy of daptomycin in this infection.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
- Premisecitation
The risk of clinically significant nephrotoxicity with even short courses of adjunctive low-dose gentamicin for S aureus bacteremia and right-sided infective endocarditis can be substantial.
“As noted above, 149 the risk of clinically significant nephrotoxicity with even short courses of adjunctive low-dose gentamicin for S aureus bacteremia and right-sided IE can be substantial.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [149] 149. Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW. Initial low- dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis. 2009;48:713-721. doi: 10.1086/597031. source
- Premisecitation
CoNS that cause prosthetic valve infective endocarditis usually are methicillin resistant, particularly when infective endocarditis develops within one year after surgery.
“CoNS that cause PVE usually are methicillin resistant, particularly when IE develops within 1 year after surgery.182”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [182] 182. Chu VH, Miro JM, Hoen B, Cabell CH, Pappas PA, Jones P, Stryjewski ME, Anguera I, Braun S, Muñoz P, Commerford P, Tornos P, Francis J, Oyonarte M, Selton-Suty C, Morris AJ, Habib G, Almirante B, Sexton DJ, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis-Prospective Cohort Study Group. Coagulase-negative staphylococcal prosthetic valve endocarditis: a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Heart. 2009;95:570-576. doi: 10.1136/hrt.2008.152975. source
The Results report methicillin resistance in 68% of CoNS strains, supporting 'usually methicillin resistant.' But the Results and Discussion say resistance was high regardless of time since valve implantation; they do not support the suggestion that it was particularly high when endocarditis developed within one year. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
In the registrational trial, daptomycin performed as well as vancomycin or beta-lactams in treating septic pulmonary emboli caused by S aureus.
“In the registrational trial, 13 however, this agent performed as well as vancomycin or β-lactams in treating septic pulmonary emboli caused by S aureus, reflecting the distinct pathogenesis of this syndrome as opposed to traditional pneumonia.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
The Patients table reports septic pulmonary emboli at baseline in 10 daptomycin recipients and 13 standard-therapy recipients. The Outcome section finds daptomycin noninferior overall for S. aureus bacteremia and endocarditis, but does not report outcomes specifically for patients with septic pulmonary emboli. It therefore does not establish that the treatments performed equally well for that syndrome. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
Linezolid-resistant strains have developed during treatment.
“However, linezolid-resistant strains have developed during treatment.201”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [201] source
- Premisecitation
In vitro evaluations suggested that ampicillin and ceftaroline in combination with daptomycin demonstrate the greatest synergistic activity compared with other β-lactam-daptomycin combinations.
“A number of in vitro evaluations [214][215][216] suggested that ampicillin and ceftaroline in combination with daptomycin demonstrate the greatest synergistic activity compared with other β-lactam-daptomycin combinations.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [214] source
- cites [215] source
The Results report that ampicillin and ceftaroline each showed in vitro synergy with daptomycin against the daptomycin-susceptible VRE strain, whereas ceftriaxone did not. But only ceftaroline showed synergy against the daptomycin-nonsusceptible strain. The paper therefore does not support presenting both combinations as the greatest across strains or compared with β-lactam combinations beyond those tested. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [216] source
- Premisecitation
Olaison and Schadewitz reported a 5-year prospective study of 78 cases of enterococcal IE treated with a β-lactam and an aminoglycoside.
“Olaison and Schadewitz 189 in Sweden reported a 5-year prospective study of 78 cases of enterococcal IE treated with a β-lactam and an aminoglycoside.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [189] 189. Olaison L, Schadewitz K; Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis. Enterococcal endo- carditis in Sweden, 1995-1999: can shorter therapy with aminogly- cosides be used? Clin Infect Dis. 2002;34:159-166. doi: 10.1086/ 338233. source
The paper describes a five-year prospective study in Sweden, but reports 93 definite enterococcal IE episodes, not 78; 78 is the number caused by E. faecalis (opening summary, p. 1; Results, p. 2). The Results (pp. 3, 5) also show that treatment varied: some patients received vancomycin, and seven received no aminoglycoside. Thus the stated treatment does not describe all cases. (LLM, conf=0.93)
Experimental — accuracy not yet measured
- Premisecitation
HACEK resistance to ampicillin-sulbactam in vitro has been described.
“In addition, ampicillin-sulbactam may be considered a treatment option, although HACEK resistance to this agent in vitro has been described.219”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [219] source
- Premisecitation
Additional laboratory screening is required to identify causes of culture-negative IE.
“Additional laboratory screening is required to identify the causes of culture-negative IE. 233”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [233] 233. Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS. A guide to utilization of the microbiology labo- ratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57:e22-e121. doi: 10.1093/cid/cit278. source
- Premisecitation
Limitations such as referral bias and sampling bias may have affected the findings of studies on culture-negative IE.
“Limitations such as referral bias and sampling bias may have affected the findings.[235][236][237]”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [235] 235. Thuny F, Fournier PE, Casalta JP, Gouriet F, Lepidi H, Riberi A, Collart F, Habib G, Raoult D. Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi. Heart. 2010;96:743-747. doi: 10.1136/hrt.2009.181594. source
- cites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
- cites [237] 237. Geissdörfer W, Moos V, Moter A, Loddenkemper C, Jansen A, Tandler R, Morguet AJ, Fenollar F, Raoult D, Bogdan C, Schneider T. High fre- quency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol. 2012;50:216-222. doi: 10.1128/JCM.05531-11. source
The Discussion (page unavailable) says regional bias could not be excluded because the study included only patients from Germany, supporting a concern that its findings may be affected by bias. It does not identify referral bias; its mention of sampling error concerns negative confirmatory test results, not sampling bias in the study's findings. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
The APA syndrome may develop secondary to IE.
“To complicate matters, the APA syndrome may develop secondary to IE. 239”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [239] 239. Kupferwasser LI, Hafner G, Mohr-Kahaly S, Erbel R, Meyer J, Darius H. The presence of infection-related antiphospholipid antibodies in infec- tive endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol. 1999;33:1365-1371. source
- Premisecitation
Three studies that included 2 cohorts of patients with native valve and prosthetic valve infective endocarditis and 1 cohort with native valve infective endocarditis showed an association between early surgery and lower mortality in infective endocarditis patients in general or in specific subgroups such as those with heart failure or paravalvular complications.
“Three studies that included 2 cohorts of patients with NVE and PVE and 1 cohort with NVE showed an association between early surgery and lower mortality in IE patients in general or in specific subgroups of patients such as those with heart failure or paravalvular complications.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [10] 10. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005-1013. doi: 10.1161/CIRCULATIONAHA.109.86 source
- cites [11] 11. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239-2247. doi: 10.1001/jama.2011.1701. source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [14] 14. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115:1721-1728. doi: 10.1161/CIRCULATIONAHA.106.658831. source
- Premisecitation
Since 2007, at least 3 studies have documented the effect of survivor bias on the association between surgery and mortality in infective endocarditis patients.
“Since 2007, at least 3 studies 15,16,258 have documented the effect of survivor bias on the association between surgery and mortality in IE patients.”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [15] 15. Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F; AEPEI Study Group. The impact of valve surgery on short-and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32:2003-2015. doi: 10.1093/eurheartj/ehp008. source
- cites [16] 16. Sy RW, Bannon PG, Bayfield MS, Brown C, Kritharides L. Survivor treat- ment selection bias and outcomes research: a case study of surgery in infective endocarditis. Circ Cardiovasc Qual Outcomes. 2009;2:469-474. doi: 10.1161/CIRCOUTCOMES.109.857938. source
- cites [258] 258. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Montori VM, Hoskin TL, Enders F, Huskins WC, Mookadam F, Wilson WR, Zimmerman V, Baddour LM. Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. J Clin Epidemiol. 2010;63:130-135. doi: 10.1016/j. jclinepi.2008.06.022. source
- Premisecitation
Between 2007 and 2013, at least 6 observational studies that adjusted for selection bias, confounding, and survivor bias were conducted.
“Between 2007 and 2013, at least 6 observational studies 10,11,[14][15][16]259 that adjusted for selection bias, confounding, and survivor bias were conducted.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [10] 10. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005-1013. doi: 10.1161/CIRCULATIONAHA.109.86 source
- cites [11] 11. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239-2247. doi: 10.1001/jama.2011.1701. source
- cites [14] 14. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115:1721-1728. doi: 10.1161/CIRCULATIONAHA.106.658831. source
- Premisecitation
Risk stratification models such as the Society of Thoracic Surgeons Endocarditis Score are available to predict morbidity and mortality risks in infective endocarditis patients after valve surgery and to assist in decision making and patient counseling.
“Risk stratification models such as the Society of Thoracic Surgeons Endocarditis Score are available to predict morbidity and mortality risks in IE patients after valve surgery and to assist in decision making and patient counseling.260”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [260] 260. Gaca JG, Sheng S, Daneshmand MA, O'Brien S, Rankin JS, Brennan JM, Hughes GC, Glower DD, Gammie JS, Smith PK. Outcomes for endocarditis surgery in North America: a simplified risk scoring sys- tem. J Thorac Cardiovasc Surg. 2011;141:98-106.e1-e2. doi: 10.1016/j. jtcvs.2010.09.016. source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Premisecitation
In surveys involving population-based and international multicenter cohorts, approximately 50% of both native valve and prosthetic valve infective endocarditis patients undergo valve surgery during the active phase of infective endocarditis.
“In surveys involving populationbased 1 and international multicenter cohorts, 10,11 ≈50% of both NVE and PVE patients undergo valve surgery during the active phase of IE (during initial hospitalization before completion of a full therapeutic course of antibiotics).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [10] 10. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005-1013. doi: 10.1161/CIRCULATIONAHA.109.86 source
The Results report that 720 of 1,552 patients with native valve endocarditis (46%) underwent early surgery in the international multicenter cohort. The Methods state that patients with prosthetic valves were excluded, so this paper does not support the approximately 50% figure for prosthetic valve endocarditis. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [11] 11. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239-2247. doi: 10.1001/jama.2011.1701. source
The Results (page unavailable) report surgery during the initial hospitalization for 839 patients with heart failure and 1,168 without it—approximately 49% of the 4,075-patient international multicenter cohort. The paper does not establish that approximately 50% of native-valve patients and 50% of prosthetic-valve patients each underwent surgery, nor does this cohort establish the rate in population-based surveys. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
Data from nonrandomized trials from a single-center experience and an international collaboration support the notion that early valve surgery may not be beneficial in all patients with native or prosthetic valve infective endocarditis caused by S aureus.
“Data from nonrandomized trials from a single-center experience 250 and an international collaboration 251 support the notion 252 that early valve surgery may not be beneficial in all patients with native or PVE caused by S aureus.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [250] 250. Desch S, Freund A, de Waha S, Eitel I, Lurz P, Stiermaier T, Fuernau G, Schuler G, Thiele H. Outcome in patients with left-sided native- valve infective endocarditis and isolated large vegetations. Clin Cardiol. 2014;37:626-633. doi: 10.1002/clc.22315. source
The Abstract and Discussion report that surgery appeared to be associated with higher mortality in patients with left-sided native-valve endocarditis and isolated large vegetations, supporting the qualified notion that surgery may not benefit every patient. The study did not examine prosthetic-valve endocarditis or establish the surgery outcome specifically for patients with S. aureus infection; it included S. aureus blood-culture status as a predictor of mortality. Page numbers are not available for the decisive Abstract and Discussion passages in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [251] 251. Chirouze C, Alla F, Fowler VG Jr, Sexton DJ, Corey GR, Chu VH, Wang A, Erpelding ML, Durante-Mangoni E, Fernández-Hidalgo N, Giannitsioti E, Hannan MM, Lejko-Zupanc T, Miró JM, Muñoz P, Murdoch DR, Tattevin P, Tribouilloy C, Hoen B; ICE Prospective Investigators. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. Clin Infect Dis. 2015;60:741- 749. doi: 10.1093/cid/ciu871. source
- cites [252] 252. Karchmer AW, Bayer AS. Editorial commentary: surgical therapy for Staphylococcus aureus prosthetic valve endocarditis: proceed with cau- tion (caveat emptor). Clin Infect Dis. 2015;60:750-752. doi: 10.1093/ cid/ciu877. source
- Premisecitation
The high rates of postoperative morbidity and mortality seen in earlier studies have resulted in a reluctance to refer patients with infective endocarditis and acute stroke for immediate valve surgery.
“The high rates of postoperative morbidity and mortality seen in earlier studies [265][266][267] have resulted in a reluctance to refer patients with IE and acute stroke for immediate valve surgery.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [265] 265. Maruyama M, Kuriyama Y, Sawada T, Yamaguchi T, Fujita T, Omae T. Brain damage after open heart surgery in patients with acute cardioem- bolic stroke. Stroke. 1989;20:1305-1310. source
- cites [266] 266. Gillinov AM, Shah RV, Curtis WE, Stuart RS, Cameron DE, Baumgartner WA, Greene PS. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg. 1996;61:1125-1129. source
- cites [267] 267. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cere- bral complications: multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745-1755. source
The section on mortality of cardiac surgery reports earlier operative mortality of 10%–37% for early valve replacement. The introduction also describes concern about operating after a cerebrovascular event because bypass could worsen brain injury. The paper does not establish that those earlier rates caused clinicians to be reluctant to refer patients for immediate surgery. Page numbers are unavailable in our copy. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
The indications for surgery in infective endocarditis have not changed appreciably over time.
“Despite the availability of new studies, the indications for surgery have not changed appreciably over time.18”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [18] 18. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL; ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treat- ment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC): endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemother source
The section on indications and optimal timing of surgery lists heart failure, uncontrolled infection, and prevention of embolic events as the three main indications for early surgery (page unavailable). It does not compare surgical indications across time or say whether new studies changed them. Searches for unchanged indications and comparisons with previous guidelines found no passage addressing that temporal claim. (LLM, conf=0.70)
Experimental — accuracy not yet measured
- Premisecitation
Fifty of 61 patients (81.9%) with CT-verified preoperative stroke survived cardiac surgery.
“Fifty of the 61 patients (81.9%) with CT-verified preoperative stroke survived cardiac surgery.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [270] 270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099. doi: 10.1161/01. STR.0000229894.28591.3f. source
- Premisecitation
In a multicenter study of patients with hemorrhagic stroke, mortality was higher when surgery was performed within 4 weeks of the hemorrhagic event compared with later surgery (75% versus 40%).
“In a multicenter study of patients with hemorrhagic stroke, mortality was higher when surgery was performed within 4 weeks of the hemorrhagic event compared with later surgery (75% versus 40%, respectively).274”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [274] source
The Surgery and Neurological Complications section reports 3 deaths among 4 patients operated on within 2 weeks (75%) and 2 among 5 operated on after 21 days (40%). Table 6 uses the same time groups; the study does not establish the claimed comparison of surgery within 4 weeks versus later surgery. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
Investigations have suggested better outcomes for infective endocarditis patients with ischemic stroke who undergo early cardiac surgery.
“Investigations have suggested better outcomes for IE patients with ischemic stroke who undergo early cardiac surgery.[268][269][270][271][272]”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [268] 268. Cooper HA, Thompson EC, Laureno R, Fuisz A, Mark AS, Lin M, Goldstein SA. Subclinical brain embolization in left-sided infective endocarditis: results from the Evaluation by MRI of the Brains of Patients With Left-Sided Intracardiac Solid Masses (EMBOLISM) pilot study. Circulation. 2009;120:585-591. doi: 10.1161/CIRCULATIONAHA. 108.834432. source
Clinical Outcomes (p. 4) reports lower mortality among surgical patients in the overall left-sided infective endocarditis cohort, and the Discussion (p. 6) says early surgery was associated with reduced mortality. For patients with clinical stroke or subclinical brain embolization, the paper reports no postoperative neurological events after early surgery, but it does not establish better survival specifically for patients with ischemic stroke who undergo early surgery. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [269] 269. Hosono M, Sasaki Y, Hirai H, Sakaguchi M, Nakahira A, Seo H, Morisaki A, Suehiro S. Considerations in timing of surgical intervention for infec- tive endocarditis with cerebrovascular complications. J Heart Valve Dis. 2010;19:321-325.
- cites [270] 270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099. doi: 10.1161/01. STR.0000229894.28591.3f. source
The Discussion reports favorable neurological recovery after cardiac surgery and recommends early surgery for uncomplicated ischemic stroke. But Postoperative Neurological Recovery says surgery within four days versus later was not a relevant factor for neurological complications or recovery, so this study does not establish better outcomes from earlier surgery. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
Full neurological recovery was achieved in 70% of 50 stroke patients.
“Full neurological recovery was achieved in 70% of 50 stroke patients.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [270] 270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099. doi: 10.1161/01. STR.0000229894.28591.3f. source
- Premisecitation
Two independent studies have confirmed that the rate of embolic events decreases dramatically during and after the first 2 to 3 weeks of successful antibiotic therapy.
“Of note, 2 independent studies have confirmed that the rate of embolic events decreases dramatically during and after the first 2 to 3 weeks of successful antibiotic therapy.”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
Other studies suggest that the risk of neurological deterioration during cardiac surgery after a stroke is lower than previously assumed, particularly in patients with silent cerebrovascular emboli.
“Other studies [6][7][8] suggest that the risk of neurological deterioration during cardiac surgery after a stroke is lower than previously assumed, particularly in patients with silent cerebrovascular emboli.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [6] 6. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS; ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress [published correction appears in JAMA. 2005;294:900]. JAMA. 2005;293:3012-3021. doi: 10.1001/jama.293.24.3012. source
- cites [7] 7. Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B; AEPEI Study Group. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54:1230-1239. doi: 10.1093/cid/cis199. source
- cites [8] 8. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infec- tive endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463- 473. doi: 10.1001/archinternmed.2008.603. source
The Results and In-Hospital Mortality sections (page numbers unavailable) report that surgery was associated with lower in-hospital mortality in patients with infective endocarditis. They do not assess neurological deterioration during surgery after stroke or outcomes in patients with silent cerebrovascular emboli. Searches for those terms found no passage addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Several studies with transthoracic echocardiography have demonstrated a trend toward higher embolic rates with left-sided vegetations greater than 1 cm in diameter.
“Several studies with TTE have demonstrated a trend toward higher embolic rates with left-sided vegetations >1 cm in diameter.55”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [55] 55. Sanfilippo AJ, Picard MH, Newell JB, Rosas E, Davidoff R, Thomas JD, Weyman AE. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol. 1991;18:1191-1199. source
In Echocardiographic Findings (page unavailable), the paper says vegetation size helps identify patients with native left-sided valve endocarditis at risk of complications, and it includes embolization among the complications assessed. The passages do not establish a higher embolic rate specifically for vegetations greater than 1 cm. (LLM, conf=0.79)
Experimental — accuracy not yet measured
- Premisecitation
Systemic embolization occurs in 22% to 50% of cases of infective endocarditis.
“Systemic embolization occurs in 22% to 50% of cases of IE. 55,57,[274][275][276][277]”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [55] 55. Sanfilippo AJ, Picard MH, Newell JB, Rosas E, Davidoff R, Thomas JD, Weyman AE. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol. 1991;18:1191-1199. source
The paper’s clinical-event definitions include systemic embolization, but the passages available from our copy do not give its frequency. Searches for the 22%–50% range and for embolization rates in the Results and Table 2 did not locate a supporting figure. (LLM, conf=0.72)
Experimental — accuracy not yet measured - cites [57] 57. Mügge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infec- tive endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989;14:631-638. doi: 10.1016/0735-1097(89)90104-6. source
- cites [274] source
The Discussion reports 25% neurological complications and 19% vascular events in this cohort, not a rate of systemic embolization. A search for the 22%–50% range and for systemic embolization incidence found no passage in our copy that supports the claimed range. (LLM, conf=0.73)
Experimental — accuracy not yet measured
- Premisecitation
A randomized trial compared oral aspirin 325 mg/d with placebo in 115 infective endocarditis patients.
“a randomized trial compared oral aspirin 325 mg/d with placebo in 115 IE patients.288”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [288] 288. Chan KL, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek MA, Robinson TI, Moher D; Investigators of the Multicenter Aspirin Study in Infective Endocarditis. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42:775-780. source
- Premisecitation
The benefits of early surgery were demonstrated in the prospective, randomized trial discussed earlier.
“The benefits of early surgery were demonstrated in the prospective, randomized trial 12 that was discussed earlier in this document.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [12] 12. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA. Infective endocarditis: diagno- sis, antimicrobial therapy, and management of complications: a state- ment for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American source
The Risk of Embolization section says the benefit of surgery to avoid catastrophic embolic events is greatest early in the treatment of infective endocarditis. It does not say that a prospective randomized trial demonstrated that benefit; that part of the claim is unsupported by this source. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
The traditional indication for valvular surgery for infective endocarditis to avoid embolization has been at least 2 major embolic events.
“The traditional indication for valvular surgery for IE to avoid embolization has been ≥2 major embolic events.284”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [284] source
The Discussion (page unavailable in our copy) says recurrent embolic events are a recognized indication for surgery in infective endocarditis, which supports the idea of more than one event. It does not specify that the events must be major or state a formal threshold of at least two major events. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Only aortic valve involvement and current IDU have been prospectively identified as independent risk factors for perivalvular abscess.
“Only aortic valve involvement and current IDU have been prospectively identified as independent risk factors for perivalvular abscess.297”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [297] 297. Middlemost S, Wisenbaugh T, Meyerowitz C, Teeger S, Essop R, Skoularigis J, Cronje S, Sareli P. A case for early surgery in native left- sided endocarditis complicated by heart failure: results in 203 patients. J Am Coll Cardiol. 1991;18:663-667. source
The Results (page unavailable in our copy) report abscesses in 38 of 110 patients with aortic valve infection, compared with 1 of 30 with mitral valve infection. This supports an association with aortic valve involvement, but the passages do not identify it as an independent risk factor or identify current injection drug use as one. Searches for drug use, prospective analysis, and independent risk factors found no supporting passage. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
The size of vegetations is not helpful for predicting perivalvular extension.
“The size of vegetations is not helpful for predicting perivalvular extension.297”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [297] 297. Middlemost S, Wisenbaugh T, Meyerowitz C, Teeger S, Essop R, Skoularigis J, Cronje S, Sareli P. A case for early surgery in native left- sided endocarditis complicated by heart failure: results in 203 patients. J Am Coll Cardiol. 1991;18:663-667. source
The Methods describe identifying vegetations by echocardiography, and the Results and Discussion report extensive infection and abscesses. None of the passages found assesses whether vegetation size predicts perivalvular extension (searched for vegetation size, abscesses, and extensive infection). Page numbers were not available in our copy. (LLM, conf=0.72)
Experimental — accuracy not yet measured
- Premisecitation
Homografts have a constant but low incidence rate of IE.
“Homografts have a constant but low incidence rate of IE. 312”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [312] source
- Premisecitation
The sensitivity of TTE for detecting perivalvular abscess is low (18% to 63% in prospective and retrospective studies, respectively).
“The sensitivity of TTE for detecting perivalvular abscess is low (18% to 63% in prospective and retrospective studies, respectively).305,306”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [305] source
The PREVIOUS ECHOCARDIOGRAPHIC STUDIES section reports low TTE sensitivity for detecting aortic root abscess, but gives a range of 18%–67%, not 18%–63%, and does not assign those values to prospective and retrospective studies. The PREOPERATIVE ECHOCARDIOGRAPHIC FINDINGS section reports 36% sensitivity in this paper’s own patients. Page numbers were not available in our copy. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [306] source
- Premisecitation
A small number of patients with periannular extension of infection or myocardial abscess may be treated successfully without surgical intervention.
“A small number of patients with periannular extension of infection or myocardial abscess may be treated successfully without surgical intervention.307,308”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [307] source
The Discussion reports successful antibiotic treatment of a mitral anular (perivalvular) abscess, supporting the claim that some patients can avoid surgery for the abscess. It does not report a medically cured myocardial abscess. The patient also underwent a subxiphoid pericardiectomy for a pericardial effusion, so the unqualified phrase “without surgical intervention” is not accurate for this case. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [308] source
- Premisecitation
Current evidence suggests that poor oral hygiene and periodontal diseases, not dental office procedures, are likely responsible for the vast majority of cases of IE that originate in the mouth.
“Current evidence suggests that poor oral hygiene and periodontal diseases, not dental office procedures, are likely to be responsible for the vast majority of cases of IE that originate in the mouth.328”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [328] source
- Premisecitation
A large, prospective study demonstrated a strong association between 3 indexes of oral hygiene and gingival disease and the incidence of bacteremia from IE-related species.
“A large, prospective study demonstrated a strong association between 3 indexes of oral hygiene and gingival disease and the incidence of bacteremia from IE-related species.327”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [327] source
- Findingnone given
Valve lesions in right-sided infective endocarditis usually do not create the peripheral emboli and immunological vascular phenomena that can result from left-sided valvular involvement.
“valve lesions in right-sided IE usually do not create the peripheral emboli and immunological vascular phenomena that can result from left-sided valvular involvement.”
Quote in the paperNot a substantial claim - Findingreasoning
Acute infective endocarditis may evolve too quickly for the development of immunological vascular phenomena.
“Acute IE may evolve too quickly for the development of immunological vascular phenomena, which are more characteristic of the later stages of the more insidious subacute form of untreated IE.”
Quote in the paperNot a substantial claim - Findingnone given
The diagnosis of infective endocarditis is straightforward in the minority of patients who present with a consistent history and classic oslerian manifestations.
“The diagnosis of IE is straightforward in the minority of patients who present with a consistent history and classic oslerian manifestations: sustained bacteremia or fungemia, evidence of active valvulitis, peripheral emboli, and immunological vascular phenomena.”
Quote in the paperNot a substantial claim - Findingreasoning
Staphylococcus aureus is now the most common causative organism of infective endocarditis in most of the industrialized world.
“S aureus is now the most common causative organism in most of the industrialized world.”
Quote in the paperNot a substantial claim - Findingown data
Follow-up in patients reclassified as rejected for infective endocarditis by the diagnostic floor documented the specificity of this diagnostic schema because no patients developed infective endocarditis during the subsequent 12 weeks of observation.
“Follow-up in these reclassified patients documented the specificity of this diagnostic schema because no patients developed IE during the subsequent 12 weeks of observation.”
Quote in the paperSubstantial claim - Findingcitation
In an analysis of 262 patients at the Duke University Medical Center who had hospital-acquired Staphylococcus aureus bacteremia, 34 (13%) were subsequently diagnosed with definite infective endocarditis.
“In an analysis of 262 patients at the Duke University Medical Center who had hospital-acquired S aureus bacteremia, 34 (13%) were subsequently diagnosed with definite IE.”
Quote in the paperSubstantial claim - Findingcitation
The incidence of infective endocarditis caused by Staphylococcus aureus has increased.
“the incidence of IE caused by Staphylococcus aureus has increased”
Quote in the paperNot a substantial claim - Findingreasoning
In most patients with infective endocarditis, textbook history and physical examination findings may be few or absent.
“In most patients, however, the”
Quote in the paperSubstantial claim - Findingcitation
Infective endocarditis caused by Bartonella and Chlamydia species often are indistinguishable in serological test results because of cross-reactions.
“IE caused by Bartonella and Chlamydia species often are indistinguishable in serological test results because of cross-reactions.41”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] 41. Raoult D, Fournier PE, Drancourt M, Marrie TJ, Etienne J, Cosserat J, Cacoub P, Poinsignon Y, Leclercq P, Sefton AM. Diagnosis of 22 new cases of Bartonella endocarditis [published correction appears in Ann Intern Med. 1997;127:249]. Ann Intern Med. 1996;125:646-652. source
- Findingcitation
Low sensitivity is a major limitation of polymerase chain reaction unless cardiac valvular tissue is available for testing.
“Low sensitivity is a major limitation of PCR unless cardiac valvular tissue is available for testing.[42][43][44][45]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42][43][44][45]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
The epidemiological profile of infective endocarditis has changed substantially.
“Epidemiological surveys from France and the International Collaboration on Endocarditis have confirmed that the epidemiological profile of IE has changed substantially.”
Quote in the paperNot a substantial claim - Findingcitation
In a study of 100 consecutive cases of pathologically proven native valve infective endocarditis, inclusion of elevated erythrocyte sedimentation rate or C-reactive protein, newly diagnosed clubbing, splenomegaly, and microscopic hematuria with the existing Duke minor criteria resulted in a 10% increase in the frequency of cases being deemed clinically definite, with no loss of specificity.
“In a study of 100 consecutive cases of pathologically proven native valve IE (NVE), inclusion of these additional parameters with the existing Duke minor criteria resulted in a 10% increase in the frequency of cases being deemed clinically definite, with no loss of specificity.”
Quote in the paperSubstantial claim - Findingcitation
The greatest risk of embolic complications appears to occur with large (≥10 mm) vegetations on the anterior mitral leaflet.
“The greatest risk of embolic complications appears to occur with large (≥10 mm) vegetations on the anterior mitral leaflet.58”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] 58. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, Giuliani ER, Wilson WR. Emboli in infective endocarditis: the prognos- tic value of echocardiography. Ann Intern Med. 1991;114:635-640. Doi: 10.7326/0003-4819-114-8-635. source
- Findingcitation
Magnetic resonance imaging has had a major impact on infective endocarditis diagnosis and management, especially as a tool to detect cerebral embolic events, many of which are clinically silent.
“MRI has had a major impact on IE diagnosis and management, especially as a tool to detect cerebral embolic events, many of which are clinically silent.69”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] 69. Duval X, Iung B, Klein I, Brochet E, Thabut G, Arnoult F, Lepage L, Laissy JP, Wolff M, Leport C; IMAGE (Resonance Magnetic Imaging at the Acute Phase of Endocarditis) Study Group. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocardi- tis: a prospective study. Ann Intern Med. 2010;152:497-504, W175. doi: 10.7326/0003-4819-152-8-201004200-00006. source
- Findingcitation
The ability of echocardiographic features to predict embolic events is limited.
“The ability of echocardiographic features to predict embolic events is limited.[55][56][57]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55][56][57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Both transesophageal and transthoracic echocardiography may produce false-negative results if vegetations are small or have embolized.
“Both TEE and TTE may produce false-negative results if vegetations are small or have embolized.53”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] 53. Bayer AS. Infective endocarditis. Clin Infect Dis. 1993;17:313-320; quiz 321. source
- Findingcitation
In an in vitro PD model, the activity of vancomycin against heterogeneous vancomycin-intermediate S aureus (hVISA) and non-hVISA isolates was reduced in the presence of a high inoculum amount (10^8 CFU/mL).
“For example, in an in vitro PD model, the activity of vancomycin against heterogeneous vancomycin-intermediate S aureus (hVISA) and non-hVISA isolates was reduced in the presence of a high inoculum amount (10 8 colony-forming units per milliliter).75”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] 75. Rose WE, Leonard SN, Rossi KL, Kaatz GW, Rybak MJ. Impact of inoc- ulum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2009;53:805-807. doi: 10.1128/AAC.01009-08. source
- Findingcitation
Investigation in adults has shown transesophageal echocardiography to be significantly more sensitive than transthoracic echocardiography for the detection of vegetations and abscesses.
“Investigation in adults has shown TEE to be significantly more sensitive than TTE for the detection of vegetations and abscesses.47”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] 47. Reynolds HR, Jagen MA, Tunick PA, Kronzon I. Sensitivity of transtho- racic versus transesophageal echocardiography for the detection of native valve vegetations in the modern era. J Am Soc Echocardiogr. 2003;16:67- 70. doi: 10.1067/mje.2003.43. source
- Interpretationcitation
Specific serological data as a surrogate marker for positive blood cultures have now been included in the Duke criteria.
“On the basis of these data, specific serological data as a surrogate marker for positive blood cultures have now been included in the Duke criteria.”
Quote in the paperSubstantial claim - Premisecitation
In the original Duke criteria, bacteremia resulting from Staphylococcus aureus or enterococci was considered to fulfill a major criterion only if it was community acquired because literature suggested that this parameter was an important surrogate marker for underlying infective endocarditis.
“In the original Duke criteria, bacteremia resulting from S aureus or enterococci was considered to fulfill a major criterion only if it was community acquired because ample literature suggested that this parameter was an important surrogate marker for underlying IE.27”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] 27. Bayer AS, Ward JI, Ginzton LE, Shapiro SM. Evaluation of new clini- cal criteria for the diagnosis of infective endocarditis. Am J Med. 1994;96:211-219. source
- Interpretationnone given
The emergence of Staphylococcus aureus infective endocarditis is due in part to the increasing importance of healthcare contact as a leading risk associated with infection.
“The emergence of S aureus IE is due in part to the increasing importance of healthcare contact as a leading risk associated with infection.”
Quote in the paperNot a substantial claim - Premisenone given
The Duke criteria incorporated echocardiographic findings into the diagnostic strategy.
“The Duke criteria incorporated echocardiographic findings into the diagnostic strategy (Tables 2 and 3; see the Echocardiography section).”
Quote in the paperNot a substantial claim - Premisenone given
Rapid detection of pathogens from valve tissue from patients undergoing surgery for infective endocarditis by polymerase chain reaction has been validated.
“the rapid detection of pathogens from valve tissue from patients undergoing surgery for IE by polymerase chain reaction (PCR) has been validated.”
Quote in the paperNot a substantial claim - Premisecitation
In 1994, Durack and colleagues proposed a diagnostic schema that stratified patients with suspected infective endocarditis into definite, possible, and rejected cases.
“In 1994, Durack and colleagues 23 from the Duke University Medical Center proposed a diagnostic schema that stratified patients with suspected IE into 3 categories: definite, possible, and rejected cases (Tables 2 and 3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] 23. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infec- tive endocarditis: utilization of specific echocardiographic findings: Duke Endocarditis Service. Am J Med. 1994;96:200-209. source
- Premisecitation
Several rigorously conducted observational studies and a randomized controlled trial have examined the impact and timing of valve surgery in infective endocarditis management.
“Several rigorously conducted observational studies 11,[14][15][16] and a randomized, controlled trial 17 have examined the impact and timing of valve surgery in IE management.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites 11,[14][15][16]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
- Premisecitation
Fluoroquinolones and aminoglycoside antibiotics are less affected by the size of the inoculum because of their different mechanisms of bactericidal activity.
“Importantly, fluoroquinolones and aminoglycoside antibiotics are less affected by the size of the inoculum because of their different mechanisms of bactericidal activity. 81,82”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [81] 81. LaPlante KL, Woodmansee S. Activities of daptomycin and vancomy- cin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob Agents Chemother. 2009;53:3880-3886. doi: 10.1128/AAC.00134-09. source
- cites [82] 82. Mizunaga S, Kamiyama T, Fukuda Y, Takahata M, Mitsuyama J. Influence of inoculum size of Staphylococcus aureus and Pseudomonas aerugi- nosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems. J Antimicrob Chemother. 2005;56:91-96. doi: 10.1093/jac/ dki163. source
- Interpretationreasoning
Bacteria that are otherwise killed at low densities by bactericidal antibiotics such as penicillins can be relatively resistant to or tolerant of their bactericidal effect in dense populations.
“In addition, bacteria that are otherwise killed at low densities by bactericidal antibiotics such as penicillins can be relatively resistant to or tolerant of their bactericidal effect in dense populations.”
Quote in the paperSubstantial claim - Interpretationreasoning
Prolonged, parenteral, bactericidal therapy is required for attempted infection cure.
“Therefore, prolonged, parenteral, bactericidal therapy is required for attempted infection cure.”
Quote in the paperSubstantial claim- Rests on an assumption: Host characteristics such as impaired immunity contribute to challenges in treating IE.
- Rests on an assumption: Antibiotics may fail to eradicate infection as a result of increased binding of the drug to serum proteins, perturbations of antibiotic penetration into the vegetation, and unique antibiotic PK/PD features.
- Interpretationreasoning
On the basis of the weight of clinical evidence involving nearly 2000 patients, patients suspected of having infective endocarditis should be clinically evaluated with the modified Duke criteria as the primary diagnostic schema.
“Thus, on the basis of the weight of clinical evidence involving nearly 2000 patients in the current literature, it appears that patients suspected of having IE should be clinically evaluated, with the modified Duke criteria as the primary diagnostic schema.”
Quote in the paperSubstantial claim - Premisecitation
Cost-effectiveness calculations suggest that transesophageal echocardiography should be the first examination in adults with suspected infective endocarditis, particularly in the setting of staphylococcal bacteremia.
“cost-effectiveness calculations suggest that TEE should be the first examination in adults with suspected IE (Table 4), particularly in the setting of staphylococcal bacteremia, 49,50”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [49] 49. Heidenreich PA, Masoudi FA, Maini B, Chou TM, Foster E, Schiller NB, Owens DK. Echocardiography in patients with suspected endocarditis: a cost-effectiveness analysis. Am J Med. 1999;107:198-208. source
- cites [50] 50. Lindner JR, Case RA, Dent JM, Abbott RD, Scheld WM, Kaul S. Diagnostic value of echocardiography in suspected endocarditis: an evaluation based on the pretest probability of disease. Circulation. 1996;93:730-736. source
- Interpretationreasoning
Because infective endocarditis is a heterogeneous disease with highly variable clinical presentations, the use of the Duke criteria alone will never suffice.
“Because IE is a heterogeneous disease with highly variable clinical presentations, the use of these criteria alone will never suffice.”
Quote in the paperSubstantial claim - Interpretationreasoning
The effective MIC at the site of infection with bacterial densities of 10^8 to 10^11 CFU per 1 g tissue can be much higher than anticipated by in vitro susceptibility tests that use a standard inoculum of 10^5.5 CFU/mL.
“Therefore, the effective minimum inhibitory concentration (MIC) at the site of infection with bacterial densities of 10 8 to 10 11 colony-forming units per 1 g tissue can be much higher than anticipated by in vitro susceptibility tests that use a standard inoculum (10 5.5 colony-forming units per milliliter).”
Quote in the paperSubstantial claim - Premisecitation
Data from animal models of IE and clinical investigations support the need for bactericidal antibiotics to sterilize vegetations in IE with high bacterial densities.
“Data from animal models of IE and clinical investigations support the need for bactericidal antibiotics to sterilize vegetations in IE with high bacterial densities.89”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] 89. Hunter TH. Speculations on the mechanism of cure of bacterial endocar- ditis. J Am Med Assoc. 1950;144:524-527. source
- Premisenone given
Stationary-phase organisms have been associated with a loss of penicillin-binding proteins that are the active target sites required for β-lactam antibacterial activity.
“Stationary-phase organisms have been associated with a loss of penicillin-binding proteins that are the active target sites required for β-lactam antibacterial activity.”
Quote in the paperSubstantial claim - Interpretationreasoning
Prolonged therapy is necessary because of the high bacterial densities within vegetations and the relatively slow bactericidal activity of some antibiotics such as β-lactams and vancomycin.
“Prolonged therapy is necessary because of the high bacterial densities within vegetations and the relatively slow bactericidal activity of some antibiotics such as β-lactams and vancomycin.”
Quote in the paperSubstantial claim - Interpretationnone given
High inocula are more likely to have antibiotic-resistant subpopulations that can emerge in the setting of antibiotic therapy.
“High inocula are also more likely to have antibiotic-resistant subpopulations that can emerge in the setting of antibiotic therapy.”
Quote in the paperNot a substantial claim - Premisecitation
In each of two studies of predominantly oral four-week regimens, including one in which more than 70% of patients were HIV seropositive, cure rates were greater than 90%.
“In each study, including one in which >70% of patients were HIV seropositive, 150 cure rates were >90%.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [150] 150. Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ, Sisson SD, Tidmore WC, vom Eigen KA, Goodman SN, Lietman PS, Petty BG, Flexner C. Oral antibiotic treatment of right-sided staphy- lococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med. 1996;101:68-76. source
- cites [151] 151. Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with cipro- floxacin and rifampicin. Lancet. 1989;2:1071-1073. source
- Premisecitation
In IDUs with uncomplicated right-sided S aureus infective endocarditis, combined short-course two-week beta-lactam plus aminoglycoside therapy was highly effective in several studies.
“For example, in IDUs with uncomplicated right-sided S aureus IE (no evidence of renal failure, extrapulmonary metastatic infections, aortic or mitral valve involvement, meningitis, or infection by MRSA), combined short-course (2 weeks) β-lactam plus aminoglycoside therapy was highly effective in several studies.91,92,148”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [91] 91. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988;109:619-624. source
- cites [92] 92. Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez- Alujas T, Almirante B, Ocaña I, Pahissa A. Effectiveness of cloxacil- lin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: a randomized, controlled trial. Ann Intern Med. 1996;125:969-974. source
- cites [148] 148. Fortún J, Navas E, Martínez-Beltrán J, Pérez-Molina J, Martín-Dávila P, Guerrero A, Moreno S. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glyco- peptides in combination with gentamicin. Clin Infect Dis. 2001;33:120- 125. doi: 10.1086/320869. source
- Premisecitation
The penetration of antibiotics is a significant issue in the treatment of IE because cardiac vegetations, which are composed of layers of fibrin and platelets, pose a considerable mechanical barrier between the antibiotic and the embedded targeted microorganisms.
“The penetration of antibiotics is a significant issue in the treatment of IE because cardiac vegetations, which are composed of layers of fibrin and platelets, pose a considerable mechanical barrier between the antibiotic and the embedded targeted microorganisms.94,95”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [94] 94. Carbon C, Crémieux AC, Fantin B. Pharmacokinetic and pharmacody- namic aspects of therapy of experimental endocarditis. Infect Dis Clin North Am. 1993;7:37-51. source
- cites [95] 95. Cremieux AC, Maziere B, Vallois JM, Ottaviani M, Azancot A, Raffoul H, Bouvet A, Pocidalo JJ, Carbon C. Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J Infect Dis. 1989;159:938-944. source
- Premisecitation
Short-course regimens with glycopeptides such as teicoplanin or vancomycin plus gentamicin appeared less effective for right-sided S aureus infective endocarditis caused by MSSA or MRSA strains.
“In contrast, short-course regimens with glycopeptides (teicoplanin or vancomycin) plus gentamicin appeared to be less effective for right-sided S aureus IE caused by either MSSA or MRSA strains.148”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [148] 148. Fortún J, Navas E, Martínez-Beltrán J, Pérez-Molina J, Martín-Dávila P, Guerrero A, Moreno S. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glyco- peptides in combination with gentamicin. Clin Infect Dis. 2001;33:120- 125. doi: 10.1086/320869. source
- Premisecitation
Nafcillin-gentamicin combination therapy increased the frequency of gentamicin-associated nephrotoxicity.
“Furthermore, combination therapy increased the frequency of gentamicin-associated nephrotoxicity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [153] 153. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to paren- teral drugs and in nonaddicts: a prospective study. Ann Intern Med. 1982;97:496-503. source
- Interpretationreasoning
Glycopeptide therapy for MRSA right-sided infective endocarditis may require more prolonged treatment regimens.
“In contrast, glycopeptide therapy for MRSA right-sided IE may require more prolonged treatment regimens.”
Quote in the paperSubstantial claim - Premisecitation
A two-week monotherapy regimen of intravenous cloxacillin was equivalent to cloxacillin plus gentamicin administered for two weeks.
“For example, 1 study showed that a 2-week monotherapy regimen of intravenous cloxacillin was equivalent to cloxacillin plus gentamicin administered for 2 weeks.92”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] 92. Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez- Alujas T, Almirante B, Ocaña I, Pahissa A. Effectiveness of cloxacil- lin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: a randomized, controlled trial. Ann Intern Med. 1996;125:969-974. source
- Premisecitation
High but still susceptible vancomycin MICs in S aureus are associated with worse clinical outcome in MRSA infections treated with vancomycin.
“An increasing body of evidence suggests an association between high (but still susceptible on the basis of the Clinical and Laboratory Standards Institute definition) vancomycin MICs in S aureus and worse clinical outcome in both MRSA infections treated with vancomycin 140”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] 140. van Hal SJ, Lodise TP, Paterson DL. The clinical significance of van- comycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis. 2012;54:755-771. doi: 10.1093/cid/cir935. source
- Premisecitation
S aureus is the most common cause of infective endocarditis in much of the developed world.
“S aureus is the most common cause of IE in much of the developed world.[6][7][8]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6][7][8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The association between higher vancomycin MIC in infecting MSSA and worse clinical outcomes among patients treated with antistaphylococcal penicillins was externally validated in a large cohort of patients with MSSA infective endocarditis.
“Importantly, this association between higher vancomycin MIC in infecting MSSA and worse clinical outcomes among patients treated with antistaphylococcal penicillins (not vancomycin) was externally validated in a large cohort of patients with MSSA IE. 142”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [142] 142. Cervera C, Castañeda X, de la Maria CG, del Rio A, Moreno A, Soy D, Pericas JM, Falces C, Armero Y, Almela M, Ninot S, Pare JC, Mestres CA, Gatell JM, Marco F, Miro JM; Hospital Clinic Endocarditis Study Group. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis. Clin Infect Dis. 2014;58:1668-1675. doi: 10.1093/cid/ciu183. source
- Premisecitation
The efficacy of antimicrobial drugs varies, depending on the degree of penetration into the vegetation, pattern of distribution within the vegetation, and vegetation size.
“The efficacy of antimicrobial drugs varies, depending on the degree of penetration into the vegetation, pattern of distribution within the vegetation, and vegetation size. 96,97”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [96] 96. Crémieux AC, Mazière B, Vallois JM, Ottaviani M, Bouvet A, Pocidalo JJ, Carbon C. Ceftriaxone diffusion into cardiac fibrin vegetation: quali- tative and quantitative evaluation by autoradiography. Fundam Clin Pharmacol. 1991;5:53-60. source
- cites [97] 97. Cremieux AC, Saleh-Mghir A, Vallois JM, Maziere B, Muffat-Joly M, Devine C, Bouvet A, Pocidalo JJ, Carbon C. Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradio- graphic diffusion pattern of [14C]temafloxacin in cardiac vegetations. Antimicrob Agents Chemother. 1992;36:2216-2221. source
- Premisecitation
Data from more than 70 million hospitalizations in the United States suggest that rates of S aureus infective endocarditis have increased significantly relative to other causes of infective endocarditis.
“Data from >70 million hospitalizations in the United States suggest that rates of S aureus IE have increased significantly relative to other causes of IE. 3”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] 3. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med. 2012;172:363-365. doi: 10.1001/ archinternmed.2011.1027.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
S lugdunensis is uniformly susceptible in vitro to most antibiotics.
“This organism is uniformly susceptible in vitro to most antibiotics.[143][144][145]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [143][144][145]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Nafcillin-gentamicin therapy reduced the duration of bacteremia by approximately one day compared with nafcillin monotherapy.
“Nafcillin-gentamicin therapy reduced the duration of bacteremia by ≈1 day compared with nafcillin monotherapy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [153] 153. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to paren- teral drugs and in nonaddicts: a prospective study. Ann Intern Med. 1982;97:496-503. source
- Premisecitation
High vancomycin MICs in S aureus are associated with worse clinical outcome in MRSA bacteremia treated with antistaphylococcal penicillins.
“and MRSA bacteremia treated with antistaphylococcal penicillins.141”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [141] 141. Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MV, Anderson TL, Roberts SA, Gao W, Christiansen KJ, Coombs GW, Johnson PD, Howden BP. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacte- remia and high vancomycin minimum inhibitory concentrations. J Infect Dis. 2011;204:340-347. doi: 10.1093/infdis/jir270. source
- Premisecitation
Two studies have evaluated predominantly oral four-week antibiotic regimens featuring ciprofloxacin plus rifampin for uncomplicated right-sided MSSA infective endocarditis in IDUs.
“Two studies have evaluated the use of predominantly oral 4-week antibiotic regimens (featuring ciprofloxacin plus rifampin) for the therapy of uncomplicated right-sided MSSA IE in IDUs.150,151”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [150] 150. Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ, Sisson SD, Tidmore WC, vom Eigen KA, Goodman SN, Lietman PS, Petty BG, Flexner C. Oral antibiotic treatment of right-sided staphy- lococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med. 1996;101:68-76. source
- cites [151] 151. Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with cipro- floxacin and rifampicin. Lancet. 1989;2:1071-1073. source
- Interpretationreasoning
Glycopeptides may be less effective for right-sided S aureus infective endocarditis because of limited bactericidal activity, poor penetration into vegetations, or increased drug clearance among IDUs.
“These glycopeptides may be less effective because of limited bactericidal activity, poor penetration into vegetations, or increased drug clearance among IDUs.”
Quote in the paperSubstantial claim - Premisecitation
In one study, 92 patients given combination therapy for right-sided S aureus infective endocarditis had excellent outcomes, including HIV-infected patients and those with large tricuspid valve vegetations greater than 10 mm.
“In 1 study, 92 patients provided such combination therapy had excellent outcomes, even HIV-infected patients and those who had large tricuspid valve vegetations (>10 mm in diameter).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] 92. Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez- Alujas T, Almirante B, Ocaña I, Pahissa A. Effectiveness of cloxacil- lin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: a randomized, controlled trial. Ann Intern Med. 1996;125:969-974. source
- Interpretationreasoning
Current evidence suggests that either parenteral beta-lactam or daptomycin short-course therapy is adequate for the treatment of uncomplicated MSSA right-sided infective endocarditis.
“Thus, current evidence suggests that either parenteral β-lactam or daptomycin short-course therapy is adequate for the treatment of uncomplicated MSSA right-sided IE.”
Quote in the paperSubstantial claim - Premisecitation
In a single noncomparative study, a similar cure rate was reported for streptomycin- and gentamicin-containing regimens.
“Although there are no published studies comparing the efficacy of regimens containing streptomycin or gentamicin, a similar cure rate was reported in a single noncomparative study.197”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [197] source
- Premisecitation
In a prospective study, patients with native valve E faecalis IE and ≥3 months' duration of symptoms were successfully treated with 6 weeks of therapy.
“Patients with ≥3 months' duration of symptoms were successfully treated with 6 weeks of therapy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [196] source
- Interpretationcitation
The potential effectiveness of daptomycin plus a beta-lactam may be due in part to the capacity of the beta-lactam agent to alter the surface charge of the organism in a nonbactericidal mechanism, allowing enhanced surface binding of daptomycin.
“The potential effectiveness of this combination may be due in part to the capacity of the β-lactam agent to alter the surface charge of the organism October 13, 2015 in a nonbactericidal mechanism, allowing enhanced surface binding of daptomycin.[169][170][171]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [169][170][171]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Early cardiac surgical interventions play an important role in maximizing outcomes in S aureus prosthetic valve infective endocarditis, especially in the presence of heart failure.
“Early cardiac surgical interventions play an important role in maximizing outcomes in S aureus PVE, 186 especially in the presence of heart failure.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [186] 186. John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcus aureus prosthetic valve endocarditis: optimal manage- ment and risk factors for death. Clin Infect Dis. 1998;26:1302-1309. source
- Premisecitation
Daptomycin is inhibited by pulmonary surfactant.
“Daptomycin is inhibited by pulmonary surfactant 160 and thus is contraindicated in the treatment of S aureus pneumonia acquired via the aspiration route.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [160] 160. Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J. Inhibition of dap- tomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005;191:2149-2152. doi: 10.1086/430352. source
- Premisecitation
Several case series suggest that ceftaroline may have utility in complicated S aureus infections, including infective endocarditis.
“Several case series suggest that it may have utility in complicated S aureus infections, including IE. [179][180][181]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [179][180][181]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In the study by Gavaldà et al, approximately half of the patients had infective endocarditis caused by high-level aminoglycoside-resistant strains of E faecalis.
“In the study by Gavaldà et al,190 approximately half of the patients had IE caused by highlevel aminoglycoside-resistant strains of E faecalis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
- Premisecitation
A prospective trial in patients with infective endocarditis caused by MRSA failed to demonstrate that the addition of rifampin to vancomycin either enhanced survival or reduced the duration of bacteremia compared with vancomycin alone.
“Of note, a prospective trial in patients with IE caused by MRSA failed to demonstrate that the addition of rifampin to vancomycin either enhanced survival or reduced the duration of bacteremia compared with treatment with vancomycin alone.163”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [163] 163. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med. 1991;115:674-680. source
- Premisecitation
Markowitz et al showed that trimethoprim-sulfamethoxazole was inferior to vancomycin in the treatment of invasive S aureus infections.
“Although Markowitz et al 165 showed that trimethoprimsulfamethoxazole was inferior to vancomycin in the treatment of invasive S aureus infections, it is sometimes used in salvage situations.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [165] 165. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim- sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med. 1992;117:390-398. doi: 10.7326/0003-4819-117-5-390. source
- Premisecitation
Prosthetic valve infective endocarditis, particularly when onset is within 12 months of cardiac valve implantation and an aortic valve prosthesis is involved, is frequently complicated by perivalvular or myocardial abscesses or valvular dysfunction.
“PVE, particularly when onset is within 12 months of cardiac valve implantation and an aortic valve prosthesis is involved, is frequently complicated by perivalvular or myocardial abscesses or valvular dysfunction.136”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [136] 136. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabé J, Morris A, Corey GR, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of pros- thetic valve endocarditis. JAMA. 2007;297:1354-1361. doi: 10.1001/ jama.297.12.1354. source
- Interpretationreasoning
In these situations, the potential risk of attempting to complete a 4- to 6-week course of gentamicin therapy may exceed the benefit.
“In these situations, the potential risk of attempting to complete a 4-to 6-week course of gentamicin therapy may exceed the benefit.193”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [193] source
- Premisecitation
Patient outcomes with linezolid therapy for S aureus left-sided infective endocarditis have generally been poor.
“Patient outcomes with linezolid therapy for S aureus left-sided IE have generally been poor.[174][175][176]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [174][175][176]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
The efficacy of trimethoprim-sulfamethoxazole and other folate antagonists may be attenuated by thymidine release from damaged host cells, such as at sites of tissue damage like abscesses.
“The efficacy of trimethoprimsulfamethoxazole and other folate antagonists may be attenuated by thymidine release from damaged host cells (eg, at sites of tissue damage such as abscesses).166”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [166] 166. Proctor RA. Role of folate antagonists in the treatment of methicillin- resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46:584- 593. doi: 10.1086/525536. source
- Interpretationreasoning
Aminoglycoside-containing regimens would not be effective therapy for patients with infective endocarditis caused by high-level aminoglycoside-resistant strains of E faecalis.
“Therefore, aminoglycoside-containing regimens would not be effective therapy for these patients.”
Quote in the paperSubstantial claim - Premisecitation
In animal studies, rifampin appears to be key in the complete sterilization of foreign bodies infected by MRSA.
“In animal studies, rifampin appears to be key in the complete sterilization of foreign bodies infected by MRSA.184,185”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [184] 184. Chuard C, Herrmann M, Vaudaux P, Waldvogel FA, Lew DP. Successful therapy of experimental chronic foreign-body infection due to methi- cillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother. 1991;35:2611-2616. source
- cites [185] 185. Lucet JC, Herrmann M, Rohner P, Auckenthaler R, Waldvogel FA, Lew DP. Treatment of experimental foreign body infection caused by meth- icillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1990;34:2312-2317. source
- Interpretationreasoning
The usefulness of empiric combination therapy with vancomycin plus an antistaphylococcal beta-lactam in patients with S aureus bacteremia until oxacillin susceptibility is known is uncertain.
“Therefore, the usefulness of empiric combination therapy in patients with S aureus bacteremia until oxacillin susceptibility is known is uncertain.”
Quote in the paperSubstantial claim - Premisecitation
An analysis of the literature demonstrated the superiority of beta-lactam-containing regimens over vancomycin monotherapy for bacteremic MSSA infections, including infective endocarditis.
“An analysis of the literature, however, compared the use of empirical combination of vancomycin and antistaphylococcal β-lactam therapy with vancomycin alone and demonstrated the superiority of β-lactam-containing regimens over vancomycin monotherapy for bacteremic MSSA infections, including IE. 154”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [154] 154. McConeghy KW, Bleasdale SC, Rodvold KA. The empirical combina- tion of vancomycin and a β-lactam for staphylococcal bacteremia. Clin Infect Dis. 2013;57:1760-1765. doi: 10.1093/cid/cit560. source
- Premisecitation
In a prospective study, patients with native valve E faecalis IE and <3 months' duration of symptoms were treated successfully with 4 weeks of antimicrobial therapy.
“Patients with <3 months' duration of symptoms were treated successfully with 4 weeks of antimicrobial therapy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [196] source
- Premisecitation
Animal studies of therapy for foreign-body infection suggest that a fluoroquinolone can be used instead of gentamicin if the organism is susceptible to a fluoroquinolone.
“In this situation, if the organism is susceptible to a fluoroquinolone, animal studies of therapy for foreign-body infection suggest that a fluoroquinolone can be used instead of gentamicin.184”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [184] 184. Chuard C, Herrmann M, Vaudaux P, Waldvogel FA, Lew DP. Successful therapy of experimental chronic foreign-body infection due to methi- cillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother. 1991;35:2611-2616. source
- Premisecitation
Quinupristin-dalfopristin and telavancin have been used successfully as salvage therapy in selected patients with MRSA infective endocarditis who clinically failed vancomycin therapy.
“Quinupristin-dalfopristin 177 and telavancin 178 have been used successfully as salvage therapy in selected patients with MRSA IE who clinically failed vancomycin therapy.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [177] 177. Sander A, Beiderlinden M, Schmid EN, Peters J. Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci. Intensive Care Med. 2002;28:1157-1160. doi: 10.1007/s00134-002-1358-7. source
- cites [178] 178. Nace H, Lorber B. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin. J Antimicrob Chemother. 2010;65:1315-1316. doi: 10.1093/jac/dkq113. source
- Premisecitation
Emergence of organisms with decreased susceptibility to daptomycin was observed in approximately 5% of daptomycin-treated patients.
“The emergence of organisms with decreased susceptibility to daptomycin was observed in ≈5% of daptomycin-treated patients.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [155] 155. Carugati M, Bayer AS, Miró JM, Park LP, Guimarães AC, Skoutelis A, Fortes CQ, Durante-Mangoni E, Hannan MM, Nacinovich F, Fernández- Hidalgo N, Grossi P, Tan RS, Holland T, Fowler VG Jr, Corey RG, Chu VH; International Collaboration on Endocarditis. High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Antimicrob Agents Chemother. 2013;57:6213-6222. doi: 10.1128/AAC.01563-13. source
- Premisecitation
In the study by Fernández-Hidalgo et al, 26% of the 272 patients had high-level aminoglycoside-resistant strains of E faecalis.
“In the study by Fernández-Hidalgo et al, 191 26% of the 272 patients had high-level aminoglycoside-resistant strains of E faecalis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
- Interpretationreasoning
There are insufficient data to recommend monotherapy with daptomycin for treatment of multidrug-resistant enterococcal IE.
“In summary, there are insufficient data to recommend monotherapy with daptomycin for the treatment of multidrugresistant enterococcal IE.”
Quote in the paperSubstantial claim - Premisecitation
Mave et al reported cure in 2 of 3 patients with E faecium IE with linezolid.
“Mave et al 203 reported cure in 2 of 3 patients with E faecium IE with linezolid.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [203] source
- Premisecitation
A smaller study by this group compared ceftriaxone-ampicillin therapy of aminoglycoside-susceptible with high-level aminoglycoside-resistant E faecalis IE.
“A smaller study by this group compared ceftriaxone-ampicillin therapy of aminoglycoside-susceptible with high-level aminoglycoside-resistant E faecalis IE. 190”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
- Premisecitation
A large, multicenter study by Spanish and Italian investigators compared ampicillin-ceftriaxone with ampicillin-gentamicin therapy of E faecalis IE.
“A large, multicenter study by Spanish and Italian investigators compared ampicillin-ceftriaxone with ampicillin-gentamicin therapy of E faecalis IE. 191”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
- Premisecitation
In one study, PVE was present in 59 (37%) and 30 (34%) of patients treated with ampicillin-ceftriaxone and ampicillin-gentamicin, respectively, with similar success rates.
“Fifth, in 1 study, PVE was present in 59 (37%) and 30 (34%) of patients treated with ampicillin-ceftriaxone and ampicillingentamicin, respectively, with similar success rates.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
- Premisecitation
The combination of ampicillin-ceftriaxone was effective therapy for gentamicin-susceptible or high-level gentamicin-resistant E faecalis experimental IE.
“This study led to additional studies of experimental IE that demonstrated that the combination of ampicillin-ceftriaxone was effective therapy for gentamicin-susceptible or high-level gentamicin-resistant E faecalis experimental IE.199”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [199] source
- Premisecitation
In a small number of patients, linezolid was effective therapy of vancomycin-resistant E faecium IE.
“In a small number of patients, linezolid was effective therapy of vancomycin-resistant E faecium IE. 174”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [174] source
- Premisecitation
The number of cases of vancomycin-resistant Enterococcus bacteremia was too small to draw significant conclusions about treatment response rates.
“The number of cases of vancomycin-resistant Enterococcus bacteremia was too small to draw significant conclusions about treatment response rates.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [203] source
- Premisecitation
Birmingham et al reported cure in 17 of 22 courses of therapy (77%) for E faecium IE with linezolid.
“Birmingham et al 202 reported cure in 17 of 22 courses of therapy (77%) for E faecium IE.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [202] source
- Premiseown data
In the larger study, patients in the ampicillin-ceftriaxone group were generally sicker and had more comorbid conditions (chronic renal failure, neoplasm, nosocomial acquisition) than the ampicillin-gentamicin group.
“Fourth, in the larger study, the median age was 70 years in both treatment groups; however, patients in the ampicillin-ceftriaxone group were generally sicker and had more comorbid conditions (eg, chronic renal failure [P=0.004],neoplasm [P=0.015], and nosocomial acquisition of infection [P=0.006]).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
- Premisecitation
Linezolid treatment failures of E faecium IE have been reported.
“However, linezolid treatment failures of E faecium IE also were reported.206”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [206] source
- Premisecitation
Most reports of multidrug-resistant E faecium IE are single case reports, reports of a small number of collected cases, or cases reported in new drug trials.
“Most of the reports of multidrug-resistant E faecium IE are single case reports, reports of a small number of collected cases, or cases reported in new drug trials.200”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [200] source
- Premisecitation
IE caused by HACEK group accounts for ≈5% to 10% of community-acquired NVE in patients who are not IDUs.
“IE caused by fastidious Gram-negative bacilli of the HACEK group (HACEK indicates Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) accounts for ≈5% to 10% of community-acquired NVE in patients who are not IDUs.218”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [218]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
High-level aminoglycoside-resistant E faecalis IE treated with ampicillin-ceftriaxone therapy was present in 50% of patients in the smaller study and 33% in the larger study.
“Second, high-level aminoglycoside-resistant E faecalis IE treated with ampicillin-ceftriaxone therapy was present in 50% of the patients in the smaller study and 33% of patients in the larger study.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
- cites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
- Premisecitation
Salmonella species have a proclivity to infect cardiovascular structures in adults.
“Salmonella species have a proclivity to infect cardiovascular structures in adults.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [222] 222. Reyes MP, Reyes KC. Gram-negative endocarditis. Curr Infect Dis Rep. 2008;10:267-274. source
- Premisecitation
Most cases of Salmonella IE are caused by S choleraesuis, S typhimurium, and S enteritidis.
“Although many serotypes have been implicated, most cases are caused by S choleraesuis, S typhimurium, and S enteritidis.222”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [222] 222. Reyes MP, Reyes KC. Gram-negative endocarditis. Curr Infect Dis Rep. 2008;10:267-274. source
- Premisecitation
In PVE cases, timing of infection onset can be important in defining pathogens.
“In PVE cases, the timing of infection onset can also be important in defining pathogens.235”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [235] 235. Thuny F, Fournier PE, Casalta JP, Gouriet F, Lepidi H, Riberi A, Collart F, Habib G, Raoult D. Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi. Heart. 2010;96:743-747. doi: 10.1136/hrt.2009.181594. source
- Premisecitation
IDU was recognized in only 4% of cases in the multinational survey (2000-2005).
“In contrast, IDU, a prominent risk factor for the development of this IE syndrome in earlier years, was recognized in only 4% of cases in the multinational survey that included cases seen between 2000 and 2005.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [221] 221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-835. source
- Premisecitation
The most prevalent pathogen among uncommon causes of culture-negative IE has varied globally according to published data.
“The most prevalent pathogen among these uncommon causes of culture-negative IE in this group has varied globally according to published data.236”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
- Premisecitation
The antimicrobial susceptibility, dose, duration, and nature of previous antimicrobial therapy together determine the length of time blood cultures remain negative.
“The antimicrobial susceptibility of the organism, the dose, and the duration and nature of previous antimicrobial therapy together determine the length of time that blood cultures will remain negative.232”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [232] 232. Tunkel AR, Kaye D. Endocarditis with negative blood cultures. N Engl J Med. 1992;326:1215-1217. doi: 10.1056/NEJM199204303261809. source
- Premisecitation
Healthcare exposure was associated with development of IE caused by non-HACEK Gram-negative aerobic bacilli in 57% of patients.
“It is noteworthy that healthcare exposure was associated with the development of IE caused by this group of organisms in 57% of patients.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [221] 221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-835. source
- Premisecitation
True culture-negative IE can be caused by uncommon or rare pathogens that do not grow in routinely used blood culture systems.
“True culture-negative IE can be caused by uncommon or rare pathogens that do not grow in routinely used blood culture systems.[234][235][236][237]”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [234] 234. Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother. 2004;48:1921-1933. doi: 10.1128/AAC.48.6.1921-1933.2004. source
- cites [235] 235. Thuny F, Fournier PE, Casalta JP, Gouriet F, Lepidi H, Riberi A, Collart F, Habib G, Raoult D. Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi. Heart. 2010;96:743-747. doi: 10.1136/hrt.2009.181594. source
- cites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
- Premisecitation
In a large multinational database of 2761 patients, only 49 cases (1.8%) were attributable to non-HACEK Gram-negative aerobic bacilli.
“In 1 large multinational database 221 that included 2761 patients seen in 61 hospitals in 28 countries, only 49 cases (1.8%) were attributable to non-HACEK Gram-negative aerobic bacilli.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [221] 221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-835. source
- Premisecitation
The HACEK group is usually susceptible in vitro to fluoroquinolones.
“The HACEK group is usually susceptible in vitro to fluoroquinolones.206”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [206] source
- Premisecitation
A European study of 820 cases indicated that ≈20% of patients with confirmed IE had all negative blood cultures.
“Although most previous studies have put the frequency of blood culture-negative IE at 5% to 10%, a European study of IE that included 820 cases indicated that ≈20% of patients with confirmed IE had all negative blood cultures.228”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [228] 228. Werner M, Andersson R, Olaison L, Hogevik H. A clinical study of cul- ture-negative endocarditis. Medicine (Baltimore). 2003;82:263-273. doi: 10.1097/01.md.0000085056.63483.d2. source
- Premisecitation
Administration of antimicrobial agents before blood cultures reduces recovery rate of bacteria by 35% to 40%.
“Administration of antimicrobial agents to IE patients before blood cultures are obtained reduces the recovery rate of bacteria by 35% to 40%.[228][229][230][231][232]”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [228] 228. Werner M, Andersson R, Olaison L, Hogevik H. A clinical study of cul- ture-negative endocarditis. Medicine (Baltimore). 2003;82:263-273. doi: 10.1097/01.md.0000085056.63483.d2. source
- cites [229] 229. Hoen B, Selton-Suty C, Lacassin F, Etienne J, Briançon S, Leport C, Canton P. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis. 1995;20:501-506. source
- cites [230] 230. Berbari EF, Cockerill FR 3rd, Steckelberg JM. Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc. 1997;72:532- 542. doi: 10.1016/S0025-6196(11)63302-8. source
- Premisecitation
The intensity of bacteremia may not be great, with <50 colony-forming units per 1 mL blood detected in the majority of patients in an investigation.
“The intensity of bacteremia may not be great, however, with <50 colony-forming units per 1 mL blood detected in the majority of patients in an investigation.227”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [227] 227. Werner AS, Cobbs CG, Kaye D, Hook EW. Studies on the bacteremia of bacterial endocarditis. JAMA. 1967;202:199-203. source
- Premisenone given
Noncardiac sites of metastatic infection often complicate fungal infective endocarditis, including endophthalmitis in patients with candidal infective endocarditis.
“Noncardiac sites of metastatic infection often complicate fungal IE; this can include, for example, endophthalmitis in patients with candidal IE, which may require both systemic and intraocular antifungal therapy.”
Quote in the paperNot a substantial claim - Premisecitation
The well-recognized risk factors for fungal infective endocarditis, such as injection drug use and immunocompromised state, have become less prevalent than the presence of a cardiovascular device, including central venous catheters, permanent pacemakers and defibrillators, and prosthetic valves.
“The well-recognized risk factors associated with fungal IE (eg, IDU and immunocompromised state) have become less prevalent compared with the presence of a cardiovascular device, including central venous catheters, permanent pacemakers and defibrillators, and prosthetic valves.[240][241][242][243][244][245][246]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [240] 240. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310. source
- cites [241] 241. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endo- carditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62. doi: 10.1086/317550. source
- cites [242] 242. Nguyen MH, Nguyen ML, Yu VL, McMahon D, Keys TF, Amidi M. Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin Infect Dis. 1996;22:262-267. source
- Premisecitation
In that analysis, no cause was defined in 35% of cases.
“Fourth, no cause was defined in 35% of cases.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
- Premisecitation
A meta-analysis of 879 cases of Candida infective endocarditis demonstrated a marked reduction in death (prevalence odds ratio, 0.56; 95% confidence interval, 0.16-1.99) among those who underwent adjunctive valve surgery.
“Results of a meta-analysis that included 879 cases of Candida IE demonstrated a marked reduction in death (prevalence odds ratio, 0.56; 95% confidence interval, 0.16-1.99)among those who underwent adjunctive valve surgery.244”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [244] 244. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, Zaas AK, Benjamin DK Jr. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230-247. doi: 10.1016/j. jinf.2004.10.016. source
- Premisecitation
Patients with Candida infective endocarditis treated with combination therapy including amphotericin B and flucytosine had reduced mortality compared with those who received antifungal monotherapy.
“In addition, patients who were treated with combination therapy including amphotericin B and flucytosine had reduced mortality compared with those who received antifungal monotherapy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [244] 244. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, Zaas AK, Benjamin DK Jr. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230-247. doi: 10.1016/j. jinf.2004.10.016. source
- Premisecitation
In that analysis, PCR identified a pathogen in two thirds of valves studied.
“Third, PCR identified a pathogen in two thirds of the valves studied.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
- Premisecitation
In a systematic review of 5 of 15 population-based infective endocarditis investigations from 7 countries, after adjustment for country, the proportion of infective endocarditis cases undergoing valve surgery increased 7% per decade (95% confidence interval, -0.4% to 14%; P=0.06) between 1969 and 2000.
“In a systematic review 5 of 15 population-based IE investigations from 7 countries, after adjustment for country, the proportion of IE cases undergoing valve surgery increased 7% per decade (95% confidence interval, -0.4% to 14%; P=0.06) between 1969 and 2000.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] 5. Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, Wilson WR, Baddour LM. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132:1025-1035. doi: 10.1378/chest.06-2048. source
- Premisecitation
In its secondary form, APA syndrome has been linked to autoimmune disorders, particularly SLE, and malignancies.
“In its secondary form, the APA syndrome has been linked to autoimmune disorders, particularly systemic lupus erythematosus, and malignancies.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [238] 238. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involve- ment (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579-1587. source
- Interpretationcitation
A correlation between longer survival and surgery may be wrongly interpreted as evidence that surgical treatment improves survival.
“A correlation between longer survival and surgery may be wrongly interpreted as evidence that surgical treatment improves survival.257”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [257] 257. van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clini- cal journals. J Clin Epidemiol. 2004;57:672-682. doi: 10.1016/j. jclinepi.2003.12.008. source
- Premisereasoning
Studies examining the association between valve surgery and outcome in left-sided infective endocarditis using propensity score analysis have demonstrated conflicting results, likely because of the use of different analytical approaches.
“Studies 14,15,136,249,[253][254][255][256] examining the association between valve surgery and outcome in left-sided IE using propensity score analysis, however, have demonstrated conflicting results, likely because of the use of different analytical approaches.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [14] 14. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115:1721-1728. doi: 10.1161/CIRCULATIONAHA.106.658831. source
- cites [15] 15. Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F; AEPEI Study Group. The impact of valve surgery on short-and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32:2003-2015. doi: 10.1093/eurheartj/ehp008. source
- cites [136] 136. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabé J, Morris A, Corey GR, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of pros- thetic valve endocarditis. JAMA. 2007;297:1354-1361. doi: 10.1001/ jama.297.12.1354. source
- Interpretationreasoning
Firm conclusions cannot be drawn from this trial on the effect of early surgery on mortality because of the small sample size.
“Thus, firm conclusions cannot be drawn from this trial on the effect of early surgery on mortality, given the small sample size of the study.”
Quote in the paperSubstantial claim - Premisecitation
In the randomized trial, 76 patients with left-sided native valve infective endocarditis, severe valve regurgitation without heart failure, and vegetations >10 mm were assigned to early surgery within 48 hours or to conventional treatment.
“In this trial, 76 patients with left-sided NVE, severe valve regurgitation without heart failure, and vegetations >10 mm were assigned to early surgery within 48 hours or to conventional treatment.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
- Premisecitation
Until 2007, none of the published studies adjusted for survivor bias.
“Until 2007, none of the published studies adjusted for survivor bias, which occurs because patients who live longer are more likely to undergo surgery than those who die early.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [257] 257. van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clini- cal journals. J Clin Epidemiol. 2004;57:672-682. doi: 10.1016/j. jclinepi.2003.12.008. source
- Premisenone given
The risk of intracranial hemorrhage in infective endocarditis patients with stroke is dependent on several factors, including extent and size of infarction, whether it is ischemic or hemorrhagic, and the exact timing of surgery.
“The risk of intracranial hemorrhage is dependent on several factors, including extent and size of infarction, whether it is ischemic or hemorrhagic, and the exact timing of surgery.”
Quote in the paperSubstantial claim - Premisenone given
No randomized trials have addressed whether early valve surgery can be safely performed within 7 days after a stroke or if it is better to postpone surgery for at least 1 week.
“No randomized trials have addressed this conundrum.”
Quote in the paperSubstantial claim - Premisenone given
There is a paucity of evidence available to define the optimal timing of valve surgery in infective endocarditis.
“There is a paucity of evidence available to define the optimal timing of valve surgery.”
Quote in the paperSubstantial claim - Premisecitation
Many patients in this trial had signs of embolization before randomization.
“Moreover, many patients had signs of embolization (a Class IIa indication for surgery) before randomization.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
- Premisenone given
Outcomes are better for patients with right-sided infective endocarditis compared with patients with left-sided infection.
“Although outcomes are better for patients with right-sided IE compared with patients with left-sided infection, surgical intervention is occasionally considered in the former group.”
Quote in the paperNot a substantial claim - Premisecitation
Only 1 small randomized trial has been performed to date to examine the role of valve surgery in the management of infective endocarditis.
“Although valve replacement surgery has served as an important option in the management of individual IE cases, only 1 small, randomized trial 17 has been performed to date to examine the role of valve surgery in the management of IE.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
- Premisecitation
Another prospective transesophageal echocardiography study found no clear correlation of vegetation size with embolization.
“Another prospective TEE study, however, found no clear correlation of vegetation size with embolization.59”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] 59. Erbel R, Rohmann S, Drexler M, Mohr-Kahaly S, Gerharz CD, Iversen S, Oelert H, Meyer J. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach: a pro- spective study. Eur Heart J. 1988;9:43-53. source
- Premisecitation
The same investigators later reported a new prospective study of 118 patients who underwent transesophageal echocardiography and found that, on multivariable analysis, risk factors associated with embolic risk included vegetation size greater than 10 mm and mitral valve involvement.
“Nevertheless, the same investigators later reported the results of a new prospective study of 118 patients who underwent TEE and found that, on multivariable analysis, risk factors associated with embolic risk included vegetation size >10 mm and mitral valve involvement.56”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] 56. Rohmann S, Erbel R, Görge G, Makowski T, Mohr-Kahaly S, Nixdorff U, Drexler M, Meyer J. Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis. Eur Heart J. 1992;13:446-452. doi: http://dx.doi.org. source
- Premisecitation
After adjustment for age, paravalvular abscess, and heart failure, the risk of hospital mortality remained nonsignificantly higher in the early surgery group (odds ratio, 2.308; 95% confidence interval, 0.942-5.652).
“After adjustment for other risk factors such as age, paravalvular abscess, and heart failure, the risk of hospital mortality remained nonsignificantly higher in the early surgery group (odds ratio, 2.308; 95% confidence interval, 0.942-5.652).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [273] source
- Premisecitation
De Castro and colleagues compared transthoracic echocardiography with multiplane transesophageal echocardiography and found that neither technique was helpful in defining embolic risk in patients with vegetations.
“De Castro and colleagues 276 compared TTE with multiplane TEE and found that neither technique was helpful in defining embolic risk in patients with vegetations.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [276] source
- Premisecitation
In a study from 1991, the embolic rate dropped from 13 to less than 1.2 embolic events per 1000 patient-days during the first 2 to 3 weeks of successful antibiotic therapy.
“In a study from 1991, the embolic rate dropped from 13 to <1.2 embolic events per 1000 patient-days during that time.58”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] 58. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, Giuliani ER, Wilson WR. Emboli in infective endocarditis: the prognos- tic value of echocardiography. Ann Intern Med. 1991;114:635-640. Doi: 10.7326/0003-4819-114-8-635. source
- Premisecitation
Differences in 1-year mortality were less pronounced, with an adjusted hazard ratio of 1.138 (95% confidence interval, 0.802-1.650).
“Differences in 1-year mortality were less pronounced, with an adjusted hazard ratio of 1.138 (95% confidence interval, 0.802-1.650).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [273] source
- Premisecitation
In a survey including the International Collaboration on Endocarditis cohort, Dickerman and colleagues demonstrated that acute stroke rates fell significantly after initiation of antibiotic therapy regardless of valve involved or pathogen identified.
“In a survey that included the International Collaboration on Endocarditis cohort, Dickerman and colleagues 280 focused on the incidence of stroke in a multicenter IE population and demonstrated that acute stroke rates fell significantly after initiation of antibiotic therapy regardless of valve involved or pathogen identified.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [280] source
- Premisecitation
In-hospital mortality in the early surgery group was comparable to that of the medically treated patients.
“In-hospital mortality in the early surgery group was comparable to that of the medically treated patients.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [273] source
- Premisecitation
Only 3.1% of the cohort suffered stroke after the first week of antimicrobial therapy.
“Moreover, only 3.1% of the cohort suffered stroke after the first week of antimicrobial therapy; this finding has led to the opinion that stroke prevention as a sole indication for valve surgery after 1 week of appropriate antibiotic therapy is not warranted.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [280] source
- Interpretationreasoning
Because of observed decreases in embolic risk during the first 2 weeks of antibiotic therapy, the benefit of surgery in avoiding catastrophic embolic events is greatest early in the treatment course of infective endocarditis.
“Because of the observed decreases in embolic risk during the first 2 weeks of antibiotic therapy, the benefit of surgery in avoiding catastrophic embolic events is greatest early in the treatment course of IE.”
Quote in the paperSubstantial claim - Premisecitation
On the basis of transesophageal echocardiography findings in 384 consecutive adult patients with definite infective endocarditis, vegetation length greater than 15 mm was a predictor of 1-year mortality (adjusted relative risk, 1.8; 95% confidence interval, 1.10-2.82; P=0.02) in multivariable analysis.
“On the basis of TEE findings in 384 consecutive adult patients with definite IE, vegetation length >15 mm was a predictor of 1-year mortality (adjusted relative risk, 1.8; 95% confidence interval, 1.10-2.82;P=0.02) in multivariable analysis.281”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [281] source
- Premisecitation
In aortic native valve infective endocarditis, perivalvular cavities generally occur through the weakest portion of the annulus, near the membranous septum and atrioventricular node.
“In aortic NVE, this generally occurs through the weakest portion of the annulus, which is near the membranous septum and atrioventricular node.299”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [299] 299. Becher H, Hanrath P, Bleifeld W, Bleese N. Correlation of echocardio- graphic and surgical findings in acute bacterial endocarditis. Eur Heart J. 1984;5(suppl C):67-70. source
- Premisecitation
An increase in vegetation size over 4 to 8 weeks of therapy as documented by transesophageal echocardiography appears to predict embolic events.
“An increase in vegetation size over 4 to 8 weeks of therapy as documented by TEE appears to predict embolic events.282”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [282] source
- Premisereasoning
The benefit of therapeutic anticoagulation has never been demonstrated convincingly in patients with native valve infective endocarditis.
“The benefit of therapeutic anticoagulation has never been demonstrated convincingly in patients with NVE.”
Quote in the paperSubstantial claim - Premisecitation
The highest embolic risk (37%) has been seen in the subset of patients with mitral vegetations attached to the anterior rather than the posterior mitral leaflet.
“As noted above, the highest embolic risk (37%) has been seen in the subset of patients with mitral vegetations attached to the anterior rather than the posterior mitral leaflet.59,63”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [59] 59. Erbel R, Rohmann S, Drexler M, Mohr-Kahaly S, Gerharz CD, Iversen S, Oelert H, Meyer J. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach: a pro- spective study. Eur Heart J. 1988;9:43-53. source
- cites [63] 63. Konstadt SN, Louie EK, Shore-Lesserson L, Black S, Scanlon P. The effects of loading changes on intraoperative Doppler assessment of mitral regurgitation. J Cardiothorac Vasc Anesth. 1994;8:19-23. source
- Premisecitation
The study with the largest number of patients (n=176) that assessed the value of transesophageal echocardiography and included silent embolism detected by CT scanning demonstrated that the risk of embolic events was highly related to vegetation size and mobility but not to other known risk factors associated with embolism in infective endocarditis.
“Moreover, the study with the largest number of patients (n=176) that assessed the value of TEE and included silent embolism detected by CT scanning demonstrated that the risk of embolic events was highly related to vegetation size and mobility but not to other known risk factors associated with embolism in IE. 283”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [283] source
- Premisenone given
Perivalvular cavities form when annular infections break through and spread into contiguous tissue.
“Perivalvular cavities form when annular infections break through and spread into contiguous tissue.”
Quote in the paperNot a substantial claim - Premisecitation
Other independent predictors of death by logistic regression modeling among 267 consecutive patients with definite or possible infective endocarditis by modified Duke criteria were diabetes mellitus, S aureus infection, and Acute Physiology And Chronic Health Evaluation II score.
“Other independent predictors of death by logistic regression modeling among 267 consecutive patients with definite or possible IE by modified Duke criteria were diabetes mellitus, S aureus infection, and Acute Physiology And Chronic Health Evaluation (APACHE) II score.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [285] source
- Premisecitation
Aspirin levels, a critical correlate of antimicrobial efficacy in an animal model, were not monitored in this study.
“Aspirin levels, a critical correlate of antimicrobial efficacy in an animal model, were not monitored in this study.289”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [289] 289. Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Sullam PM, Filler SG, Bayer AS. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation. 1999;99:2791-2797. source
- Interpretationreasoning
The mechanical effects of broad and abrupt leaflet excursion, occurring twice per heartbeat, may contribute to the propensity of a vegetation in this location to fragment and embolize.
“This suggests that the mechanical effects of broad and abrupt leaflet excursion, occurring twice per heartbeat, may contribute to the propensity of a vegetation in this location to fragment and embolize.”
Quote in the paperSubstantial claim - Premisecitation
In 1 analysis, an embolic event was 1 of 4 early predictors of in-hospital death caused by infective endocarditis.
“In 1 analysis, an embolic event was 1 of 4 early predictors of in-hospital death caused by IE. 285”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [285] source
- Premisecitation
Anticoagulation in infective endocarditis patients is controversial, particularly in mechanical valve infective endocarditis.
“Anticoagulation in IE patients is controversial, particularly in mechanical valve IE. 286”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [286] source
- Premisereasoning
In general, mitral vegetations of any size are associated with a higher risk of embolization (25%) than aortic vegetations (10%).
“Overall, these data are compatible with previous observations that indicate that, in general, mitral vegetations of any size are associated with a higher risk of embolization (25%) than aortic vegetations (10%).”
Quote in the paperNot a substantial claim - Premisenone given
All series that included more than 100 patients who underwent transesophageal echocardiography showed a positive relationship between embolic events and vegetation size.
“However, all of the series that included >100 patients who underwent TEE showed a positive relationship between embolic events and vegetation size.”
Quote in the paperSubstantial claim - Premisecitation
In another study, the effect of vegetation size on embolic potential was dependent on the infecting organism, with large vegetations independently predicting embolic events only in the setting of streptococcal infective endocarditis.
“In another study, the effect of vegetation size on embolic potential was dependent on the infecting organism, with large vegetations independently predicting embolic events only in the setting of streptococcal IE. 60”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] 60. Rohmann S, Erbel R, Darius H, Görge G, Makowski T, Zotz R, Mohr- Kahaly S, Nixdorff U, Drexler M, Meyer J. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr. 1991;4:465-474. source
- Premisecitation
The mortality rate was 41% in a series of patients with aorto-cavitary fistulization despite surgical intervention in 87%.
“The mortality rate was 41% in a series 304 of patients with aorto-cavitary fistulization despite surgical intervention in 87%.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [304] source
- Premisenone given
In some cases, progressive periannular infection totally disrupts the ventricular-aortic continuity or the mitral-aortic trigone.
“In some cases, progressive periannular infection totally disrupts the ventricular-aortic continuity or the mitral-aortic trigone.”
Quote in the paperNot a substantial claim - Premisecitation
The overall mortality rate among IE patients with ICMAs is 60%.
“The overall mortality rate among IE patients with ICMAs is 60%.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [315] source
- cites [316]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Among patients with unruptured ICMAs, the mortality rate is 30%.
“Among patients with unruptured ICMAs, the mortality rate is 30%;”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [315] source
- cites [316]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Drainage of abscess cavities, excision of necrotic tissue, and closure of fistulous tracts often accompany valve replacement or repair surgery.
“Drainage of abscess cavities, excision of necrotic tissue, and closure of fistulous tracts often accompany valve replacement or repair surgery.309”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [309]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Periannular infection is of even greater concern with prosthetic valve infective endocarditis, occurring in 56% to 100% of patients.
“Periannular infection is of even greater concern with PVE, occurring in 56% to 100% of patients.298,302”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [298] 298. Blumberg EA, Karalis DA, Chandrasekaran K, Wahl JM, Vilaro J, Covalesky VA, Mintz GS. Endocarditis-associated paravalvular abscesses: do clinical parameters predict the presence of abscess? Chest. 1995;107:898-903. source
- cites [302] 302. Carpenter JL. Perivalvular extension of infection in patients with infec- tious endocarditis. Rev Infect Dis. 1991;13:127-138. source
- Premisenone given
Under the influence of systemic intravascular pressures, abscesses may progress to fistulous tracts that create intracardiac or pericardial shunts.
“Under the influence of systemic intravascular pressures, abscesses may progress to fistulous tracts that create intracardiac or pericardial shunts.”
Quote in the paperNot a substantial claim - Premisecitation
Persistent bacteremia or fever, recurrent emboli, heart block, heart failure, or a new pathological murmur in a patient with IE on appropriate antibiotics may suggest perivalvular extension.
“Persistent bacteremia or fever, recurrent emboli, heart block, heart failure, or a new pathological murmur in a patient with IE on appropriate antibiotics may suggest extension.303”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [303] 303. Anguera I, Miro JM, Vilacosta I, Almirante B, Anguita M, Muñoz P, Roman JA, de Alarcon A, Ripoll T, Navas E, Gonzalez-Juanatey C, Cabell CH, Sarria C, Garcia-Bolao I, Fariñas MC, Leta R, Rufi G, Miralles F, Pare C, Evangelista A, Fowler VG Jr, Mestres CA, de Lazzari E, Guma JR; Aorto-cavitary Fistula in Endocarditis Working Group. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J. 2005;26:288-297. doi: 10.1093/eurheartj/ehi034. 304. source
- Premisecitation
Multiple ICMAs occur in 20% of cases.
“Multiple ICMAs occur in 20% of cases 319”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [319] source
- Premisecitation
Mortality rates are similar for multiple and single distal ICMAs.
“mortality rates are similar for multiple and single distal ICMAs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [319] source
- Premisecitation
Symptomatic cerebral emboli frequently but not invariably precede the finding of an ICMA.
“Symptomatic cerebral emboli frequently but not invariably precede the finding of an ICMA.315”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [315] source
- Premisecitation
In patients with ruptured ICMAs, the mortality rate approaches 80%.
“in patients with ruptured ICMAs, the mortality rate approaches 80%.315,316”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [315] source
- cites [316]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The mortality rate for patients with proximal ICMAs is >50%.
“The mortality rate for patients with proximal ICMAs is >50%.321”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [321]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In some patients with ICMAs, there are no clinically recognized premonitory findings before sudden subarachnoid or intraventricular hemorrhage.
“In other patients, there are no clinically recognized premonitory findings before sudden subarachnoid or intraventricular hemorrhage.315”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [315] source
- Premisecitation
The reported occurrence of ICMAs is 1.2% to 5% of IE cases.
“The reported occurrence of ICMAs in 1.2% to 5% of cases [316][317][318][319][320]”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationreasoning
The reported occurrence of ICMAs is probably underestimated because some ICMAs remain asymptomatic and resolve with antimicrobial therapy.
“is probably underestimated because some ICMAs remain asymptomatic and resolve with antimicrobial therapy.”
Quote in the paperNot a substantial claim - Premisecitation
ICMAs are seen with increased frequency among IDUs with IE.
“and ICMAs are seen with increased frequency among IDUs with IE. 318”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [318] source
- May combine two claims. 88
- Classified as probably not a substantial claim. 18
- The quote only partly states this claim. 2
May combine two claims.
Premisenone givenThese initial studies included a limited number of patients, and risk adjustments were not performed.
“However, these initial studies included a limited number of patients, and risk adjustments were not performed.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [265] 265. Maruyama M, Kuriyama Y, Sawada T, Yamaguchi T, Fujita T, Omae T. Brain damage after open heart surgery in patients with acute cardioem- bolic stroke. Stroke. 1989;20:1305-1310. source
- cites [266] 266. Gillinov AM, Shah RV, Curtis WE, Stuart RS, Cameron DE, Baumgartner WA, Greene PS. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg. 1996;61:1125-1129. source
- cites [267] 267. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cere- bral complications: multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745-1755. source
The Discussion (page unavailable) says earlier studies had limited numbers of cases but describes this study’s 181 analyzed patients as sufficient for examining surgical timing. Patients and methods (page unavailable) also reports stepwise regression analysis of risk factors, contrary to the unqualified claim that risk adjustments were not performed. (LLM, conf=0.83)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationExtension of infective endocarditis beyond the valve annulus predicts a higher mortality rate, more frequent development of heart failure, and more frequent need for cardiac surgery.
“Extension of IE beyond the valve annulus predicts a higher mortality rate, more frequent development of heart failure, and more frequent need for cardiac surgery.284,297,298”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [284] source
The Abstract (page unavailable) says early echocardiographic findings were not predictive of in-hospital death. Table 1 (page unavailable) reports no statistically significant association between abscess and death (OR 1.52; P=0.525), contrary to the claimed mortality prediction. The Discussion identifies perivalvular extension as an indication for surgery, but does not show that it predicts more frequent heart failure or surgery. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [297] 297. Middlemost S, Wisenbaugh T, Meyerowitz C, Teeger S, Essop R, Skoularigis J, Cronje S, Sareli P. A case for early surgery in native left- sided endocarditis complicated by heart failure: results in 203 patients. J Am Coll Cardiol. 1991;18:663-667. source
The Methods define extensive infection as spread to the annulus or adjacent tissues, and the Results report five postoperative deaths among patients with extensive aortic infection versus two with limited aortic infection. But this was a surgical series of patients with heart failure; it does not establish that extension predicts more frequent heart failure or a greater need for surgery, and the authors conclude that extensive infection is not necessarily associated with high surgical risk when surgery is early (Discussion). No page number is available in our copy. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [298] 298. Blumberg EA, Karalis DA, Chandrasekaran K, Wahl JM, Vilaro J, Covalesky VA, Mintz GS. Endocarditis-associated paravalvular abscesses: do clinical parameters predict the presence of abscess? Chest. 1995;107:898-903. source
May combine two claims.
FindingcitationOf 59 consecutive patients with Staphylococcus aureus infective endocarditis, 45.8% had nosocomial infections, and 50.8% had a removable focus of infection.
“of 59 consecutive patients with S aureus IE, 45.8% had nosocomial infections, and 50.8% had a removable focus of infection.39”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [39] 39. Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, Ryan T, Sexton DJ, Roussakis G, Harrell LJ, Corey GR. Infective endocar- ditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis. 1999;28:106-114. doi: 10.1086/515076. source
Table 2 reports 27 hospital-acquired cases among 59 patients (45.8%). The Sources of Infection section reports that an intravascular device was the presumed source in 30 patients (50.8%), but it does not establish that all 30 had a removable focus of infection. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
FindingcitationIn the predefined subgroup with MRSA bacteremia, daptomycin demonstrated a 44.4% success rate compared with 31.8% for standard therapy; this difference was not statistically significant (absolute difference 12.6%, 95% CI -7.4 to 32.6; P=0.28).
“In the predefined subgroup of those with MRSA bacteremia, daptomycin demonstrated a 44.4% success rate compared with 31.8% for standard therapy; this difference was not statistically significant (absolute difference, 12.6%, 95% confidence interval, -7.4 to 32.6; P=0.28).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
May combine two claims.
InterpretationcitationPatterns of diffusion differ by class of antibiotic, which may have implications for therapeutic outcomes in patients being treated for IE.
“Patterns of diffusion differ by class of antibiotic, which may have implications for therapeutic outcomes in patients being treated for IE.[98][99][100]”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [98] 98. Fantin B, Leclercq R, Ottaviani M, Vallois JM, Maziere B, Duval J, Pocidalo JJ, Carbon C. In vivo activities and penetration of the two com- ponents of the streptogramin RP 59500 in cardiac vegetations of experi- mental endocarditis. Antimicrob Agents Chemother. 1994;38:432-437. source
The Discussion describes different diffusion patterns for RPI and RPII in rabbit cardiac vegetations, and the Results report differences in their penetration. This supports the diffusion point, but the study compares two components of one streptogramin combination, not antibiotic classes generally, and does not establish therapeutic implications in patients with infective endocarditis. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [99] 99. Mertes PM, Jehl F, Burtin P, Dopff C, Pinelli G, Villemot JP, Monteil H, Dureux JB. Penetration of ofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans. Antimicrob Agents Chemother. 1992;36:2493-2496. 100. Nicolau DP, Freeman CD, Nightingale CH, Coe CJ, Quintiliani R. Minocycline versus vancomycin for treatment of experimental endocar- ditis caused by oxacillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1994;38:1515-1518. 101. Rybak MJ. Pharmacodynamics: relation to antimicrobial resistance. Am J Med. 2006;119(suppl 1):S37-S44. doi: source
- cites [100] 100. Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP. Therapeutic monitoring of vanco- mycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists [published correction appears in Am J Health Syst Pharm. 2009;66:887]. Am J Health Syst Pharm. 2009;66:82-98. doi: 10.2146/ajhp080434. 113. source
May combine two claims.
PremisecitationIn a post hoc analysis of the landmark clinical trial, the addition of low-dose short-course gentamicin in one arm was significantly associated with renal toxicity, which occurred early and often, and the clinical association between gentamicin dose and duration was minimal.
“Of note, in a post hoc analysis of this landmark clinical trial, 149 the addition of even such low-dose, short-course gentamicin in 1 arm of the study was significantly associated with renal toxicity, which occurred early and often, and the clinical association between gentamicin dose and duration was minimal.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [149] 149. Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW. Initial low- dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis. 2009;48:713-721. doi: 10.1086/597031. source
May combine two claims.
PremisecitationUse of rifampin as adjunct therapy for S aureus native valve infective endocarditis has been associated with higher rates of adverse events, primarily hepatotoxicity, and a significantly lower survival rate.
“Moreover, use of rifampin as adjunct therapy for S aureus NVE has been associated with higher rates of adverse events (primarily hepatotoxicity) and a significantly lower survival rate.162”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [162] 162. Riedel DJ, Weekes E, Forrest GN. Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus. Antimicrob Agents Chemother. 2008;52:2463- 2467. doi: 10.1128/AAC.00300-08. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe 2005 AHA document recommended streptomycin for patients with gentamicin-resistant strains of enterococci.
“The 2005 AHA document 12 recommended streptomycin for patients with gentamicin-resistant strains of enterococci.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [12] 12. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA. Infective endocarditis: diagno- sis, antimicrobial therapy, and management of complications: a state- ment for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American source
The section on enterococci resistant to gentamicin recommends a streptomycin regimen, but specifically for strains susceptible to streptomycin, penicillin, and vancomycin. It says only some gentamicin-resistant strains remain susceptible to streptomycin, so the claim is too broad without that qualification. No page number is available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn that study, the median duration of aminoglycoside therapy was 15 days, and microbiological cure and survival rates were similar to those for patients who received longer courses of gentamicin therapy.
“The median duration of aminoglycoside therapy was 15 days, and the microbiological cure and survival rates were similar to those for patients who received longer courses of gentamicin therapy.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [189] 189. Olaison L, Schadewitz K; Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis. Enterococcal endo- carditis in Sweden, 1995-1999: can shorter therapy with aminogly- cosides be used? Clin Infect Dis. 2002;34:159-166. doi: 10.1086/ 338233. source
The Results (p. 3) report a median of 15 days of aminoglycoside therapy in episodes with clinical cure. The Discussion (pp. 6–7) describes good outcomes with shortened treatment, but our copy does not report similar microbiological-cure and survival rates compared with a longer-course gentamicin group; it discusses several aminoglycosides. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn one survey, 60% of HACEK isolates did not grow adequately in control wells, and no valid in vitro susceptibility results were available.
“In 1 survey, 60% of isolates did not grow adequately in control wells, and no valid in vitro susceptibility results were available.219”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [219] source
May combine two claims.
Premisecitationβ-lactamase-producing strains of HACEK are appearing with increased frequency; rarely, resistance to ampicillin can occur in β-lactamase-negative strains.
“However, β-lactamaseproducing strains of HACEK are appearing with increased frequency; rarely, resistance to ampicillin can occur in β-lactamase-negative strains.219”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [219] source
The discussion following Table 1 reports penicillin/ampicillin resistance in one Eikenella corrodens isolate without β-lactamase production, supporting the rare-exception claim. The paper also identifies two β-lactamase-positive isolates, but it does not establish that β-lactamase-producing HACEK strains are appearing with increased frequency. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationSome laboratory-based diagnostic techniques for fastidious pathogens are not available in most clinical laboratories and require considerable time if sent to a referral laboratory.
“Moreover, some of the laboratory-based diagnostic techniques to define fastidious or unusual pathogens are not available in most clinical laboratories and require considerable time for completion of testing if specimens are sent to a referral laboratory.233”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [233] 233. Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS. A guide to utilization of the microbiology labo- ratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57:e22-e121. doi: 10.1093/cid/cit278. source
May combine two claims.
PremisecitationWhen adjusted for survivor bias, analyses have shown either a statistical loss of benefit of early surgery or findings indicating that the surgical intervention may actually result in harm.
“When adjusted for survivor bias, analyses have shown either a statistical loss of benefit of early surgery or findings indicating that the surgical intervention may actually result in harm.”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [15] 15. Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F; AEPEI Study Group. The impact of valve surgery on short-and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32:2003-2015. doi: 10.1093/eurheartj/ehp008. source
- cites [16] 16. Sy RW, Bannon PG, Bayfield MS, Brown C, Kritharides L. Survivor treat- ment selection bias and outcomes research: a case study of surgery in infective endocarditis. Circ Cardiovasc Qual Outcomes. 2009;2:469-474. doi: 10.1161/CIRCOUTCOMES.109.857938. source
- cites [258] 258. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Montori VM, Hoskin TL, Enders F, Huskins WC, Mookadam F, Wilson WR, Zimmerman V, Baddour LM. Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. J Clin Epidemiol. 2010;63:130-135. doi: 10.1016/j. jclinepi.2008.06.022. source
May combine two claims.
PremisecitationEmboli can occur before diagnosis, during therapy, or after therapy is completed, although most emboli occur within the first 2 to 4 weeks of antimicrobial therapy.
“Emboli can occur before diagnosis, during therapy, or after therapy is completed, although most emboli occur within the first 2 to 4 weeks of antimicrobial therapy.58,278”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationRuttmann et al analyzed 65 patients who underwent cardiac surgery after cardioembolic stroke (median time, 4 days; range, 0-38 days); surgery in this time frame was not associated with worse patient outcomes.
“Ruttmann et al 270 analyzed 65 patients who underwent cardiac surgery after cardioembolic (embolic) stroke (median time, 4 days; range, 0-38 days).Surgery in this time frame was not associated with worse patient outcomes.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [270] 270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099. doi: 10.1161/01. STR.0000229894.28591.3f. source
May combine two claims.
PremisecitationVilacosta et al confirmed the reduced frequency of embolization after 2 weeks of therapy and reemphasized the increased risk of embolization with increasing vegetation size during therapy, mitral valve involvement, and staphylococcal pathogenesis.
“Vilacosta et al 278 confirmed the reduced frequency of embolization after 2 weeks of therapy.Moreover, the latter study reemphasized the increased risk of embolization with increasing vegetation size during therapy, mitral valve involvement, and staphylococcal pathogenesis.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [278] source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe largest early series of operated patients with cerebral complications included 181 patients; hospital mortality rates were 66.3% when surgery was performed within 24 hours of stroke and gradually decreased every week to 7.0% with surgery more than 4 weeks after stroke.
“The largest early series of operated patients with cerebral complications included 181 patients.267 Hospital mortality rates as a function of the interval between evidence of cerebral infarction to cardiac surgery were 66.3% when surgery was performed within 24 hours of stroke and gradually decreased every week to 7.0% with surgery >4 weeks after stroke.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [267] 267. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cere- bral complications: multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745-1755. source
The Conclusion reports 181 patients with infective endocarditis and cerebral complications. The ‘Influence of cardiac surgery on preoperative cerebral infarction’ section gives the claimed 66.3% mortality within 24 hours and 7.0% after more than four weeks, but mortality did not decrease every week: it rose from 10.0% at 15–21 days to 26.3% at 22–28 days. The supplied passages have no page numbers. (LLM, conf=0.91)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationLatency between the neurological event and cardiac surgery was not a significant factor with respect to the perioperative neurological complication rate or the postoperative neurological recovery rate.
“Latency between the neurological event and cardiac surgery was not a significant factor with respect to the perioperative neurological complication rate or the postoperative neurological recovery rate.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [270] 270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099. doi: 10.1161/01. STR.0000229894.28591.3f. source
May combine two claims.
PremisecitationRetrospective, observational studies have examined the impact of long-term antiplatelet therapy before the onset of infective endocarditis on infection-related outcomes, and findings have been mixed.
“Retrospective, observational studies 290-296 have examined the impact, if any, of long-term antiplatelet therapy before the onset of IE on infection-related outcomes.Findings from these investigations have been mixed in terms of IE-related outcomes.”
Quote in the paperSubstantial claim1 of 7 sources checked- cites [290] 290. Anavekar NS, Tleyjeh IM, Anavekar NS, Mirzoyev Z, Steckelberg JM, Haddad C, Khandaker MH, Wilson WR, Chandrasekaran K, Baddour LM. Impact of prior antiplatelet therapy on risk of embolism in infective endo- carditis [published correction appears in Clin Infect Dis. 2007;44:1398]. Clin Infect Dis. 2007;44:1180-1186. doi: 10.1086/513197. source
- cites [291] 291. Chan KL, Tam J, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek M, Robinson T, Williams K. Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis. 2008;46:37-41. doi: 10.1086/524021. source
- cites [292] 292. Eisen DP, Corey GR, McBryde ES, Fowler VG Jr, Miro JM, Cabell CH, Street AC, Paiva MG, Ionac A, Tan RS, Tribouilloy C, Pachirat O, Jones SB, Chipigina N, Naber C, Pan A, Ravasio V, Gattringer R, Chu VH, Bayer AS; ICE Investigators. Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiv- ing acetyl-salicylic acid. J Infect. 2009;58:332-338. doi: 10.1016/j. jinf.2009.03.006. source
- cites [293] 293. Pepin J, Tremblay V, Bechard D, Rodier F, Walker C, Dufresne D, Lafontaine A, Li N, Lacroix C, Lanthier L. Chronic antiplatelet therapy and mortality among patients with infective endocarditis. Clin Microbiol Infect. 2009;15:193-199. doi: 10.1111/j.1469-0691. 2008.02665.x. source
- cites [294] 294. Snygg-Martin U, Rasmussen RV, Hassager C, Bruun NE, Andersson R, Olaison L. The relationship between cerebrovascular complica- tions and previously established use of antiplatelet therapy in left- sided infective endocarditis. Scand J Infect Dis. 2011;43:899-904. doi: 10.3109/00365548.2011.603742. source
- cites [295] 295. Anavekar NS, Schultz JC, De Sa DD, Thomas JM, Lahr BD, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM. Modifiers of symptomatic embolic risk in infective endocarditis [published correction appears in Mayo Clin Proc. 2012;87:309]. Mayo Clin Proc. 2011;86:1068-1074. doi: 10.4065/mcp.2011.0111. source
- cites [296] 296. Omari B, Shapiro S, Ginzton L, Robertson JM, Ward J, Nelson RJ, Bayer AS. Predictive risk factors for periannular extension of native valve endocarditis: clinical and echocardiographic analyses. Chest. 1989;96:1273-1279. source
May combine two claims.
PremisecitationNo significant benefit was observed in aspirin-treated patients in terms of vegetation resolution and embolic events, and there was a trend toward more bleeding episodes in the aspirin-treated patients.
“No significant benefit was observed in aspirin-treated patients in terms of vegetation resolution and embolic events.Moreover, there was a trend toward more bleeding episodes in the aspirin-treated patients.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [288] 288. Chan KL, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek MA, Robinson TI, Moher D; Investigators of the Multicenter Aspirin Study in Infective Endocarditis. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42:775-780. source
May combine two claims.
PremisecitationTEE dramatically improves the sensitivity for defining periannular extension of IE (76% to 100%) while retaining excellent specificity (95%) and positive and negative predictive values (87% and 89%, respectively).
“TEE dramatically improves the sensitivity for defining periannular extension of IE (76% to 100%) while retaining excellent specificity (95%) and positive and negative predictive values (87% and 89%, respectively).54,307”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [54] 54. Daniel WG, Mügge A, Martin RP, Lindert O, Hausmann D, Nonnast- Daniel B, Laas J, Lichtlen PR. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991;324:795-800. doi: 10.1056/NEJM199103213241203. source
The Transesophageal Echocardiography section (p. 2) reports that TEE detected more endocarditis-associated abscesses than transthoracic echocardiography, with specificity of 94.6%—approximately the claimed 95%. It reports TEE sensitivity of 87%, positive predictive value of 90.9%, and negative predictive value of 92.1%, not the claimed sensitivity range of 76% to 100% and predictive values of 87% and 89%. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [307] source
The case report describes echocardiographic identification of a mitral anular abscess (Course and echocardiographic findings; Discussion, pp. 953–955). Our copy does not assess TEE against another method or report the claimed sensitivity, specificity, or predictive values; searches for those terms and figures found no supporting passage. (LLM, conf=0.78)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationUnder conditions of extensive destruction of periannular supporting tissues, human aortic homografts, when available, can be used to replace the damaged aortic valve and to reconstruct the damaged aorta.
“Under these conditions, human aortic homografts, when available, can be used to replace the damaged aortic valve and to reconstruct the damaged aorta.310,311”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
FindingcitationFournier et al studied 20 pathologically confirmed cases of Q fever infective endocarditis; when the original Duke criteria were used, 4 of the 20 patients were classified as having possible infective endocarditis, and when Q fever serological results and a single blood culture positive for Coxiella burnetii were considered a major criterion, each of these 4 cases was reclassified from possible to
“Fournier et al 40 studied 20 pathologically confirmed cases of Q fever IE.When the original Duke criteria were used, 4 of the 20 patients were classified as having possible IE.When Q fever serological results and a single blood culture positive for C burnetii were considered to be a major criterion, however, each of these 4 cases was reclassified from possible IE to definite IE.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] 40. Fournier PE, Casalta JP, Habib G, Messana T, Raoult D. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med. 1996;100:629-633. source
May combine two claims.
Findingown dataIn a reanalysis of patients in the Duke University database containing records on more than 800 cases of definite and possible infective endocarditis since 1984, the echocardiographic minor criterion was used in only 5% of cases and was never used in the final analysis of any patient who underwent transesophageal echocardiography.
“In a reanalysis of patients in the Duke University database (containing records collected prospectively on >800 cases of definite and possible IE since 1984), this echocardiographic criterion was used in only 5% of cases and was never used in the final analysis of any patient who underwent transesophageal echocardiography (TEE).”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningCases with limited manifestations of infective endocarditis may occur early during infection, particularly among injection drug users, in whom infective endocarditis is often the result of acute Staphylococcus aureus infection of right-sided heart valves.
“Cases with limited manifestations of IE may occur early during IE, particularly among patients who are injection drug users (IDUs), in whom IE is often the result of acute S aureus infection of right-sided heart valves.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationThe overall incidence of infective endocarditis has remained stable.
“Although the overall IE incidence has remained stable, 1,2,[5][6][7][8][9]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 1,2,[5][6][7][8][9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingnone givenThe major limitations of erythrocyte sedimentation rate and C-reactive protein are that they are nonspecific and particularly challenging to interpret in patients with comorbid conditions.
“The major limitations of the erythrocyte sedimentation rate and C-reactive protein are that they are nonspecific and particularly challenging to interpret in patients with comorbid conditions.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenRight-sided infective endocarditis can cause septic pulmonary emboli.
“Right-sided IE, however, can cause septic pulmonary emboli.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationCharacteristics of infective endocarditis patients have shifted toward increased mean patient age, a higher proportion of prosthetic valves and other cardiac devices, and a decreasing proportion of rheumatic heart disease.
“Characteristics of IE patients have also shifted toward an increased mean patient age, a higher proportion of prosthetic valves and other cardiac devices, and a decreasing proportion of rheumatic heart disease.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationDirect analyses of the Duke criteria in 12 major studies including nearly 1700 patients confirmed the high sensitivity and specificity of the Duke criteria and the diagnostic utility of echocardiography in identifying clinically definite cases.
“The studies [27][28][29][30][31][32][33][34][35][36][37][38] confirmed the high sensitivity and specificity of the Duke criteria and the diagnostic utility of echocardiography in identifying clinically definite cases.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27][28][29][30][31][32][33][34][35][36][37][38]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S4 (based).
Findingnone givenSome patients will have significant valvular dysfunction at the end of otherwise successful antimicrobial treatment that will require eventual valvular surgery.
“Some patients will have significant valvular dysfunction at the end of otherwise successful antimicrobial treatment that will require eventual valvular surgery.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Findingnone givenAll patients who have experienced an episode of infective endocarditis remain at increased risk for recurrent infection indefinitely.
“All patients who have experienced an episode of IE remain at increased risk for recurrent infection indefinitely.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationBoth β-lactam therapy alone and combination therapy with nafcillin and an aminoglycoside for only 2 weeks have been effective in patients with uncomplicated right-sided IE caused by S aureus.
“Both β-lactam therapy alone and combination therapy with nafcillin and an aminoglycoside for only 2 weeks have been effective in patients with uncomplicated right-sided IE caused by S aureus 91 ; monotherapy with a β-lactam would be selected for use in cases of uncomplicated IE. 92”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] 91. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988;109:619-624. source
May combine two claims.
FindingcitationIn a prospective study of 25 infective endocarditis cases, 18F-fluorodeoxyglucose positron emission tomography/computed tomography was useful in identifying peripheral embolization in 11 patients and in detecting infective endocarditis extracardiac manifestations in 7 patients who did not demonstrate any clinical manifestations of infective endocarditis.
“In a prospective study of 25 IE cases, 18 F-fluorodeoxyglucose positron emission tomography/ CT was useful in identifying peripheral embolization in 11 patients and in detecting IE extracardiac manifestations in 7 patients who did not demonstrate any clinical manifestations of IE. 70”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] 70. Van Riet J, Hill EE, Gheysens O, Dymarkowski S, Herregods MC, Herijgers P, Peetermans WE, Mortelmans L. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging. 2010;37:1189-1197. doi: 10.1007/s00259-010-1380-x. source
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenCriteria changes that add sensitivity often do so at the expense of specificity and vice versa.
“Criteria changes that add sensitivity often do so at the expense of specificity and vice versa.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationIn the setting of a prosthetic valve, transthoracic images are greatly hampered by the structural components of the prosthesis and are inadequate for assessment of the perivalvular area where those infections often start.
“In the setting of a prosthetic valve, transthoracic images are greatly hampered by the structural components of the prosthesis and are inadequate for assessment of the perivalvular area where those infections often start.48”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [48] 48. Daniel WG, Mügge A, Grote J, Hausmann D, Nikutta P, Laas J, Lichtlen PR, Martin RP. Comparison of transthoracic and transesophageal echocar- diography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions. Am J Cardiol. 1993;71:210-215. source
May combine two claims.
FindingcitationAn interval increase in vegetation size on serial echocardiography despite the administration of appropriate antibiotic therapy has serious implications and has been associated with an increased risk of complications and the need for surgery.
“An interval increase in vegetation size on serial echocardiography despite the administration of appropriate antibiotic therapy has serious implications and has been associated with an increased risk of complications and the need for surgery.60”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] 60. Rohmann S, Erbel R, Darius H, Görge G, Makowski T, Zotz R, Mohr- Kahaly S, Nixdorff U, Drexler M, Meyer J. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr. 1991;4:465-474. source
May combine two claims.
FindingcitationSeveral echocardiographic features identify patients at high risk for a complicated course or with a need for surgery, including large (>10 mm) vegetations, severe valvular insufficiency, abscess cavities or pseudoaneurysms, valvular perforation or dehiscence, and evidence of decompensated heart failure.
“Several echocardiographic features identify patients at high risk for a complicated course or with a need for surgery (Table 5).These features include large (>10 mm in diameter) vegetations, severe valvular insufficiency, abscess cavities or pseudoaneurysms, valvular perforation or dehiscence, and evidence of decompensated heart failure.21”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] 21. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA 3rd, Gewitz M, Newburger JW, Schron EB, Taubert KA; on behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; and Interdisciplinary Council on Quality of Care. Update on cardiovascu- lar implantable electronic device infections and their management: source
May combine two claims.
Findingnone givenLower temporal and lateral resolution with 3-dimensional echocardiography compared with 2-dimensional echocardiography leads to an overestimation of vegetation size and technically challenging visualization of fast-moving structures.
“the lower temporal and lateral resolution with 3D echocardiography compared with 2-dimensional echocardiography leads to an overestimation of vegetation size and technically challenging visualization of fast-moving structures.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe role of cerebral magnetic resonance imaging and magnetic resonance angiography in the diagnosis and management of infective endocarditis has been better defined in several studies.
“the role of cerebral MRI and magnetic resonance angiography in the diagnosis and management of IE has been better defined in several studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenSeveral risk stratification models for quantifying morbidity and mortality in infective endocarditis patients overall and particularly in those undergoing valve surgeries have been developed and validated.
“several risk stratification models for quantifying morbidity and mortality in IE patients overall and particularly in those undergoing valve surgeries have been developed and validated.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenSix common but less specific findings of infective endocarditis were included as minor criteria in the original Duke schema.
“Six common but less specific findings of IE were included as minor criteria in the original Duke schema (Tables 2 and 3).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenDiagnostic innovations have emerged through new imaging techniques such as 3-dimensional echocardiography, head-to-toe multislice computed tomography, and cardiac magnetic resonance imaging.
“diagnostic innovations have emerged through new imaging techniques such as 3-dimensional (3D) echocardiography,”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe Duke criteria gave diagnostic weight to bacteremia with staphylococci or enterococci only, on the basis of the location of acquisition and without an apparent primary focus; these types of bacteremia have the highest risk of being associated with infective endocarditis.
“The Duke criteria gave diagnostic weight to bacteremia with staphylococci or enterococci only, on the basis of the location of acquisition and without an apparent primary focus; these types of bacteremia have the highest risk of being associated with IE. 23,25,26”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [23] 23. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infec- tive endocarditis: utilization of specific echocardiographic findings: Duke Endocarditis Service. Am J Med. 1994;96:200-209. source
- cites [25] 25. Bayer AS, Lam K, Ginzton L, Norman DC, Chiu CY, Ward JI. Staphylococcus aureus bacteremia: clinical, serologic, and echocardio- graphic findings in patients with and without endocarditis. Arch Intern Med. 1987;147:457-462. source
- cites [26] 26. Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163:2066- 2072. doi: 10.1001/archinte.163.17.2066. source
May combine two claims.
PremisecitationInfected vegetations are characterized by focal infection with high bacterial density, slow bacterial growth within biofilms, and low microorganism metabolic activity.
“These characteristics include focal infection with high bacterial density, slow rate of bacterial growth within biofilms, and low microorganism metabolic activity.72”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72] 72. Durack DT, Beeson PB. Experimental bacterial endocarditis, II: survival of a bacteria in endocardial vegetations. Br J Exp Pathol. 1972;53:50-53.
May combine two claims.
InterpretationcitationLoss of penicillin-binding proteins during stationary-phase growth may be responsible in part for the inoculum effect observed in vivo and may account for the failure of penicillin in both experimental and human cases of severe streptococcal infections.
“This loss of penicillin-binding proteins during stationary-phase growth may be responsible in part for the inoculum effect observed in vivo and may account for the failure of penicillin in both experimental and human cases of severe streptococcal infections.80”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] 80. Stevens DL, Yan S, Bryant AE. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis. 1993;167:1401-1405. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe Duke criteria were originally developed to facilitate epidemiological and clinical research efforts so that investigators could compare and contrast the clinical features and outcomes of various case series of patients.
“the Duke criteria were originally developed to facilitate epidemiological and clinical research efforts so that investigators could compare and contrast the clinical features and outcomes of various case series of patients.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNafcillin-gentamicin combination therapy did not reduce mortality or the frequency of cardiac complications.
“However, combination therapy did not reduce mortality or the frequency of cardiac complications.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [153] 153. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to paren- teral drugs and in nonaddicts: a prospective study. Ann Intern Med. 1982;97:496-503. source
May combine two claims.
InterpretationcitationA growing body of evidence suggests that the addition of adjunctive aminoglycoside therapy is unnecessary for patients with uncomplicated right-sided native valve S aureus infective endocarditis and may cause harm.
“A growing body of evidence suggests that the addition of adjunctive aminoglycoside therapy not only is unnecessary for patients with uncomplicated right-sided native valve S aureus IE but may cause harm.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationLinezolid was reported to be effective in the treatment of persistent MRSA bacteremia, but this study had important study design weaknesses.
“Linezolid was reported to be effective in the treatment of persistent MRSA bacteremia, 172 but this study had important study design weaknesses.173”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIn an observational study, high-dose daptomycin at approximately 9 mg/kg per dose for treatment of left-sided infective endocarditis was as effective as standard-of-care therapy and cleared MRSA bacteremia significantly faster than standard-of-care treatment.
“However, in an observational study, high-dose daptomycin (≈9 mg/kg per dose) for treatment of left-sided IE was as effective as standard-of-care therapy and cleared MRSA bacteremia significantly faster than did standard-ofcare treatment.155”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [155] 155. Carugati M, Bayer AS, Miró JM, Park LP, Guimarães AC, Skoutelis A, Fortes CQ, Durante-Mangoni E, Hannan MM, Nacinovich F, Fernández- Hidalgo N, Grossi P, Tan RS, Holland T, Fowler VG Jr, Corey RG, Chu VH; International Collaboration on Endocarditis. High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Antimicrob Agents Chemother. 2013;57:6213-6222. doi: 10.1128/AAC.01563-13. source
May combine two claims.
PremisecitationCompared with other patients with infective endocarditis, patients with enterococcal infective endocarditis are older, often debilitated, may have complicated underlying urological conditions including pre-existing renal failure, may have healthcare-associated infections, and have significant other underlying comorbidities common in older age groups.
“Compared with other patients with IE, in general, patients with enterococcal IE are older; are often debilitated; may have complicated, underlying urological conditions, including pre-existing renal failure; may have healthcare-associated infections; and have significant other underlying comorbidities common in older age groups.192”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [192] source
May combine two claims.
PremisecitationExperimental infective endocarditis models caused by methicillin-resistant staphylococci demonstrated that vancomycin combined with rifampin and gentamicin is the optimal regimen, and limited clinical reports support this approach.
“Experimental IE models caused by methicillin-resistant staphylococci demonstrated that vancomycin combined with rifampin and gentamicin is the optimal regimen, and limited clinical reports support this approach.183”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [183] 183. Drinković D, Morris AJ, Pottumarthy S, MacCulloch D, West T. Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. J Antimicrob Chemother. 2003;52:820- 825. doi: 10.1093/jac/dkg440. source
Classified as probably not a substantial claim.
PremisecitationBecause of the high mortality rate associated with S aureus prosthetic valve infective endocarditis, combination antimicrobial therapy is recommended.
“Because of the high mortality rate associated with S aureus PVE, 136 combination antimicrobial therapy is recommended (Table 11).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [136] 136. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabé J, Morris A, Corey GR, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of pros- thetic valve endocarditis. JAMA. 2007;297:1354-1361. doi: 10.1001/ jama.297.12.1354. source
May combine two claims.
PremisecitationIn the Markowitz et al report, all treatment failures with trimethoprim-sulfamethoxazole occurred in patients infected with MSSA, whereas patients with MRSA infection were uniformly cured.
“Interestingly, all treatment failures with trimethoprim-sulfamethoxazole occurred in patients infected with MSSA in that report, 165 whereas patients with MRSA infection were uniformly cured.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [165] 165. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim- sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med. 1992;117:390-398. doi: 10.7326/0003-4819-117-5-390. source
May combine two claims.
PremisecitationIncreasing the dose of gentamicin in patients with normal renal function did not result in enhanced efficacy but did increase the risk of nephrotoxicity.
“Increasing the dose of gentamicin in these patients did not result in enhanced efficacy but did increase the risk of nephrotoxicity.194”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [194] source
May combine two claims.
Study design and conductcitationThe meta-analysis included small, retrospective studies, which limits support for initial combination therapy by some experts.
“The meta-analysis included small, retrospective studies, however, which limits support for initial combination therapy by some experts.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [154] 154. McConeghy KW, Bleasdale SC, Rodvold KA. The empirical combina- tion of vancomycin and a β-lactam for staphylococcal bacteremia. Clin Infect Dis. 2013;57:1760-1765. doi: 10.1093/cid/cit560. source
May combine two claims.
PremisecitationLevine and Lamp reported daptomycin cure in 6 of 9 patients with E faecium IE; both daptomycin-treated patients reported by Segreti et al died.
“Levine and Lamp 208 reported daptomycin cure in 6 of 9 patients with E faecium IE; both daptomycin-treated patients with E faecium IE reported by Segreti et al 209 died.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Interpretationown dataThe major advantages of the ampicillin-ceftriaxone regimen are the lower risk of nephrotoxicity and the lack of need for measuring aminoglycoside serum concentrations.
“The major advantages of the ampicillin-ceftriaxone regimen are the lower risk of nephrotoxicity and the lack of need for measuring aminoglycoside serum concentrations.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn the larger study, there were no significant differences between ampicillin-ceftriaxone and ampicillin-gentamicin in need for surgery, complications (except fewer renal failure cases in ampicillin-ceftriaxone), relapse, or mortality.
“Sixth, in the larger study, there were no significant differences between ampicillin-ceftriaxone and ampicillin-gentamicin in the need for surgery, complications (except for fewer cases of renal failure in the ampicillin-ceftriaxone group), relapse, or mortality.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
May combine two claims.
PremisecitationThe combination of ampicillin and imipenem acted synergistically in vitro and was effective therapy of multidrug-resistant enterococcal experimental IE.
“The combination of ampicillin and imipenem acted synergistically in vitro and was effective therapy of multidrug-resistant enterococcal experimental IE.198”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [198] source
May combine two claims.
PremisecitationNone of the patients in either study developed nephrotoxicity with ampicillin-ceftriaxone therapy, whereas 20 of 87 (23%) ampicillin-gentamicin-treated patients developed nephrotoxicity (P<0.001).
“Third, none of the patients in either study developed nephrotoxicity with ampicillin-ceftriaxone therapy, whereas 20 of 87 (23%) ampicillin-gentamicin-treated patients developed nephrotoxicity (P<0.001).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
- cites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
May combine two claims.
PremisecitationMultiple other case reports describe daptomycin failures, some due to emergence of daptomycin resistance during treatment.
“Multiple other case reports describe daptomycin failures, some as a result of emergence of daptomycin-resistance during treatment.210,211”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationThese are the largest series of E faecalis IE reported to date, 43 patients in one study and 272 in the other.
“First, these are the largest series of E faecalis IE reported to date, 43 patients in 1 study 190 and 272 in the other study.191”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
- cites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
May combine two claims.
PremisecitationMave et al compared daptomycin with linezolid for vancomycin-resistant Enterococcus bacteremia; 5 patients had E faecium IE, 1 of 2 daptomycin-treated and 2 of 3 linezolid-treated survived.
“Mave et al 203 compared daptomycin with linezolid for vancomycin-resistant Enterococcus bacteremia.Five patients had E faecium IE; 1 of 2 daptomycin-treated patients and 2 of 3 linezolid-treated patients survived.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [203] source
May combine two claims.
Premisecitation>90% of enterococci are reportedly susceptible in vitro to daptomycin, but daptomycin resistance is an increasing problem.
“Although >90% of enterococci are reportedly susceptible in vitro to daptomycin, the emergence of daptomycin resistance is an increasing problem.207”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [207] source
May combine two claims.
PremisecitationPositive blood cultures are a major diagnostic criterion in IE and key to identifying a pathogenic agent and optimal antimicrobial regimen.
“Positive blood cultures are a major diagnostic criterion in IE and key to identifying an pathogenic agent and an optimal antimicrobial regimen.225,226”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [225] 225. Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med. 1981;94(pt 1):505-518. source
- cites [226] 226. Washington JA. The microbiological diagnosis of infective endocarditis. J Antimicrob Chemother. 1987;20(suppl A):29-39. source
May combine two claims.
PremisecitationEscherichia coli and Pseudomonas aeruginosa accounted for 51% of cases, and 59% had PVE.
“Escherichia coli and Pseudomonas aeruginosa accounted for 51% of cases, and 59% had PVE.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [221] 221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-835. source
Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
PremisecitationIn-hospital mortality rate was 24% for non-HACEK Gram-negative IE.
“Although management included cardiac surgery in 51% of cases, the in-hospital mortality rate was 24%.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [221] 221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-835. source
May combine two claims.
PremisecitationIn that analysis, serological results were positive in 47.7% of cases, primarily for Coxiella and Bartonella species.
“Second, serological results were positive in 47.7% of cases, primarily for Coxiella and Bartonella species infection.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
May combine two claims.
PremisecitationFungal infective endocarditis is rare but can develop in a wide range of patients.
“Fungal IE is rare but can develop in a wide range of patients.240,241”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [240] 240. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310. source
- cites [241] 241. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endo- carditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62. doi: 10.1086/317550. source
May combine two claims.
PremisecitationIn a large prospective analysis of referred samples, a pathogen was identified in 62.7% of 759 cases; in 2.5%, a noninfectious origin was confirmed.
“First, there was identification of a pathogen in 62.7% of 759 cases; in 2.5%, a noninfectious origin (see below) was confirmed.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
May combine two claims.
PremisecitationAspergillus is a cause of culture-negative infective endocarditis, and when this occurs it is usually in a patient with a prosthetic cardiac valve.
“Thus, Aspergillus is a cause of culture-negative IE, and when this occurs, it is usually in a patient with a prosthetic cardiac valve.240”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [240] 240. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAnti-phospholipid antibody syndrome has been described as both a primary and secondary syndrome and is associated with presence of APA.
“Perhaps the one that has received the most attention is anti-phospholipid antibody (APA) syndrome, 238 which has been described as both a primary and a secondary syndrome and is associated with the presence of APA.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [238] 238. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involve- ment (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579-1587. source
May combine two claims.
PremisecitationFungal infective endocarditis has been recognized as a cause of early prosthetic valve endocarditis, but in a single-center case series 43% of these cases had symptom onset more than 1 year after prosthetic valve placement.
“Fungal IE has been recognized as a cause of early PVE, but a case series from a single medical center demonstrated that 43% of these cases had symptom onset >1 years after prosthetic valve placement.242”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [242] 242. Nguyen MH, Nguyen ML, Yu VL, McMahon D, Keys TF, Amidi M. Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin Infect Dis. 1996;22:262-267. source
May combine two claims.
PremisecitationBlood cultures are ultimately positive in most cases of Candida infective endocarditis, whereas they are rarely positive in cases caused by Aspergillus.
“Blood cultures are ultimately positive in most cases caused by the former pathogen, whereas they are rarely positive in cases caused by the latter fungus.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [240] 240. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310. source
- cites [241] 241. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endo- carditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62. doi: 10.1086/317550. source
May combine two claims.
PremisecitationA meta-analysis of 64 reported patients with Candida infective endocarditis who did not undergo valve surgery because they were deemed unacceptable surgical candidates supports the notion that fluconazole suppressive therapy is useful; 20 of 21 patients (95%) ultimately treated with long-term suppressive therapy survived during follow-up of at least 6 months.
“A meta-analysis that included 64 reported patients with Candida IE who did not undergo valve surgery because they were deemed to be unacceptable surgical candidates supports the notion that fluconazole suppressive therapy is useful; 20 of 21 patients (95%) who were ultimately treated with long-term suppressive therapy survived during follow-up, which was ≥6 months.244”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [244] 244. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, Zaas AK, Benjamin DK Jr. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230-247. doi: 10.1016/j. jinf.2004.10.016. source
May combine two claims.
PremisecitationCandida and Aspergillus species account for the large majority of fungal infective endocarditis, and Candida-related infective endocarditis is much more common than Aspergillus-related disease.
“Candida and Aspergillus species account for the large majority of fungal IE, and Candida-related IE is much more common than Aspergillus-related disease.240,241”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [240] 240. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310. source
- cites [241] 241. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endo- carditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62. doi: 10.1086/317550. source
May combine two claims.
PremisecitationPatients in this trial were young, had limited comorbidity based on a EuroSCORE, a low prevalence of S aureus infective endocarditis, and lower mortality compared with most contemporary patient cohorts.
“In addition, patients in this trial were young and had limited comorbidity based on a EuroSCORE, a calculated risk of surgical mortality (http://www.euroscore.org), a low prevalence of S aureus IE, and lower mortality compared with most contemporary patient cohorts.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
Probably not a substantial claim: may not pass S1 (asserted), S4 (based). The quote only partly states this claim.
PremisecitationSubgroup analysis indicated lower in-hospital and 1-year mortality with early surgery only in the group of prosthetic valve infective endocarditis patients with the highest surgical propensity.
“Subgroup analysis indicated a lower in-hospital and 1-year mortality with early surgery only in the group of patients with the highest surgical propensity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [259] 259. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, Fowler VG Jr, Gordon D, Grossi P, Hannan M, Hoen B, Muñoz P, Rizk H, Kanj SS, Selton-Suty C, Sexton DJ, Spelman D, Ravasio V, Tripodi MF, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis [published correction appears in JAMA Intern Med. 2013;173:1846]. JAMA Intern Med. 2013;173:1495-1504. doi: 10.1001/jamainternmed. 2013.8203. source
May combine two claims.
PremisecitationOnly 1 study examined the role of valve surgery in prosthetic valve infective endocarditis; after adjustment for differences in clinical characteristics and survival bias, early valve replacement was not associated with lower mortality compared with medical therapy in the overall cohort.
“Only 1 study examined the role of valve surgery in PVE.259 After adjustment for differences in clinical characteristics and survival bias, early valve replacement was not associated with lower mortality compared with medical therapy in the overall cohort.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [259] 259. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, Fowler VG Jr, Gordon D, Grossi P, Hannan M, Hoen B, Muñoz P, Rizk H, Kanj SS, Selton-Suty C, Sexton DJ, Spelman D, Ravasio V, Tripodi MF, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis [published correction appears in JAMA Intern Med. 2013;173:1846]. JAMA Intern Med. 2013;173:1495-1504. doi: 10.1001/jamainternmed. 2013.8203. source
May combine two claims.
Interpretationnone givenAfter stroke, neurological deterioration can occur as a result of hemorrhagic transformation with anticoagulation during cardiopulmonary bypass or exacerbation of cerebral ischemia attributable to hypotension during cardiac surgery.
“After stroke, neurological deterioration can occur as a result of hemorrhagic transformation with anticoagulation during cardiopulmonary bypass or exacerbation of cerebral ischemia attributable to hypotension during cardiac surgery.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe trial reported a reduction in the composite outcome of in-hospital deaths and embolic events with early surgery (3% versus 23%), but the difference between groups was driven by a significant decrease in embolic events with early surgery.
“Although the authors 17 report a reduction in the composite outcome of in-hospital deaths and embolic events with early surgery (3% versus 23%), the differences between the 2 groups were driven by a significant decrease in embolic events with early surgery.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
May combine two claims.
PremisecitationIn a study based on transesophageal echocardiography, mitral vegetations greater than 1 cm in diameter were associated with the greatest frequency of embolism, and the association was strengthened when the analysis was limited to patients who had not yet experienced a clinical embolic event.
“In a study 57 based on TEE, mitral vegetations >1 cm in diameter were associated with the greatest frequency of embolism.The association was strengthened when the analysis was limited to those patients who had not yet experienced a clinical embolic event.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] 57. Mügge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infec- tive endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989;14:631-638. doi: 10.1016/0735-1097(89)90104-6. source
May combine two claims.
PremisecitationThe first study to evaluate the timing of surgery after stroke in infective endocarditis that included a risk adjustment for differences in patient characteristics comprised 198 patients; 58 patients underwent surgery within 1 week of stroke and 140 underwent surgery at least 8 days after stroke.
“The first study to evaluate the timing of surgery after stroke in IE that included a risk adjustment for differences in patient characteristics comprised 198 patients.273 Fifty-eight patients who underwent surgery within 1 week of stroke were compared with 140 patients who underwent surgery ≥8 days after stroke.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [273] source
May combine two claims.
PremisecitationUp to 65% of embolic events involve the central nervous system, and more than 90% of central nervous system emboli lodge in the distribution of the middle cerebral artery.
“Up to 65% of embolic events involve the CNS, and >90% of CNS emboli lodge in the distribution of the middle cerebral artery.277”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [277] source
May combine two claims.
PremisecitationHospital mortality was numerically but not significantly higher in the early surgery group (22.4% versus 12%).
“Hospital mortality was numerically but not significantly higher in the early surgery group (22.4% versus 12%).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [273] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenRates of embolization can be higher if noninvasive imaging, including MRI and CT scanning, is routinely done to detect asymptomatic emboli.
“Rates can be higher if noninvasive imaging, including MRI and CT scanning, is routinely done to detect asymptomatic (silent) emboli.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAfter hemorrhagic stroke, the risk of exacerbation by surgery is prohibitively high in the first month but can extend beyond 1 month in some patients, possibly because of the presence of undetected mycotic aneurysms.
“After hemorrhagic stroke, the risk of exacerbation by surgery is prohibitively high in the first month but can extend beyond 1 month in some patients, possibly because of the presence of undetected mycotic aneurysms (MAs).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA second, infrequent peak of late embolic events has been observed to occur 15 to 30 weeks after the diagnosis of infective endocarditis and has been associated with nonhealing vegetations as defined by echocardiography.
“In addition, a second, albeit infrequent, peak of late embolic events has been observed to occur 15 to 30 weeks after the diagnosis of IE and has been associated with nonhealing vegetations (failure of a vegetation to stabilize or diminish in size) as defined by echocardiography.63”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] 63. Konstadt SN, Louie EK, Shore-Lesserson L, Black S, Scanlon P. The effects of loading changes on intraoperative Doppler assessment of mitral regurgitation. J Cardiothorac Vasc Anesth. 1994;8:19-23. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningThe role of echocardiography in predicting embolic events has been controversial.
“The role of echocardiography in predicting embolic events has been controversial.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn a survey that included 4 echocardiographers blinded to clinical data, interobserver agreement was high for the presence of vegetation (98%) and involved site (97%), but considerably less for vegetation size (73%), mobility (57%), shape (37%), and attachment (40%).
“In 1 survey 282 that included 4 echocardiographers who were blinded to clinical data, interobserver agreement was mixed on the characterization of vegetations.Agreement was high for the presence of vegetation (98%) and involved site (97%); interobserver agreement was considerably less for vegetation size (73%), mobility (57%), shape (37%), and attachment (40%).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [282] source
May combine two claims.
InterpretationcitationThe anatomic vulnerability of the area near the membranous septum and atrioventricular node explains both why abscesses occur in this location and why heart block is a frequent sequela.
“The anatomic vulnerability of this area explains both why abscesses occur in this location and why heart block is a frequent sequela.300”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [300] 300. Arnett EN, Roberts WC. Prosthetic valve endocarditis: clinicopathologic analysis of 22 necropsy patients with comparison observations in 74 nec- ropsy patients with active infective endocarditis involving natural left- sided cardiac valves. Am J Cardiol. 1976;38:281-292. source
May combine two claims.
InterpretationreasoningThe criterion of at least 2 major embolic events for valvular surgery is arbitrary and excludes cutaneous embolization, which is common, or embolism occurring before the institution of therapy, which is common among infective endocarditis patients who develop embolic events.
“This criterion is arbitrary and excludes cutaneous embolization, which is common, or embolism occurring before the institution of therapy, which is common among IE patients who develop embolic events.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Interpretationnone givenA period of at least 2 weeks after a central nervous system embolic event should allow for thrombus organization and prevent the acute hemorrhagic transformation of embolic lesions.
“This time should allow for thrombus organization and prevent the acute hemorrhagic transformation of embolic lesions.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningEarly surgical intervention may preclude a primary or recurrent major embolic event but exposes the patient to both immediate and lifelong risks of valve replacement if the valve cannot be primarily repaired.
“Early surgical intervention may preclude a primary or recurrent major embolic event but exposes the patient to both immediate and lifelong risks of valve replacement if the valve cannot be primarily repaired.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSplenic abscesses generally require splenectomy or a drainage procedure because the usefulness of antimicrobial therapy is in preventing disease extension in the spleen and treating systemic infection rather than eliminating abscesses.
“For example, splenic abscesses generally require splenectomy or a drainage procedure because the usefulness of antimicrobial therapy is in preventing disease extension in the spleen and treating systemic infection rather than eliminating abscesses.314”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [314] source
May combine two claims.
InterpretationreasoningStructural lesions and intracardiac fistulas from periannular infection may be catastrophic; even if their hemodynamic impact is tolerated, these lesions will not heal with medical treatment alone and require urgent operative intervention.
“Such structural lesions and intracardiac fistulas may be catastrophic; even if their hemodynamic impact is tolerated, these lesions will not heal with medical treatment alone and require urgent operative intervention.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPerivalvular abscesses are particularly common with prosthetic valves because the annulus, rather than the leaflet, is the usual primary site of infection, especially in early prosthetic valve infective endocarditis and on bioprosthetic valves.
“Perivalvular abscesses are particularly common with prosthetic valves because the annulus, rather than the leaflet, is the usual primary site of infection, especially in early PVE and on bioprosthetic valves.302”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [302] 302. Carpenter JL. Perivalvular extension of infection in patients with infec- tious endocarditis. Rev Infect Dis. 1991;13:127-138. source
May combine two claims.
PremisecitationOn ECG, new atrioventricular block has a positive predictive value of 88% for abscess formation but low (45%) sensitivity.
“On ECG, new atrioventricular block has a positive predictive value of 88% for abscess formation but low (45%) sensitivity.298”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [298] 298. Blumberg EA, Karalis DA, Chandrasekaran K, Wahl JM, Vilaro J, Covalesky VA, Mintz GS. Endocarditis-associated paravalvular abscesses: do clinical parameters predict the presence of abscess? Chest. 1995;107:898-903. source
May combine two claims.
PremisecitationPeriannular extension is common, occurring in 10% to 40% of all native valve infective endocarditis and complicating aortic infective endocarditis more commonly than mitral or tricuspid infective endocarditis.
“Periannular extension is common, occurring in 10% to 40% of all NVE and complicating aortic IE more commonly than mitral or tricuspid IE. [301][302][303][304]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [301] 301. Fernicola DJ, Roberts WC. Frequency of ring abscess and cuspal infec- tion in active infective endocarditis involving bioprosthetic valves. Am J Cardiol. 1993;72:314-323. source
- cites [302] 302. Carpenter JL. Perivalvular extension of infection in patients with infec- tious endocarditis. Rev Infect Dis. 1991;13:127-138. source
- cites [303] 303. Anguera I, Miro JM, Vilacosta I, Almirante B, Anguita M, Muñoz P, Roman JA, de Alarcon A, Ripoll T, Navas E, Gonzalez-Juanatey C, Cabell CH, Sarria C, Garcia-Bolao I, Fariñas MC, Leta R, Rufi G, Miralles F, Pare C, Evangelista A, Fowler VG Jr, Mestres CA, de Lazzari E, Guma JR; Aorto-cavitary Fistula in Endocarditis Working Group. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J. 2005;26:288-297. doi: 10.1093/eurheartj/ehi034. 304. source
May combine two claims.
PremisecitationMultivariate analysis demonstrated that factors associated with an increased risk of death included moderate to severe heart failure, prosthetic valve infective endocarditis, and urgent or emergency surgical intervention.
“Multivariate analysis demonstrated that factors associated with an increased risk of death included moderate to severe heart failure, PVE, and urgent or emergency surgical intervention.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [304] source
May combine two claims.
PremisecitationOPAT is efficacious, safe, and cost-effective for a variety of infections, including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.
“Outpatient parenteral antibiotic therapy (OPAT) is efficacious, safe, and cost-effective for a variety of infections, [323][324][325] including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationNeurological signs and symptoms in ICMAs are nonspecific and may suggest a mass lesion or an embolic event.
“Neurological signs and symptoms are nonspecific and may suggest a mass lesion or an embolic event.315,317”
Quote in the paperNot a substantial claim0 of 2 sources checked
The paper relies on this without support.
Outcomes of infective endocarditis have not improved despite medical and surgical advances.
“changes in pathogen prevalence, in particular a more common staphylococcal origin, have affected outcomes, which have not improved despite medical and surgical advances.”
The paper relies on this without support.
The modified Duke criteria are universally accepted.
“These additional parameters have not been formally integrated into the modified Duke criteria, 24 however, which are universally accepted.”
The paper relies on this without support.
Host characteristics such as impaired immunity contribute to challenges in treating IE.
“Host characteristics such as impaired immunity also contribute to challenges in therapeutics.”
The paper relies on this without support.
Antibiotics may fail to eradicate infection as a result of increased binding of the drug to serum proteins, perturbations of antibiotic penetration into the vegetation, and unique antibiotic PK/PD features.
“In addition, antibiotics may fail to eradicate infection as a result of increased binding of the drug to serum proteins, perturbations of antibiotic penetration into the vegetation, and unique antibiotic pharmacokinetic/pharmacodynamic (PK/PD) features.”
The paper relies on this without support.
For enterococci, bactericidal activity can be achieved by the combination of certain β-lactam antibiotics with an aminoglycoside.
“For enterococci, bactericidal activity can be achieved by the combination of certain β-lactam antibiotics (eg, penicillin, ampicillin, and piperacillin) with an aminoglycoside.”
The paper relies on this without support.
The rate of bactericidal activity against some other organisms can be enhanced by a combination of a β-lactam antibiotic plus an aminoglycoside.
“The rate of bactericidal activity against some other organisms can also be enhanced by a combination of a β-lactam antibiotic plus an aminoglycoside.”
The paper relies on this without support.
The addition of gentamicin sulfate to penicillin exerts a synergistic killing effect in vitro on VGS and S gallolyticus (bovis).
“The addition of gentamicin sulfate to penicillin exerts a synergistic killing effect in vitro on VGS and S gallolyticus (bovis).”
The paper relies on this without support.
The combination of penicillin or ceftriaxone with gentamicin results in synergistic killing in animal models of VGS or S gallolyticus (bovis) experimental IE.
“The combination of penicillin or ceftriaxone with gentamicin results in synergistic killing in animal models of VGS or S gallolyticus (bovis) experimental IE.”
The paper relies on this without support.
Both penicillin and ceftriaxone are overall well tolerated but have the potential for causing adverse drug events; common ones include rash, fever, diarrhea, and neutropenia.
“Both penicillin and ceftriaxone are overall well tolerated but, like all antimicrobials, have the potential for causing adverse drug events; some of the more common ones include rash, fever, diarrhea, and neutropenia.”
The paper relies on this without support.
Prolonged intravenous use of vancomycin may be complicated by thrombophlebitis, rash, fever, neutropenia, and rarely ototoxic reactions.
“Prolonged intravenous use of vancomycin may be complicated by thrombophlebitis, rash, fever, neutropenia, and rarely ototoxic reactions.”
The paper relies on this without support.
The likelihood of red man syndrome is reduced with an infusion of vancomycin over at least 1 hour.
“The likelihood of “red man” syndrome is reduced with an infusion of vancomycin over ≥1 hour.”
The paper relies on this without support.
Penicillin resistance in vitro occurs among some strains of VGS and S gallolyticus (bovis).
“Penicillin resistance in vitro occurs among some strains of VGS and S gallolyticus (bovis).”
The paper relies on this without support.
In non-IDUs, S aureus infective endocarditis involves primarily the left side of the heart.
“In non-IDUs, S aureus IE involves primarily the left side of the heart and is associated with mortality rates ranging from 25% to 40%.”
The paper relies on this without support.
In non-IDUs, S aureus infective endocarditis is associated with mortality rates ranging from 25% to 40%.
“In non-IDUs, S aureus IE involves primarily the left side of the heart and is associated with mortality rates ranging from 25% to 40%.”
The paper relies on this without support.
S aureus infective endocarditis in IDUs often involves the tricuspid valve.
“S aureus IE in IDUs often involves the tricuspid valve.”
The paper relies on this without support.
Most CoNS are resistant to methicillin.
“Most CoNS are resistant to methicillin.”
The paper relies on this without support.
S lugdunensis tends to cause a substantially more virulent form of infective endocarditis, with a high rate of perivalvular extension of infection and metastatic infection.
“This species of CoNS tends to cause a substantially more virulent form of IE, with a high rate of perivalvular extension of infection and metastatic infection.”
The paper relies on this without support.
Cefazolin has inadequate blood-brain barrier penetrability.
“In cases of brain abscess complicating MSSA IE, nafcillin is the preferred agent rather than cefazolin, which has inadequate blood-brain barrier penetrability.”
The paper relies on this without support.
Current laboratory screening procedures for detecting penicillin susceptibility may not be reliable.
“Unfortunately, the current laboratory screening procedures for detecting penicillin susceptibility may not be reliable.”
The paper relies on this without support.
Enterococci are the third leading cause of infective endocarditis and account for approximately 10% of cases in non-IDUs.
“Enterococci are the third leading cause of IE and account for ≈10% of cases in non-IDUs.”
The paper relies on this without support.
E faecalis causes approximately 97% of cases of enterococcal infective endocarditis; E faecium causes approximately 1% to 2%; and other species cause approximately 1%.
“E faecalis causes ≈97% of cases of IE; E faecium, ≈1% to 2%; and other species, ≈1%.”
The paper relies on this without support.
Killing of susceptible strains of enterococci requires the synergistic action of penicillin, ampicillin, or vancomycin in combination with either gentamicin or streptomycin.
“Killing of susceptible strains of enterococci requires the synergistic action of penicillin, ampicillin, or vancomycin in combination with either gentamicin or streptomycin.”
The paper relies on this without support.
Enterococci are relatively impermeable to aminoglycosides.
“Enterococci are relatively impermeable to aminoglycosides.”
The paper relies on this without support.
High concentrations of aminoglycosides in the extracellular environment are required to achieve sufficient concentrations of the drug at the ribosomal target within the bacterial cell for bactericidal activity.
“High concentrations of aminoglycosides in the extracellular environment are required to achieve sufficient concentrations of the drug at the site of the ribosomal target within the bacterial cell for bactericidal activity.”
The paper relies on this without support.
If an enterococcal strain is resistant to the cell wall-active agent or high concentrations of an aminoglycoside, then the combination of an aminoglycoside and the cell wall-active agent will not result in bactericidal activity in vitro or in vivo, nor predictably produce a microbiological cure in human enterococcal infective endocarditis.
“If an enterococcal strain is resistant to the cell wall-active agent or high concentrations of an aminoglycoside (500 µg/mL gentamicin or 1000 µg/mL streptomycin), then the combination of an aminoglycoside and the cell wall-active agent will not result in bactericidal activity in vitro or in vivo (ie, in experimental IE models), nor will it predictably produce a microbiological cure in human enter”
The paper relies on this without support.
Since the 2005 AHA statement on antimicrobial therapy of patients with infective endocarditis, the frequency of aminoglycoside-resistant strains of enterococci has increased significantly.
“Since the publication of the latest (2005) AHA statement on antimicrobial therapy of patients with IE, 12 the frequency of aminoglycoside-resistant strains of enterococci has increased significantly.”
The paper relies on this without support.
Approximately 97% of cases of enterococcal infective endocarditis are caused by E faecalis, and the majority of these remain susceptible to beta-lactams and vancomycin, but aminoglycoside resistance is increasing in frequency.
“Approximately 97% of cases of enterococcal IE are caused by E faecalis, and the majority of these remain susceptible to β-lactams and vancomycin, but aminoglycoside resistance is increasing in frequency.”
The paper relies on this without support.
Patients with preexisting mild or severe renal failure may not be able to safely complete a 4- to 6-week course of gentamicin therapy because of gentamicin-associated nephrotoxicity.
“Patients with preexisting mild (creatinine clearance, 30-50 mL/min) or severe (creatinine clearance, <30 mL/min) renal failure may not be able to safely complete a 4-to 6-week course of gentamicin therapy because of gentamicin-associated nephrotoxicity.”
The paper relies on this without support.
Streptomycin is less nephrotoxic than gentamicin.
“The main advantage is that streptomycin is less nephrotoxic than gentamicin.”
The paper relies on this without support.
Streptomycin has a higher risk of ototoxicity than gentamicin, which may not be reversible.
“There are several disadvantages of using streptomycin-containing regimens, including a lack of familiarity among clinicians with streptomycin, a higher risk of ototoxicity, which may not be reversible, and drug availability limitations.”
The paper relies on this without support.
Most strains of E faecalis are inhibited but not killed in vitro by penicillin or ampicillin, with MICs usually 2 to 4 µg/mL penicillin; ampicillin MICs are usually 1 dilution lower.
“Most strains of E faecalis are inhibited but not killed in vitro by penicillin or ampicillin, with MICs usually 2 to 4 µg/ mL penicillin; ampicillin MICs are usually 1 dilution lower.”
The paper relies on this without support.
Cephalosporins and antistaphylococcal penicillins have minimal or no in vitro activity against enterococci.
“Cephalosporins and antistaphylococcal penicillins (oxacillin, nafcillin) have minimal or no in vitro activity against enterococci.”
The paper relies on this without support.
The in vitro activity of carbapenems is variable, with imipenem being most active.
“The in vitro activity of carbapenems is variable, with imipenem being most active.”
The paper relies on this without support.
The likely mechanism of double-β-lactam combinations against enterococci is saturation of different penicillin-binding proteins.
“The likely mechanism of double-β-lactam combinations against enterococci is saturation of different penicillin-binding proteins.”
The paper relies on this without support.
The potential disadvantage of ampicillin-ceftriaxone is the possibility of hypersensitivity reactions to 2 separate β-lactams.
“The potential disadvantage is the possibility of hypersensitivity reactions to 2 separate β-lactams.”
The paper relies on this without support.
Aminoglycoside resistance in enterococci is most commonly the result of acquisition of plasmid-mediated aminoglycoside-modifying enzymes.
“Aminoglycoside resistance in enterococci is most commonly the result of the acquisition of plasmid-mediated aminoglycoside-modifying enzymes.”
The paper relies on this without support.
E faecalis strains resistant to high levels of gentamicin are resistant to most other aminoglycosides, although some are susceptible to streptomycin.
“E faecalis strains resistant to high levels of gentamicin are resistant to most other aminoglycosides, although some of them are susceptible to streptomycin.”
The paper relies on this without support.
The total number of cases published in European studies far exceeds the relatively small number of reported streptomycin-treated patients with enterococcal IE.
“The total number of cases published in the European studies far exceeds the relatively small number of reported streptomycin-treated patients with enterococcal IE.”
The paper relies on this without support.
Combinations of penicillin or ampicillin with gentamicin are preferable to combined vancomycin-gentamicin because of the potential increased risk of ototoxicity and nephrotoxicity with the vancomycin-gentamicin combination.
“Combinations of penicillin or ampicillin with gentamicin are preferable to combined vancomycin-gentamicin because of the potential increased risk of ototoxicity and nephrotoxicity with the vancomycin-gentamicin combination.”
The paper relies on this without support.
Combinations of penicillin or ampicillin and gentamicin are more active than combinations of vancomycin and gentamicin in vitro and in animal models of experimental IE.
“Moreover, combinations of penicillin or ampicillin and gentamicin are more active than combinations of vancomycin and gentamicin in vitro and in animal models of experimental IE.”
The paper relies on this without support.
Rarely, strains of E faecalis produce an inducible β-lactamase.
“Rarely, strains of E faecalis produce an inducible β-lactamase.”
The paper relies on this without support.
β-lactamase-producing E faecalis strains are susceptible to ampicillin-sulbactam and to vancomycin.
“These β-lactamase-producing strains are susceptible to ampicillin-sulbactam and to vancomycin.”
The paper relies on this without support.
Intrinsic penicillin resistance is uncommon in E faecalis but is common in E faecium.
“Intrinsic penicillin resistance is uncommon in E faecalis but is common in E faecium.”
The paper relies on this without support.
Most vancomycin-resistant enterococci are E faecium, and as many as 95% of strains express multidrug resistance to vancomycin, aminoglycosides, and penicillins.
“Most of these strains are E faecium, and as many as 95% of strains express multidrug resistance to vancomycin, aminoglycosides, and penicillins.”
The paper relies on this without support.
Only about 3% of E faecalis strains are multidrug resistant, and many vancomycin-resistant E faecalis are penicillin susceptible.
“Only about 3% of E faecalis strains are multidrug resistant, and many vancomycin-resistant E faecalis are penicillin susceptible.”
The paper relies on this without support.
E faecium IE is uncommon.
“Fortunately, E faecium IE is uncommon.”
The paper relies on this without support.
Linezolid and daptomycin are the only 2 antimicrobial agents currently available in the United States that may be useful for treatment of multidrug-resistant E faecium IE.
“Linezolid and daptomycin are the only 2 antimicrobial agents currently available in the United States that may be useful for the treatment of multidrug-resistant E faecium IE.”
The paper relies on this without support.
Quinupristin-dalfopristin may be active in vitro but only against E faecium and is inactive against E faecalis.
“Quinupristin-dalfopristin may be active in vitro but only against strains of E faecium and is inactive against E faecalis.”
The paper relies on this without support.
Quinupristin-dalfopristin is rarely used because of severe side effects, including intractable muscle pain.
“Quinupristin-dalfopristin is rarely used because of severe side effects, including intractable muscle pain.”
The paper relies on this without support.
Tigecycline is active in vitro against some strains of multidrug-resistant enterococci, but there are minimal published data on its clinical use.
“Tigecycline is active in vitro against some strains of multidrug-resistant enterococci, but there are minimal published data on its use clinically.”
The paper relies on this without support.
Linezolid is bacteriostatic in vitro against enterococci, and susceptibility ranges from 97% to 99%, including multidrug-resistant strains.
“Linezolid is bacteriostatic in vitro against enterococci, and susceptibility of enterococci to linezolid ranges from 97% to 99%, including strains that are multidrug resistant.”
The paper relies on this without support.
Daptomycin has bactericidal activity in vitro against susceptible strains of enterococci.
“Daptomycin is a cyclic lipopeptide antibiotic that has bactericidal activity in vitro against susceptible strains of enterococci.”
The paper relies on this without support.
HACEK microorganisms grow slowly in standard blood culture media, and recovery may require prolonged incubation.
“These microorganisms grow slowly in standard blood culture media, and recovery may require prolonged incubation.”
The paper relies on this without support.
Typically, only a small fraction of blood culture bottles in patients with HACEK IE demonstrate growth.
“Typically, only a small fraction of blood culture bottles in patients with HACEK IE demonstrate growth.”
The paper relies on this without support.
Bacteremia caused by HACEK microorganisms in the absence of an obvious focus of infection is highly suggestive of IE even without typical physical findings.
“Bacteremia caused by HACEK microorganisms in the absence of an obvious focus of infection is highly suggestive of IE even without typical physical findings of IE.”
The paper relies on this without support.
Almost all strains of the HACEK group are susceptible to ceftriaxone (or other third- or fourth-generation cephalosporins).
“Almost all strains of the HACEK group are susceptible to ceftriaxone (or other third-or fourth-generation cephalosporins).”
The paper relies on this without support.
There are only a few case reports of HACEK IE treated with a fluoroquinolone.
“There are only a few case reports of HACEK IE treated with a fluoroquinolone, however.”
The paper relies on this without support.
IE caused by non-HACEK Gram-negative aerobic bacilli is rare.
“IE caused by non-HACEK Gram-negative aerobic bacilli (Enterobacteriaceae and Pseudomonas species) is rare.”
The paper relies on this without support.
Prospective trial data are lacking to define the optimal antimicrobial regimen for IE caused by non-HACEK Gram-negative aerobic bacilli.
“Prospective trial data are lacking to define the optimal antimicrobial regimen for the treatment of IE caused by non-HACEK Gram-negative aerobic bacilli.”
The paper relies on this without support.
Medical therapy may be successful in right-sided P aeruginosa IE in 50% to 75% of cases.
“Medical therapy may be successful in right-sided P aeruginosa IE in 50% to 75% of cases.”
The paper relies on this without support.
Patients with right-sided P aeruginosa IE have typically been IDUs and have high recidivism risk.
“Typically, these patients have been IDUs, and because of their high recidivism risk, avoidance of placement of prosthetic valves is desirable.”
The paper relies on this without support.
Continuous bacteremia and a high frequency of positive blood cultures are typical hallmarks of IE.
“Continuous bacteremia and a high frequency of positive blood cultures are typical hallmarks of this infection.”
The paper relies on this without support.
Failure to culture microorganisms that cause IE can be a major problem that complicates diagnosis and timely, effective treatment.
“Failure to culture microorganisms that cause IE can be a major problem that complicates diagnosis and timely, effective treatment.”
The paper relies on this without support.
The causes of culture-negative IE may include inadequate microbiological techniques, infection with highly fastidious bacteria or fungi, noncultivatable agents, or previous administration of antimicrobial agents before blood cultures.
“This may be attributable to inadequate microbiological techniques, infection with highly fastidious bacteria or fungi, noncultivatable agents, or the previous administration of antimicrobial agents before blood cultures were obtained.”
The paper relies on this without support.
IE patients with blood cultures initially negative after only a few days of antibiotic therapy may have positive blood cultures after several days without antibiotics.
“IE patients with blood cultures that are initially negative after only a few days of antibiotic therapy may have positive blood cultures after several days without antibiotics.”
The paper relies on this without support.
The blood cultures of patients who receive longer courses of high-dose bactericidal antimicrobials may remain negative for weeks.
“The blood cultures of patients who receive longer courses of high-dose bactericidal antimicrobials may remain negative for weeks.”
The paper relies on this without support.
Certain therapeutic agents, including aminoglycosides, have potentially toxic effects that dictate limitation or avoidance of use if at all possible.
“On the other hand, certain therapeutic agents, including aminoglycosides, have potentially toxic effects that dictate limitation or avoidance of use if at all possible.”
The paper relies on this without support.
During the period between collection of blood cultures and determination of a pathogen, patients are often treated empirically for the more common bacterial causes of IE, which can result in exposure to potentially toxic therapy that could be avoided with earlier pathogen identification.
“During this period, patients are often treated empirically for the more common bacterial causes of IE, which can result in exposure to potentially toxic therapy that could be avoided with earlier pathogen identification.”
The paper relies on this without support.
During the period between collection of blood cultures and determination of a pathogen or if blood cultures are ultimately deemed culture negative, empirical therapy is generally required.
“During the period between the collection of blood cultures and the determination of a pathogen or if blood cultures are ultimately deemed culture negative, empirical therapy is generally required.”
The paper relies on this without support.
Collection of additional clinical and laboratory data often dictates subsequent revisions in initial empirical therapy.
“Collection of additional clinical and laboratory data often dictates subsequent revisions in initial empirical therapy that will be administered over the treatment course.”
The paper relies on this without support.
The organisms that have garnered the most attention as causes of culture-negative IE are Bartonella species, Chlamydia species, C burnetii, Brucella species, Legionella species, Tropheryma whipplei, Candida, and non-Candida fungi.
“The organisms that have garnered the most attention are Bartonella species, Chlamydia species, C burnetii, Brucella species, Legionella species, Tropheryma whipplei, Candida, and non-Candida fungi (particularly Aspergillus species).”
The paper relies on this without support.
The last 2 groups of organisms (Candida and non-Candida fungi) are especially relevant to PV recipients.
“The last 2 groups of organisms are especially relevant to PV recipients.”
The paper relies on this without support.
With special diagnostic techniques, Bartonella species, C burnetii, and Brucella species have been identified in the majority of cases of culture-negative IE caused by fastidious organisms.
“With the use of special diagnostic techniques, Bartonella species, C burnetii, and Brucella species have been identified in the majority of cases of culture-negative IE caused by fastidious organisms.”
The paper relies on this without support.
In some cases, serological and special blood culture techniques can be helpful for culture-negative IE.
“In some cases, serological and special blood culture techniques can be helpful.”
The paper relies on this without support.
In other cases, tissue (usually valve) screening is required for culture-negative IE.
“In other cases, tissue (usually valve) screening is required.”
The paper relies on this without support.
Diagnostic methods for resected valve tissue include microbiological, histopathological, and molecular techniques, the last of which includes gene amplification with PCR.
“Diagnostic methods for resected valve tissue include microbiological, histopathological, and molecular techniques, the last of which includes gene amplification with PCR methods.”
The paper relies on this without support.
Most clinical laboratories do not perform molecular screening, and specimens must be sent to reference laboratories.
“Unfortunately, most clinical laboratories do not perform molecular screening, and specimens must be sent to reference laboratories.”
The paper relies on this without support.
Incidence data from population-based surveys for IE caused by these organisms are lacking in the United States.
“Incidence data from population-based surveys for IE caused by these organisms are lacking in the United States.”
The paper relies on this without support.
Treatment of culture-negative IE without prior antibiotic exposure is based on limited data.
“Treatment of the wide variety of microorganisms that cause culture-negative IE without prior antibiotic exposure has been described anecdotally, and regimens of choice are based on limited data and can be found in other publications.”
The paper relies on this without support.
Noninfectious causes of valvular vegetations can produce a syndrome similar to culture-negative IE.
“Noninfectious causes of valvular vegetations can produce a syndrome similar to culture-negative IE.”
The paper relies on this without support.
Sterile valvular vegetations form and embolize, clinically mimicking culture-negative IE.
“Sterile valvular vegetations form and embolize, clinically mimicking in many respects culture-negative IE.”
The paper relies on this without support.
The mitral valve is most often affected, and valvular regurgitation is the predominant functional abnormality in APA syndrome with valvular involvement.
“The mitral valve is most often affected, and valvular regurgitation is the predominant functional abnormality seen in APA syndrome with complicating valvular involvement.”
The paper relies on this without support.
Numerous other causes of noninfective vegetative endocarditis can mimic IE.
“Numerous other causes of noninfective vegetative endocarditis can mimic IE.”
The paper relies on this without support.
The survival rate for patients with mold-related infective endocarditis is less than 20%.
“The survival rate for patients with mold-related IE is <20%.”
The paper relies on this without support.
Stroke is an independent risk factor for postoperative mortality in infective endocarditis patients.
“Stroke is an independent risk factor for postoperative mortality in IE patients.”
The paper relies on this without support.
The novel oral anticoagulants are not approved for use with either mechanical valves or bioprosthetic valves when risk factors for thromboembolism exist.
“The novel oral anticoagulants are not approved for use with either mechanical valves or bioprosthetic valves when risk factors for thromboembolism exist (eg, atrial fibrillation).”
The paper relies on this without support.
Clinical parameters for the diagnosis of perivalvular extension of IE are inadequate.
“Clinical parameters for the diagnosis of perivalvular extension of IE are inadequate.”
The paper relies on this without support.
TEE can demonstrate the distinctive flow patterns of fistulas and pseudoaneurysms and can rule out communications from unruptured abscess cavities.
“When combined with spectral and color Doppler techniques, TEE can demonstrate the distinctive flow patterns of fistulas and pseudoaneurysms and can rule out communications from unruptured abscess cavities.”
The paper relies on this without support.
The most frequent complications of IE are heart failure and systemic emboli.
“Patients selected for OPAT should be at low risk for the complications of IE, the most frequent of which are heart failure and systemic emboli.”
The paper relies on this without support.
The period of greatest risk for systemic emboli is before or within the first 1 to 2 weeks of antimicrobial therapy.
“The period of greatest risk for systemic emboli is before or within the first 1 to 2 weeks of antimicrobial therapy, although serious complications such as heart failure and rupture of MAs may develop weeks to months after the initiation of antimicrobial therapy.”
The paper relies on this without support.
Serious complications such as heart failure and rupture of MAs may develop weeks to months after the initiation of antimicrobial therapy.
“although serious complications such as heart failure and rupture of MAs may develop weeks to months after the initiation of antimicrobial therapy.”
The paper relies on this without support.
The risk for drug-related side effects usually increases with a prolonged drug exposure.
“The risk for drug-related side effects usually increases with a prolonged drug exposure (eg, vestibular, auditory, and nephrotoxicity resulting from aminoglycosides; leukopenia caused by β-lactams and vancomycin; and nephrotoxicity resulting from the combination of vancomycin and gentamicin) and requires close monitoring by the home infusion team consisting of representatives from nursing and pha”
The paper relies on this without support.
The majority of patients with IE are cured with appropriate medical and, if necessary, surgical treatment.
“The majority of patients with IE are cured with appropriate medical and, if necessary, surgical treatment.”
The paper relies on this without support.
Routine blood cultures after completion of antimicrobial therapy have a low likelihood of positive result in a patient who is otherwise without evidence of active infection.
“Routine blood cultures are no longer recommended after the completion of antimicrobial therapy because the likelihood of a positive culture result in a patient who is otherwise without evidence of active infection is low.”
The paper relies on this without support.
Developing or worsening heart failure is a complication that should be considered during short-term follow-up.
“Developing or worsening heart failure is a second complication that should be considered during short-term followup.”
The paper relies on this without support.
Valve function can deteriorate as a result of ongoing infection or mechanical stress unrelated to infection.
“Although new onset of heart failure caused by valvular dysfunction is unlikely during this period, valve function can deteriorate as a result of ongoing infection or mechanical stress unrelated to infection.”
The paper relies on this without support.
Antibiotic toxicity still can occur after the completion of treatment.
“Antibiotic toxicity still can occur after the completion of treatment and is the third complication that should be considered during short-term follow-up.”
The paper relies on this without support.
Delayed ototoxicity can occur because of previous use of aminoglycosides.
“The first is delayed ototoxicity because of the previous use of aminoglycosides.”
The paper relies on this without support.
No tools are routinely available for monitoring vestibular function.
“No tools are routinely available for monitoring vestibular function, and patients should be told to report the onset of any symptoms of vestibular toxicity during or after treatment.”
The paper relies on this without support.
Clostridium difficile infection is an antibiotic-related adverse event.
“The second antibiotic-related adverse event is Clostridium difficile infection.”
The paper relies on this without support.
Onset of C. difficile diarrhea can be delayed as long as 4 weeks after the last dose of antibiotic.
“Onset of diarrhea can be delayed as long as 4 weeks after the last dose of antibiotic.”
The paper relies on this without support.
IE can mimic a variety of febrile illnesses.
“This is necessary because IE can mimic a variety of febrile illnesses.”
The paper relies on this without support.
Antibiotics prescribed for nonspecific or unproved febrile syndromes are a major cause of culture-negative IE.
“Antibiotics prescribed for nonspecific or unproved febrile syndromes are a major cause of (blood) culture-negative IE, and this practice should be strongly discouraged.”
The paper relies on this without support.
Dental disease is almost entirely preventable if patients are compliant with 4 measures.
“Dental disease is almost entirely preventable if patients are compliant with 4 measures.”
The paper relies on this without support.
The cause of both periodontal disease and caries is bacterial plaque accumulation on teeth, and prevention is dependent on keeping teeth free of plaque.
“First, the cause of both periodontal disease and caries is bacterial plaque accumulation on teeth, and prevention is dependent on keeping teeth free of plaque.”
The paper relies on this without support.
The degree to which sugar and other refined carbohydrates are eliminated from the diet will have a major impact on the growth of pathogenic bacterial species, some of which are responsible for IE.
“The degree to which sugar and other refined carbohydrates are eliminated from the diet will have a major impact on the growth of pathogenic bacterial species, some of which are responsible for IE.”
The paper relies on this without support.
Daily use of a high-concentration fluoridated toothpaste will help to ensure that acid from plaque does not decalcify tooth structures and result in caries.
“Finally, the daily use of a high-concentration fluoridated toothpaste will help to ensure that the acid from plaque does not decalcify tooth structures and result in caries.”
The paper relies on this without support.
Fluoroquinolones are highly active in vitro against HACEK microorganisms.
“Fluoroquinolones are highly active in vitro against HACEK microorganisms.”
The paper relies on this without support.
Published data on the use of fluoroquinolones for endocarditis caused by HACEK are minimal.
“Published data on the use of fluoroquinolones for endocarditis caused by HACEK are minimal.”
The paper relies on this without support.
Intramuscular injection of ceftriaxone is painful.
“Patientsshould be informed that intramuscular injection of ceftriaxone is painful.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The early-surgery trial has conflicting citation numbers
MinorThe surgical-management section identifies the randomized early-surgery trial as reference 17. A later discussion calls the previously discussed trial reference 12, which the reference list identifies as an earlier AHA statement.
“The benefits of early surgery were demonstrated in the prospective, randomized trial 12 that was discussed earlier in this document.”
“only 1 small, randomized trial 17 has been performed to date to examine the role of valve surgery in the management of IE.”
The recommendation class for vancomycin differs
MinorFor relatively penicillin-resistant VGS or S gallolyticus endocarditis in patients intolerant of β-lactams, the discussion assigns vancomycin monotherapy Class IIb, while the numbered recommendation assigns it Class IIa.
“Vancomycin alone may be a reasonable alternative if the patient is intolerant of β-lactam therapy (Class IIb; Level of Evidence C).”
“Vancomycin alone may be a reasonable alternative in patients who are intolerant of β-lactam therapy (Class IIa; Level of Evidence C).”
Daptomycin is named as an alternative to itself
MinorThe treatment discussion names daptomycin as an alternative to daptomycin for MRSA left-sided native-valve endocarditis. The corresponding recommendation names vancomycin as the drug it may replace.
“daptomycin may be a reasonable alternative to daptomycin for left-sided NVE caused by MRSA”
“Daptomycin may be a reasonable alternative to vancomycin for treatment of left-sided IE resulting from MRSA”
Cites
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · see citing works
Self-citationLiu, C., Bayer, A. S., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,211 · see citing works
Self-citationProposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027 · see citing works
Self-citationCraig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908 · see citing works
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572 · see citing works
Murdoch, D. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.603 · Cited by 2,362 · see citing works
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W., Steckelberg, J. M., Rao, N., Hanssen, A. D., & Wilson, W. R. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis803 · Cited by 2,289 · see citing works
Self-citationGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014 · see citing works
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795 · see citing works
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707 · see citing works
Self-citationLiu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599 · see citing works
Self-citationFowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459 · see citing works
Self-citationStaphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174 · see citing works
Self-citationPharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101 · see citing works
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095 · see citing works
Baddour, L. M., Epstein, A. E., Erickson, C. C., Knight, B. P., Levison, M. E., Lockhart, P. B., Masoudi, F. A., Okum, E. J., Wilson, W. R., Beerman, L. B., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192665 · Cited by 1,030 · see citing works
Self-citationAntimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Drusano, G. L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro862 · Cited by 930 · see citing works
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W., Steckelberg, J. M., Rao, N., Hanssen, A. D., & Wilson, W. R. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis966 · Cited by 926 · see citing works
Self-citationEarly Surgery versus Conventional Treatment for Infective Endocarditis
Kang, D.-H., Kim, Y.-J., Kim, S.-H., Sun, B. J., Kim, D.-H., Yun, S.-C., Song, J.-M., Choo, S. J., Chung, C.-H., Song, J.-K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112843 · Cited by 902 · see citing works
Infective Endocarditis: An Analysis Based on Strict Case Definitions
VON REYN, C. F., LEVY, B. S., ARBEIT, R. D., FRIEDLAND, G., & CRUMPACKER, C. S. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-4-505 · Cited by 775 · see citing works
Daniel, W. G., Mügge, A., Martin, R. P., Lindert, O., Hausmann, D., Nonnast-Daniel, B., Laas, J., & Lichtlen, P. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241203 · Cited by 723 · see citing works
Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey
Selton-Suty, C., Célard, M., Le Moing, V., Doco-Lecompte, T., Chirouze, C., Iung, B., Strady, C., Revest, M., Vandenesch, F., Bouvet, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis199 · Cited by 710 · see citing works
Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis
Wang, A. (2007) · JAMA · doi:10.1001/jama.297.12.1354 · Cited by 703 · see citing works
Thuny, F., Disalvo, G., Belliard, O., Avierinos, J.-F., Pergola, V., Rosenberg, V., Casalta, J.-P., Gouvernet, J., Derumeaux, G., Iarussi, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.493155 · Cited by 703 · see citing works
Mügge, A., Daniel, W. G., Frank, G., & Lichtlen, P. R. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90104-6 · Cited by 654 · see citing works
Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia
Fowler, V. G., Olsen, M. K., Corey, G. R., Woods, C. W., Cabell, C. H., Reller, L. B., Cheng, A. C., Dudley, T., & Oddone, E. Z. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.17.2066 · Cited by 652 · see citing works
Self-citationGould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593 · see citing works
Baron, E. J., Miller, J. M., Weinstein, M. P., Richter, S. S., Gilligan, P. H., Thomson, R. B., Bourbeau, P., Carroll, K. C., Kehl, S. C., Dunne, W. M., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit278 · Cited by 592 · see citing works
Wilson, W. R., Bower, T. C., Creager, M. A., Amin‐Hanjani, S., O’Gara, P. T., Lockhart, P. B., Darouiche, R. O., Ramlawi, B., Derdeyn, C. P., Bolger, A. F., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000457 · Cited by 578 · see citing works
Self-citationLevine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577 · see citing works
García-Cabrera, E., Fernández-Hidalgo, N., Almirante, B., Ivanova-Georgieva, R., Noureddine, M., Plata, A., Lomas, J. M., Gálvez-Acebal, J., Hidalgo-Tenorio, C., Ruíz-Morales, J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000813 · Cited by 546 · see citing works
Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact
Silverman, J. A., Mortin, L. I., VanPraagh, A. D. G., Li, T., & Alder, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/430352 · Cited by 541 · see citing works
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N. (2004) · Clinical Infectious Diseases · doi:10.1086/420939 · Cited by 532 · see citing works
Recommendations for Treatment of Human Infections Caused by<i>Bartonella</i>Species
Rolain, J. M., Brouqui, P., Koehler, J. E., Maguina, C., Dolan, M. J., & Raoult, D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.1921-1933.2004 · Cited by 528 · see citing works
Hoen, B., & Duval, X. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1206782 · Cited by 518 · see citing works
van Hal, S. J., Lodise, T. P., & Paterson, D. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir935 · Cited by 512 · see citing works
Fournier, P., Thuny, F., Richet, H., Lepidi, H., Casalta, J., Arzouni, J., Maurin, M., Célard, M., Mainardi, J., Caus, T., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/653675 · Cited by 506 · cited 2× · see citing works
“The most prevalent pathogen among these uncommon causes of culture-negative IE in this group has varied globally according to published data.(236) Incidence data from population-based surveys for IE caused by these organisms are lacking in the United States.”
BackgroundFungal Endocarditis: Evidence in the World Literature, 1965-1995
Ellis, M. E., Al-Abdely, H., Sandridge, A., Greer, W., & Ventura, W. (2001) · Clinical Infectious Diseases · doi:10.1086/317550 · Cited by 505 · see citing works
Poor oral hygiene as a risk factor for infective endocarditis–related bacteremia
Lockhart, P. B., Brennan, M. T., Thornhill, M., Michalowicz, B. S., Noll, J., Bahrani-Mougeot, F. K., & Sasser, H. C. (2009) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2009.0046 · Cited by 504 · see citing works
Self-citationWilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492 · see citing works
Self-citationNonvalvular Cardiovascular Device–Related Infections
Baddour, L. M., Bettmann, M. A., Bolger, A. F., Epstein, A. E., Ferrieri, P., Gerber, M. A., Gewitz, M. H., Jacobs, A. K., Levison, M. E., Newburger, J. W., et al. (2003) · Circulation · doi:10.1161/01.cir.0000093201.57771.47 · Cited by 489 · see citing works
Self-citationRisk of embolization after institution of antibiotic therapy for infective endocarditis
Vilacosta, I., Graupner, C., SanRomán, J., Sarriá, C., Ronderos, R., Fernández, C., Mancini, L., Sanz, O., Sanmartín, J., & Stoermann, W. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01790-4 · Cited by 468 · see citing works
Kullar, R., Davis, S. L., Levine, D. P., & Rybak, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir124 · Cited by 463 · see citing works
Self-citationEchocardiography predicts embolic events in infective endocarditis
Di Salvo, G., Habib, G., Pergola, V., Avierinos, J.-F., Philip, E., Casalta, J.-P., Vailloud, J.-M., Derumeaux, G., Gouvernet, J., Ambrosi, P., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01206-7 · Cited by 457 · see citing works
Yu, V. L., Chiou, C. C. C., Feldman, C., Ortqvist, A., Rello, J., Morris, A. J., Baddour, L. M., Luna, C. M., Snydman, D. R., Ip, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/377534 · Cited by 451 · see citing works
Self-citationErbel, R., Rohmann, S., Drexler, M., Mohr-Kahaly, S., Gerharz, C. D., Iversen, S., OELERT, H., & MEYER, J. (1988) · European Heart Journal · doi:10.1093/ehj/9.1.43 · Cited by 451 · see citing works
Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome
Hojnik, M., George, J., Ziporen, L., & Shoenfeld, Y. (1996) · Circulation · doi:10.1161/01.cir.93.8.1579 · Cited by 443 · see citing works
Early Predictors of In-Hospital Death in Infective Endocarditis
Chu, V. H., Cabell, C. H., Benjamin, D. K., Kuniholm, E. F., Fowler, V. G., Engemann, J., Sexton, D. J., Corey, G. R., & Wang, A. (2004) · Circulation · doi:10.1161/01.cir.0000124719.61827.7f · Cited by 429 · see citing works
Self-citationBirmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/345744 · Cited by 428 · see citing works
Multislice Computed Tomography in Infective Endocarditis
Feuchtner, G. M., Stolzmann, P., Dichtl, W., Schertler, T., Bonatti, J., Scheffel, H., Mueller, S., Plass, A., Mueller, L., Bartel, T., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.077 · Cited by 422 · see citing works
Heiro, M., Nikoskelainen, J., Engblom, E., Kotilainen, E., Marttila, R., & Kotilainen, P. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2781 · Cited by 415 · see citing works
Emboli in Infective Endocarditis: The Prognostic Value of Echocardiography
Steckelberg, J. M., Murphy, J. G., Ballard, D., Bailey, K., Tajik, A. J., Taliercio, C. P., Giuliani, E. R., & Wilson, W. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-635 · Cited by 411 · see citing works
Self-citationInfective Endocarditis in Childhood: 2015 Update
Baltimore, R. S., Gewitz, M. H., Baddour, L. M., Beerman, L. B., Jackson, M. A., Lockhart, P. B., Pahl, E., Schutze, G. E., Shulman, S. T., & Willoughby, R. E. (2015) · Circulation · doi:10.1161/cir.0000000000000298 · Cited by 396 · see citing works
Self-citationThuny, F., Avierinos, J.-F., Tribouilloy, C., Giorgi, R., Casalta, J.-P., Milandre, L., Brahim, A., Nadji, G., Riberi, A., Collart, F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm005 · Cited by 396 · see citing works
Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing
Goldenberger, D., Künzli, A., Vogt, P., Zbinden, R., & Altwegg, M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.11.2733-2739.1997 · Cited by 390 · see citing works
Management of multidrug-resistant enterococcal infections
Arias, C. A., Contreras, G., & Murray, B. E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03214.x · Cited by 384 · see citing works
Temporal Trends in Infective Endocarditis in the Context of Prophylaxis Guideline Modifications
Duval, X., Delahaye, F., Alla, F., Tattevin, P., Obadia, J.-F., Le Moing, V., Doco-Lecompte, T., Celard, M., Poyart, C., Strady, C., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.029 · Cited by 383 · see citing works
Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria
Kashuba, A. D. M., Nafziger, A. N., Drusano, G. L., & Bertino, J. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.623 · Cited by 380 · cited 1× · see citing works
“For concentration-dependent antibiotics such as aminoglycosides and fluoroquinolones, a ratio of maximum serum concentration to MIC of >10 was associated with improved efficacy in patients with Gram-negative pneumonia, whereas an AUC 24 /MIC >125 was associated with an improved clinical efficacy for ciprofloxacin agai…”
BackgroundDiagnosis of 22 New Cases of <i>Bartonella</i> Endocarditis
Raoult, D., Fournier, P. E., Drancourt, M., Marrie, T. J., Etienne, J., Cosserat, J., Cacoub, P., Poinsignon, Y., Leclercq, P., & Sefton, A. M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-8-199610150-00004 · Cited by 379 · see citing works
Dickerman, S. A., Abrutyn, E., Barsic, B., Bouza, E., Cecchi, E., Moreno, A., Doco-Lecompte, T., Eisen, D. P., Fortes, C. Q., Fowler, V. G., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.023 · Cited by 374 · see citing works
Self-citationKORZENIOWSKI, O., & SANDE, M. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-4-496 · Cited by 355 · see citing works
Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria
Eng, R. H., Padberg, F. T., Smith, S. M., Tan, E. N., & Cherubin, C. E. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1824 · Cited by 350 · see citing works
Fridkin, S. K., Hageman, J., McDougal, L. K., Mohammed, J., Jarvis, W. R., Perl, T. M., Tenover, F. C., & the Vancomycin‐Intermediate Staphylococcus aureus Epidemiology Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/346207 · Cited by 344 · see citing works
Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343 · see citing works
Time-dependent bias was common in survival analyses published in leading clinical journals
van Walraven, C., Davis, D., Forster, A. J., & Wells, G. A. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.12.008 · Cited by 337 · see citing works
Vikram, H. R., Buenconsejo, J., Hasbun, R., & Quagliarello, V. (2003) · JAMA · doi:10.1001/jama.290.24.3207 · Cited by 332 · see citing works
Sanfilippo, A. J., Picard, M. H., Newell, J. B., Rosas, E., Davidoff, R., Thomas, J. D., & Weyman, A. E. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90535-h · Cited by 328 · see citing works
A Systematic Review of Population-Based Studies of Infective Endocarditis
Tleyjeh, I. M., Abdel-Latif, A., Rahbi, H., Scott, C. G., Bailey, K. R., Steckelberg, J. M., Wilson, W. R., & Baddour, L. M. (2007) · Chest · doi:10.1378/chest.06-2048 · Cited by 324 · see citing works
Self-citationSnygg‐Martin, U., Gustafsson, L., Rosengren, L., Alsiö, Å., Ackerholm, P., Andersson, R., & Olaison, L. (2008) · Clinical Infectious Diseases · doi:10.1086/588663 · Cited by 320 · see citing works
Pogliano, J., Pogliano, N., & Silverman, J. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00011-12 · Cited by 319 · see citing works
Dramatic Reduction in Infective Endocarditis–Related Mortality With a Management-Based Approach
Botelho-Nevers, É., Thuny, F., Casalta, J., Richet, H., Gouriet, F., Collart, F., Ribéri, A., Habib, G., & Raoult, D. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.192 · Cited by 317 · see citing works
Fernández-Hidalgo, N., Almirante, B., Gavaldà, J., Gurgui, M., Peña, C., de Alarcón, A., Ruiz, J., Vilacosta, I., Montejo, M., Vallejo, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit052 · Cited by 311 · see citing works
Cosgrove, S. E., Vigliani, G. A., Campion, M., Fowler, Jr., Abrutyn, E., Corey, G. R., Levine, D. P., Rupp, M. E., Chambers, H. F., Karchmer, A. W., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597031 · Cited by 309 · see citing works
Self-citationLalani, T., Cabell, C. H., Benjamin, D. K., Lasca, O., Naber, C., Fowler, V. G., Corey, G. R., Chu, V. H., Fenely, M., Pachirat, O., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.864488 · Cited by 308 · see citing works
Self-citationDaniel, W. G., Mügge, A., Grote, J., Hausmann, D., Nikutta, P., Laas, J., Lichtlen, P. R., & Martin, R. P. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90740-4 · Cited by 306 · see citing works
Non-HACEK Gram-Negative Bacillus Endocarditis
Morpeth, S., Murdoch, D., Cabell, C. H., Karchmer, A. W., Pappas, P., Levine, D., Nacinovich, F., Tattevin, P., Fernández-Hidalgo, N., Dickerman, S., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-12-200712180-00002 · Cited by 302 · see citing works
Self-citationSurgical management of infective endocarditis associated with cerebral complications
Eishi, K., Kawazoe, K., Kuriyama, Y., Kitoh, Y., Kawashima, Y., & Omae, T. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70038-2 · Cited by 299 · see citing works
Fungal Endocarditis, 1995–2000
Pierrotti, L. C., & Baddour, L. M. (2002) · Chest · doi:10.1378/chest.122.1.302 · Cited by 299 · see citing works
Self-citation(2022) · Cineca Institutional Research Information System (Tor Vergata University) · doi:10.1161/circulationaha · Cited by 291 · see citing works
Heldman, A. W., Hartert, T. V., Ray, S. C., Daoud, E. G., Kowalski, T. E., Pompili, V. J., Sisson, S. D., Tidmore, W. C., vom Eigen, K. A., Goodman, S. N., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00070-8 · Cited by 289 · see citing works
Duval, X., Iung, B., Klein, I., Brochet, E., Thabut, G., Arnoult, F., Lepage, L., Laissy, J.-P., Wolff, M., Leport, C., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-8-201004200-00006 · Cited by 289 · see citing works
Neurological Outcome of Septic Cardioembolic Stroke After Infective Endocarditis
Ruttmann, E., Willeit, J., Ulmer, H., Chevtchik, O., Höfer, D., Poewe, W., Laufer, G., & Müller, L. C. (2006) · Stroke · doi:10.1161/01.str.0000229894.28591.3f · Cited by 285 · see citing works
LaPlante, K. L., & Rybak, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4665-4672.2004 · Cited by 284 · see citing works
Self-citationLalani, T. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.8203 · Cited by 284 · see citing works
Health Care–Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Benito, N., Miró, J. M., de Lazzari, E., Cabell, C. H., del Río, A., Altclas, J., Commerford, P., Delahaye, F., Dragulescu, S., Giamarellou, H., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00004 · Cited by 277 · see citing works
Self-citationBacterial intracranial aneurysm
Bohmfalk, G. L., Story, J. L., Wissinger, J. P., & Brown, W. E. (1978) · Journal of Neurosurgery · doi:10.3171/jns.1978.48.3.0369 · Cited by 266 · see citing works
Outcomes for endocarditis surgery in North America: A simplified risk scoring system
Gaca, J. G., Sheng, S., Daneshmand, M. A., O’Brien, S., Rankin, J. S., Brennan, J. M., Hughes, G. C., Glower, D. D., Gammie, J. S., & Smith, P. K. (2011) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.09.016 · Cited by 254 · see citing works
Bai, A. D., Showler, A., Burry, L. D., Steinberg, M., Ricciuto, D. R., Fernandes, T., Chiu, A., Raybardhan, S., Science, M. E., Fernando, E., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ120 · Cited by 253 · see citing works
Studies on the Bacteremia of Bacterial Endocarditis
Werner, A. S. (1967) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1967.03130160073013 · Cited by 253 · see citing works
Dhand, A., Bayer, A. S., Pogliano, J., Yang, S.-J., Bolaris, M., Nizet, V., Wang, G., & Sakoulas, G. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir340 · Cited by 252 · see citing works
Self-citationAnguera, I., Miro, J. M., Vilacosta, I., Almirante, B., Anguita, M., Muñoz, P., Roman, J. A. S., de Alarcon, A., Ripoll, T., Navas, E., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi034 · Cited by 250 · see citing works
Self-citationA randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis
Chan, K.-L., Dumesnil, J. G., Cujec, B., Sanfilippo, A. J., Jue, J., Turek, M. A., Robinson, T. I., & Moher, D. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00829-5 · Cited by 244 · see citing works
Infective Endocarditis Due to Unusual or Fastidious Microorganisms
Berbari, E. F., Cockerill, F. R., & Steckelberg, J. M. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.6.532 · Cited by 242 · see citing works
Self-citationKiefer, T., Park, L., Tribouilloy, C., Cortes, C., Casillo, R., Chu, V., Delahaye, F., Durante-Mangoni, E., Edathodu, J., Falces, C., et al. (2011) · JAMA · doi:10.1001/jama.2011.1701 · Cited by 242 · see citing works
HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort
Chambers, S. T., Murdoch, D., Morris, A., Holland, D., Pappas, P. A., Almela, M., Fernández‐Hidalgo, N., Almirante, B., Bouza, E., Forno, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063181 · Cited by 239 · see citing works
Holmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O’Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Gao, W., Christiansen, K. J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir270 · Cited by 228 · see citing works
Evaluation of new clinical criteria for the diagnosis of infective endocarditis
Bayer, A. S., Ward, J. I., Ginzton, L. E., & Shapiro, S. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90144-9 · Cited by 227 · see citing works
Self-citationEarly Surgery in Patients with Infective Endocarditis: A Propensity Score Analysis
Aksoy, O., Sexton, D. J., Wang, A., Pappas, P. A., Kourany, W. M., Chu, V. H. Y., Fowler, V. G., Woods, C. W., Engemann, J. J., Corey, G. R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510583 · Cited by 225 · see citing works
Self-citationHoen, B., Selton-Suty, C., Lacassin, F., Etienne, J., Briancon, S., Leport, C., & Canton, P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.3.501 · Cited by 225 · see citing works
Cooper, H. A., Thompson, E. C., Laureno, R., Fuisz, A., Mark, A. S., Lin, M., & Goldstein, S. A. (2009) · Circulation · doi:10.1161/circulationaha.108.834432 · Cited by 223 · see citing works
Fournier, P. E., Casalta, J. P., Habib, G., Messana, T., & Raoult, D. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00040-x · Cited by 220 · see citing works
de Sa, D. D. C., Tleyjeh, I. M., Anavekar, N. S., Schultz, J. C., Thomas, J. M., Lahr, B. D., Bachuwar, A., Pazdernik, M., Steckelberg, J. M., Wilson, W. R., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0585 · Cited by 216 · see citing works
Self-citationInfective Endocarditis Due to Staphylococcus aureus: Deleterious Effect of Anticoagulant Therapy
Tornos, P., Almirante, B., Mirabet, S., Permanyer, G., Pahissa, A., & Soler-Soler, J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.473 · Cited by 214 · see citing works
Chambers, H. F., Miller, R. T., & Newman, M. D. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-8-619 · Cited by 214 · see citing works
Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis
Sabik, J. F., Lytle, B. W., Blackstone, E. H., Marullo, A. G. M., Pettersson, G. B., & Cosgrove, D. M. (2002) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)03779-7 · Cited by 211 · see citing works
Stevens, D. L., Van, S., & Bryant, A. E. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1401 · Cited by 211 · see citing works
Huston, J., Nichols, D. A., Luetmer, P. H., Goodwin, J. T., Meyer, F. B., Wiebers, D. O., & Weaver, A. L. (1994) · PubMed Central · Cited by 207 · see citing works
Mandell, G. L. (1970) · Archives of Internal Medicine · doi:10.1001/archinte.125.2.258 · Cited by 207 · see citing works
CHUN, C. H., RAFF, M. J., CONTRERAS, L., VARGHESE, R., WATERMAN, N., DAFFNER, R., & MELO, J. C. (1980) · Medicine · doi:10.1097/00005792-198001000-00003 · Cited by 205 · see citing works
Anguera, I., Del Río, A., Miró, J. M., Matínez-Lacasa, X., Marco, F., Gumá, J. R., Quaglio, G., Claramonte, X., Moreno, A., Mestres, C. A., et al. (2005) · Heart · doi:10.1136/hrt.2004.040659 · Cited by 202 · see citing works
Gavaldà, J., Len, O., Miró, J. M., Muñoz, P., Montejo, M., Alarcón, A., de la Torre-Cisneros, J., Peña, C., Martínez-Lacasa, X., Sarria, C., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00008 · Cited by 202 · see citing works
Reynolds, H. R., Jagen, M. A., Tunick, P. A., & Kronzon, I. (2003) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2003.43 · Cited by 198 · see citing works
Fowler, Jr., Sanders, L. L., Kong, L. K., McClelland, R. S., Gottlieb, G. S., Li, J., Ryan, T., Sexton, D. J., Roussakis, G., Harrell, L. J., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515076 · Cited by 196 · see citing works
Arnett, E. N., & Roberts, W. C. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90169-7 · Cited by 196 · see citing works
Sexton, D. J., Tenenbaum, M. J., Wilson, W. R., Steckelberg, J. M., Tice, A. D., Gilbert, D., Dismukes, W., Drew, R. H., Durack, D. T., & Endocarditis Treatment Consortium Group (1998) · Clinical Infectious Diseases · doi:10.1086/515038 · Cited by 195 · see citing works
Self-citationAntithrombotic Therapy in Valvular Heart Disease
Salem, D. N., Levine, H. J., Pauker, S. G., Eckman, M. H., & Daudelin, D. H. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.590s · Cited by 194 · see citing works
Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations.
(1972) · PubMed Central · Cited by 191 · see citing works
Lamas, C. C., & Eykyn, S. J. (1997) · Clinical Infectious Diseases · doi:10.1086/513765 · Cited by 188 · see citing works
Ribera, E., Gomez-Jimenez, J., Cortes, E., del Valle, O., Planes, A., Gonzalez-Alujas, M. T., Almirante, B., Ocana, I., & Pahissa, A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00005 · Cited by 187 · see citing works
Emergence of Coagulase-Negative Staphylococci as a Cause of Native Valve Endocarditis
Chu, V. H., Woods, C. W., Miro, J. M., Hoen, B., Cabell, C. H., Pappas, P. A., Federspiel, J., Athan, E., Stryjewski, M. E., Nacinovich, F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/524666 · Cited by 187 · see citing works
Self-citationValve replacement in patients with endocarditis and acute neurologic deficit
Gillinov, A. M., Shah, R. V., Curtis, W. E., Scott Stuart, R., Cameron, D. E., Baumgartner, W. A., & Greene, P. S. (1996) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(96)00014-8 · Cited by 186 · see citing works
Bannay, A., Hoen, B., Duval, X., Obadia, J.-F., Selton-Suty, C., Le Moing, V., Tattevin, P., Iung, B., Delahaye, F., Alla, F., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehp008 · Cited by 182 · see citing works
Kupferwasser, L. I., Yeaman, M. R., Nast, C. C., Kupferwasser, D., Xiong, Y.-Q., Palma, M., Cheung, A. L., & Bayer, A. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16876 · Cited by 181 · see citing works
Self-citationROHMANN, S., ERBEL, R., GÖRGE, G., MAKOWSKI, T., MOHR-KAHALY, S., NIXDORFF, U., DREXLER, M., & MEYER, J. (1992) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060195 · Cited by 180 · see citing works
Fagman, E., Perrotta, S., Bech-Hanssen, O., Flinck, A., Lamm, C., Olaison, L., & Svensson, G. (2012) · European Radiology · doi:10.1007/s00330-012-2491-5 · Cited by 178 · see citing works
Sabath, L. D., Garner, C., Wilcox, C., et al. (1975) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.8.3.344 · Cited by 178 · see citing works
Chirouze, C., Athan, E., Alla, F., Chu, V. H., Ralph Corey, G., Selton-Suty, C., Erpelding, M.-L., Miro, J. M., Olaison, L., & Hoen, B. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12166 · Cited by 176 · see citing works
Sakoulas, G., Bayer, A. S., Pogliano, J., Tsuji, B. T., Yang, S.-J., Mishra, N. N., Nizet, V., Yeaman, M. R., & Moise, P. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05551-11 · Cited by 176 · see citing works
Self-citationPharmacodynamics of Daptomycin in a Murine Thigh Model of <i>Staphylococcus aureus</i> Infection
Louie, A., Kaw, P., Liu, W., Jumbe, N., Miller, M. H., & Drusano, G. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.845-851.2001 · Cited by 172 · see citing works
Dworkin, R. J., Sande, M. A., Lee, B. L., & Chambers, H. F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91083-0 · Cited by 170 · see citing works
Kupferwasser, L. I., Yeaman, M. R., Shapiro, S. M., Nast, C. C., Sullam, P. M., Filler, S. G., & Bayer, A. S. (1999) · Circulation · doi:10.1161/01.cir.99.21.2791 · Cited by 169 · see citing works
Self-citationFalagas, M. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl219 · Cited by 167 · see citing works
Enterococcal Endocarditis in Sweden, 1995–1999: Can Shorter Therapy with Aminoglycosides Be Used?
Olaison, L., Schadewitz, K., & Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis (2002) · Clinical Infectious Diseases · doi:10.1086/338233 · Cited by 166 · see citing works
Prediction of Rapid versus Prolonged Healing of Infective Endocarditis by Monitoring Vegetation Size
Rohmann, S., Erbel, R., Darius, H., Görge, G., Makowski, T., Zotz, R., Mohr-Kahaly, S., Nixdorff, U., Drexler, M., & Meyer, J. (1991) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(14)80380-5 · Cited by 165 · see citing works
Evaluation of Antibiotic Diffusion into Cardiac Vegetations by Quantitative Autoradiography
Cremieux, A.-C., Maziere, B., Vallois, J.-M., Ottaviani, M., Azancot, A., Raffoul, H., Bouvet, A., Pocidalo, J.-J., & Carbon, C. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.5.938 · Cited by 162 · see citing works
Transesophageal echocardiography in right-sided endocarditis
Román, J. S., Vilacosta, I., Zamorano, J., Almería, C., & Sánchez-Harguindey, L. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90250-5 · Cited by 162 · see citing works
Treatment of Streptomycin-Susceptible and Streptomycin-Resistant Enterococcal Endocarditis
WILSON, W. R., WILKOWSKE, C. J., WRIGHT, A. J., SANDE, M. A., & GERACI, J. E. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-816 · Cited by 159 · see citing works
Self-citationBarsic, B., Dickerman, S., Krajinovic, V., Pappas, P., Altclas, J., Carosi, G., Casabé, J. H., Chu, V. H., Delahaye, F., Edathodu, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis878 · Cited by 157 · see citing works
Self-citationWang, A., Pappas, P. A., Anstrom, K. J., Abrutyn, E., Fowler, V. G., Hoen, B., Miró, J. M., Corey, G. R., Olaison, L., Stafford, J. A., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.01.023 · Cited by 156 · see citing works
Self-citationVan Riet, J., Hill, E. E., Gheysens, O., Dymarkowski, S., Herregods, M.-C., Herijgers, P., Peetermans, W. E., & Mortelmans, L. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1380-x · Cited by 154 · see citing works
John, M. D. V., Hibberd, P. L., Karchmer, A. W., Sleeper, L. A., & Calderwood, S. B. (1998) · Clinical Infectious Diseases · doi:10.1086/516378 · Cited by 153 · see citing works
Sambola, A., Miró, J. M., Tornos, M. P., Almirante, B., Torrico, A. M., Gurguí, M., Martínez, E., del Rı́o, A., Azqueta, M., Marco, F., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/340538 · Cited by 152 · see citing works
Kupferwasser, L. I., Yeaman, M. R., Nast, C. C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316876 · Cited by 152 · see citing works
(1990) · Infectious Diseases Newsletter · doi:10.1016/0278-2316(90)90059-o · Cited by 149 · see citing works
Bayer, A. S. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.3.313 · Cited by 148 · see citing works
Self-citationFrancioli, P., Ruch, W., Stamboulian, D., & International Infective Endocarditis Study Group (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1406 · Cited by 147 · see citing works
High Frequency of Tropheryma whipplei in Culture-Negative Endocarditis
Geißdörfer, W., Moos, V., Moter, A., Loddenkemper, C., Jansen, A., Tandler, R., Morguet, A. J., Fenollar, F., Raoult, D., Bogdan, C., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05531-11 · Cited by 146 · see citing works
Glazier, J. J., Verwilghen, J., Donaldson, R. M., & Ross, D. N. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90851-y · Cited by 144 · see citing works
Chuard, C., Herrmann, M., Vaudaux, P., Waldvogel, F. A., & Lew, D. P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2611 · Cited by 143 · see citing works
Mehta, S., Singh, C., Plata, K. B., Chanda, P. K., Paul, A., Riosa, S., Rosato, R. R., & Rosato, A. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-12 · Cited by 142 · see citing works
Lucet, J. C., Herrmann, M., Rohner, P., Auckenthaler, R., Waldvogel, F. A., & Lew, D. P. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2312 · Cited by 142 · see citing works
Middlemost, S., Wisenbaugh, T., Meyerowitz, C., Teeger, S., Essop, R., Skoularigis, J., Cronje, S., & Sareli, P. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90785-8 · Cited by 141 · see citing works
Cabell, C. H., Abrutyn, E., Fowler, V. G., Hoen, B., Miró, J. M., Corey, G. R., Olaison, L., Pappas, P. A., Anstrom, K. J., Stafford, J. A., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.03.057 · Cited by 139 · see citing works
Self-citationRole of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
Goldstein, E. J. C., & Proctor, R. A. (2008) · Clinical Infectious Diseases · doi:10.1086/525536 · Cited by 138 · see citing works
Impact of Prior Antiplatelet Therapy on Risk of Embolism in Infective Endocarditis
Anavekar, N. S., Tleyjeh, I. M., Anavekar, N. S., Mirzoyev, Z., Steckelberg, J. M., Haddad, C., Khandaker, M. H., Wilson, W. R., Chandrasekaran, K., & Baddour, L. M. (2007) · Clinical Infectious Diseases · doi:10.1086/513197 · Cited by 138 · see citing works
Self-citationMandell, G. L. (1970) · Archives of Internal Medicine · doi:10.1001/archinte.1970.00310020064005 · Cited by 138 · see citing works
The Impact of Valve Surgery on 6-Month Mortality in Left-Sided Infective Endocarditis
Tleyjeh, I. M., Ghomrawi, H. M. K., Steckelberg, J. M., Hoskin, T. L., Mirzoyev, Z., Anavekar, N. S., Enders, F., Moustafa, S., Mookadam, F., Huskins, W. C., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.658831 · Cited by 137 · see citing works
Self-citationRiedel, D. J., Weekes, E., & Forrest, G. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00300-08 · Cited by 136 · see citing works
Gavaldà, J., Torres, C., Tenorio, C., López, P., Zaragoza, M., Capdevila, J. A., Almirante, B., Ruiz, F., Borrell, N., Gomis, X., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.639 · Cited by 134 · see citing works
McGiffin, D. C., Galbraith, A. J., McLachlan, G. J., Stower, R. E., Wong, M. L., Stafford, E. G., Gardner, M. A., Pohlner, P., & O’Brien, M. F. (1992) · PubMed · Cited by 134 · see citing works
Werth, B. J., Sakoulas, G., Rose, W. E., Pogliano, J., Tewhey, R., & Rybak, M. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01586-12 · Cited by 134 · see citing works
Self-citationRight-sided infective endocarditis: surgical management
Akinosoglou, K., Apostolakis, E. E., Koutsogiannis, N., Leivaditis, V., & Gogos, C. A. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezs084 · Cited by 133 · see citing works
Lutas, E. M., Roberts, R. B., Devereux, R. B., & Prieto, L. M. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90687-3 · Cited by 131 · see citing works
Ho, T. T., Cadena, J., Childs, L. M., Gonzalez-Velez, M., & Lewis, J. S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks006 · Cited by 130 · see citing works
Federspiel, J. J. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.1027 · Cited by 129 · cited 1× · see citing works
“United States suggest that rates of S aureus IE have increased significantly relative to other causes of IE.(3) This increase is”
BackgroundDe Castro, S., Magni, G., Beni, S., Cartoni, D., Fiorelli, M., Venditti, M., Schwartz, S. L., Fedele, F., & Pandian, N. G. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00598-5 · Cited by 129 · see citing works
A Clinical Study of Culture-Negative Endocarditis
Werner, M., Andersson, R., Olaison, L., & Hogevik, H. (2003) · Medicine · doi:10.1097/01.md.0000085056.63483.d2 · Cited by 129 · cited 1× · see citing works
“Although most previous studies have put the frequency of blood culture–negative IE at 5% to 10%, a European study of IE that included 820 cases indicated that ≈20% of patients with confirmed IE had all negative blood cultures.(228) This may be attributable to inadequate microbiological techniques, infection with highl…”
ResultAndrews, M., & von Reyn, C. F. (2001) · Clinical Infectious Diseases · doi:10.1086/321814 · Cited by 129 · see citing works
Lindner, J. R., Case, R. A., Dent, J. M., Abbott, R. D., Scheld, W. M., & Kaul, S. (1996) · Circulation · doi:10.1161/01.cir.93.4.730 · Cited by 127 · see citing works
A meta-analysis of medical versus surgical therapy for Candida endocarditis
Steinbach, W. J., Perfect, J. R., Cabell, C. H., Fowler, V. G., Corey, G. R., Li, J. S., Zaas, A. K., & Benjamin, D. K. (2005) · Journal of Infection · doi:10.1016/j.jinf.2004.10.016 · Cited by 127 · see citing works
Self-citationFortún, J., Navas, E., Martínez‐Beltrán, J., Pérez‐Molina, J., Martín‐Dávila, P., Guerrero, A., & Moreno, S. (2001) · Clinical Infectious Diseases · doi:10.1086/320869 · Cited by 126 · see citing works
Musci, M., Siniawski, H., Pašić, M., Grauhan, O., Weng, Y., Meyer, R., Yankah, C., & Hetzer, R. (2007) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2007.02.034 · Cited by 123 · see citing works
Geraci, J. E. (1958) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)34262-6 · Cited by 123 · see citing works
Pharmacodynamics: Relation to Antimicrobial Resistance
Rybak, M. J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.04.001 · Cited by 120 · see citing works
Self-citationEchocardiography in patients with suspected endocarditis: a cost-effectiveness analysis
Heidenreich, P. A., Masoudi, F. A., Maini, B., Chou, T. M., Foster, E., Schiller, N. B., & Owens, D. K. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00216-8 · Cited by 119 · see citing works
Hoen, B., Béguinot, I., Rabaud, C., Jaussaud, R., Selton‐Suty, C., May, T., & Canton, P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.2.298 · Cited by 119 · see citing works
Combination Antibiotic Therapy for Infective Endocarditis
Le, T., & Bayer, A. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367661 · Cited by 117 · see citing works
Self-citationLi, J., Echevarria, K. L., Hughes, D. W., Cadena, J. A., Bowling, J. E., & Lewis, J. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02800-14 · Cited by 117 · see citing works
Negative predictive value of the Duke criteria for infective endocarditis
Dodds, G. A., Sexton, D. J., Durack, D. T., Bashore, T. M., Corey, G. R., Kisslo, J., & Service, T. D. E. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89372-1 · Cited by 115 · see citing works
Infectious Intracranial Aneurysms
Clare, C. E., & Barrow, D. L. (1992) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30646-6 · Cited by 114 · see citing works
Endocarditis-Associated Paravalvular Abscesses
Blumberg, E. A., Karalis, D. A., Chandrasekaran, K., Wahl, J. M., Vilaro, J., Covalesky, V. A., & Mintz, G. S. (1995) · Chest · doi:10.1378/chest.107.4.898 · Cited by 114 · see citing works
Endocarditis with Negative Blood Cultures
Tunkel, A. R., & Kaye, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261809 · Cited by 114 · see citing works
Successful Treatment of Vancomycin-Resistant Enterococcus Endocarditis with Oral Linezolid
Babcock, H. M., Ritchie, D. J., Christiansen, E., Starlin, R., Little, R., & Stanley, S. (2001) · Clinical Infectious Diseases · doi:10.1086/319986 · Cited by 113 · see citing works
Jang, H., Kim, S., Kim, K. H., Kim, C. J., Lee, S., Song, K., Jeon, J. H., Park, W. B., Kim, H. B., Park, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/600295 · Cited by 113 · see citing works
McGiffin, D. C., Galbraith, A. J., McLachlan, G. J., Stower, R. E., Wong, M. L., Stafford, E. G., Gardner, M. A. H., Pohlner, P. G., & O’Brien, M. F. (1992) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)34813-5 · Cited by 113 · see citing works
Indications for cardiac surgery in patients with active infective endocarditis
Alsip, S. G., Blackstone, E. H., Kirklin, J. W., & Cobbs, C. G. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90376-6 · Cited by 112 · see citing works
Stockheim, J. A., Chadwick, E. G., Kessler, S., Amer, M., Haq, N. A., Dajani, A. S., & Shulman, S. T. (1998) · Clinical Infectious Diseases · doi:10.1086/515021 · Cited by 112 · see citing works
LaPlante, K. L., & Woodmansee, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00134-09 · Cited by 110 · see citing works
Candida Prosthetic Valve Endocarditis: Prospective Study of Six Cases and Review of the Literature
Nguyen, M. H., Nguyen, M. L., Vu, V. L., McMahon, D., Keys, T. F., & Amidi, M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.262 · Cited by 109 · see citing works
Lin, J. C., Fierer, J., Aung, G., Johns, S., Thomas, A., Jahng, M., Fierer, J., & Fierer, J. (2013) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0449-9 · Cited by 109 · see citing works
Chu, V. H., Miro, J. M., Hoen, B., Cabell, C. H., Pappas, P. A., Jones, P., Stryjewski, M. E., Anguera, I., Braun, S., Muñoz, P., et al. (2009) · Heart · doi:10.1136/hrt.2008.152975 · Cited by 109 · see citing works
Self-citationDahl, A., Rasmussen, R. V., Bundgaard, H., Hassager, C., Bruun, L. E., Lauridsen, T. K., Moser, C., Sogaard, P., Arpi, M., & Bruun, N. E. (2013) · Circulation · doi:10.1161/circulationaha.112.001170 · Cited by 108 · see citing works
Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy
Casapao, A. M., Davis, S. L., Barr, V. O., Klinker, K. P., Goff, D. A., Barber, K. E., Kaye, K. S., Mynatt, R. P., Molloy, L. M., Pogue, J. M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02371-13 · Cited by 108 · see citing works
Self-citationInfective endocarditis in children: clinical analyses and evaluation of two diagnostic criteria
MARCÓ DEL PONT, J., DE CICCO, L. T., VARTALITIS, C., ITHURRALDE, M., GALLO, J. P., VARGAS, F., GIANANTONIO, C. A., & QUIRÓS, R. E. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199512000-00010 · Cited by 106 · see citing works
Clindamycin therapy of staphylococcus aureus endocarditis
Watanakunakorn, C. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90758-0 · Cited by 106 · see citing works
Neurologic Complications of Infective Endocarditis
Lerner, P. I. (1985) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31050-1 · Cited by 105 · see citing works
Kupferwasser, L. I., Hafner, G., Mohr-Kahaly, S., Erbel, R., Meyer, J., & Darius, H. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00024-8 · Cited by 105 · see citing works
Daptomycin in the Treatment of Patients with Infective Endocarditis: Experience from a Registry
Levine, D. P., & Lamp, K. C. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.07.011 · Cited by 105 · see citing works
Hoen, B., Selton-Suty, C., Danchin, N., Weber, M., Villemot, J.-P., Mathieu, P., Floquet, J., & Canton, P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.4.905 · Cited by 104 · see citing works
Preoperative Evaluation in Aortic Endocarditis: Findings on Cardiac CT
Gahide, G., Bommart, S., Demaria, R., Sportouch, C., Dambia, H., Albat, B., & Vernhet-Kovacsik, H. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.08.2120 · Cited by 104 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Kanavos K Antoniadou A Venetis C Gezerlis P Giamarellou H. Retrospective analysis of Duke’s criteria in 60 cases of infective endocarditis in Greece [abstract 138]. Paper presented at: Third International Symposium on Modern Concepts in Endocarditis; July 13–15 1995; Boston MA.
- 10.1016/S0025-6196(11)63302-8 · DOI
- 10.1016/S0025-6196(11)64307-3 · DOI
Cited by
Sorted by citations
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621 · see citing works
“Although it is well known that endocarditis requires prolonged antimicrobial therapy, severe disease more typically presents as cardiac failure/cardiogenic shock and emboli rather than as sepsis or septic shock [206, 207].”
BackgroundSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652 · see citing works
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Turner, N., Sharma‐Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0147-4 · Cited by 2,093 · see citing works
Self-citationIsselbacher, E. M., Preventza, O., Hamilton Black, J., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001106 · Cited by 2,082 · see citing works
2023 ESC Guidelines for the management of endocarditis
Delgado, V., Marsan, N. A., de Waha, S., Bonaros, N. E., Brida, M., Burri, H., Caselli, S., Doenst, T., Éderhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,975 · see citing works
Self-citationWeiss, S. L., Peters, M. J., Alhazzani, W. A., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,268 · see citing works
Sharma, S. J., Mohler, J. L., Mahajan, S. D., Schwartz, S. A., Bruggemann, L., & Aalinkeel, R. (2023) · Microorganisms · doi:10.3390/microorganisms11061614 · Cited by 1,017 · see citing works
Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
Iversen, K. K., Ihlemann, N., Gill, S. U. A., Madsen, T., Elming, H., Jensen, K. T., Bruun, N. E., Høfsten, D. E., Fuursted, K., Christensen, J. J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1808312 · Cited by 826 · see citing works
Evaluation and Management of Penicillin Allergy: A Review
Shenoy, E. S., Macy, E., Rowe, T., & Blumenthal, K. G. (2019) · JAMA · doi:10.1001/jama.2018.19283 · Cited by 830 · see citing works
“Antimicrobial Prophylaxis Antimicrobial prophylaxis includesdental prophylaxis toprevent infective endocarditis in select high-risk patients.(29,30) Administration of perioperative antibiotics reduces the risk of surgical site infections (SSIs).”
BackgroundThe Enterococcus: a Model of Adaptability to Its Environment
Garcia-Solache, M. A., & Rice, L. B. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-18 · Cited by 779 · see citing works
Challenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaün, E., Pettersson, G., Schäfers, H., & Prendergast, B. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 724 · see citing works
Self-citationStaphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies
Schilcher, K., & Horswill, A. R. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00026-19 · Cited by 731 · see citing works
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease
Isselbacher, E. M., Preventza, O. A., Black, J. H., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.004 · Cited by 674 · see citing works
Weiss, S. L., Peters, M. J., Alhazzani, W. A., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 638 · see citing works
Maida, C. D., Norrito, R. L., Daidone, M., Tuttolomondo, A., & Pinto, A. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186454 · Cited by 594 · see citing works
“Still, the incidence of stroke in patients affected by endocarditis is relatively high; this pathology is complicated by cerebral ischemia in around 20% of the cases [143].”
BackgroundWilson, W. R., Bower, T. C., Creager, M. A., Amin‐Hanjani, S., O’Gara, P. T., Lockhart, P. B., Darouiche, R. O., Ramlawi, B., Derdeyn, C. P., Bolger, A. F., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000457 · Cited by 578 · see citing works
Self-citationProsthetic Heart Valve Thrombosis
Dangas, G., Weitz, J. I., Giustino, G., Makkar, R., & Mehran, R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.958 · Cited by 508 · see citing works
Lamy, B., Dargère, S., Arendrup, M. C., Parienti, J., & Tattevin, P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00697 · Cited by 448 · see citing works
Blomström‐Lundqvist, C., TRAYKOV, V. B., Erba, P. A., Burri, H., Nielsen, J. C., Bongiorni, M. G., Poole, J. E., Boriani, G., Costa, R., Deharo, J., et al. (2019) · EP Europace · doi:10.1093/europace/euz246 · Cited by 424 · see citing works
A new class of synthetic retinoid antibiotics effective against bacterial persisters
Kim, W., Zhu, W., Hendricks, G. L., Tyne, D. V., Steele, A. D., Keohane, C. E., Fricke, N., Conery, A. L., Shen, S., Pan, W., et al. (2018) · Nature · doi:10.1038/nature26157 · Cited by 412 · see citing works
Pettersson, G., Coselli, J. S., Pettersson, G., Coselli, J. S., Hussain, S. T., Griffin, B. P., Blackstone, E. H., Gordon, S. M., LeMaire, S. A., & Woc-Colburn, L. E. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.09.093 · Cited by 418 · see citing works
Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miró, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 448 · see citing works
Self-citationInfective Endocarditis in Childhood: 2015 Update
Baltimore, R. S., Gewitz, M. H., Baddour, L. M., Beerman, L. B., Jackson, M. A., Lockhart, P. B., Pahl, E., Schutze, G. E., Shulman, S. T., & Willoughby, R. E. (2015) · Circulation · doi:10.1161/cir.0000000000000298 · Cited by 396 · see citing works
Self-citationManagement Considerations in Infective Endocarditis
Wang, A., Gaca, J. G., & Chu, V. H. Y. (2018) · JAMA · doi:10.1001/jama.2018.7596 · Cited by 372 · see citing works
Trends in Infective Endocarditis in California and New York State, 1998-2013
Toyoda, N., Chikwe, J., Itagaki, S., Gelijns, A. C., Adams, D. H., & Egorova, N. (2017) · JAMA · doi:10.1001/jama.2017.4287 · Cited by 340 · see citing works
Group B Streptococcus ( Streptococcus agalactiae )
Raabe, V., & Shane, A. L. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0007-2018 · Cited by 333 · see citing works
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis
Bai, A. D., Lo, C. K. L., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senécal, J., Corpo, O. D., Stefanova, I. Z., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.03.015 · Cited by 321 · see citing works
Blomström‐Lundqvist, C., TRAYKOV, V. B., Erba, P. A., Burri, H., Nielsen, J. C., Bongiorni, M. G., Poole, J. E., Boriani, G., Costa, R., Deharo, J., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezz296 · Cited by 318 · see citing works
Diagnostic value of imaging in infective endocarditis: a systematic review
Gomes, A., Glaudemans, A. W. J. M., Touw, D. J., van Melle, J. P., Willems, T. P., Maass, A. H., Natour, E., Prakken, N. H. J., Borra, R., van Geel, P. P., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30141-4 · Cited by 279 · see citing works
Current AATS guidelines on surgical treatment of infective endocarditis
Pettersson, G., & Hussain, S. T. (2019) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2019.10.05 · Cited by 274 · see citing works
“05 to operate, how to prepare the patient for operation, how to operate, and other issues relevant to management and follow up of patients after surgery (1-6).”
BackgroundMethodInfluentialHighly multiplexed spatial mapping of microbial communities
Shi, H., Shi, Q., Grodner, B., Lenz, J. S., Zipfel, W. R., Brito, I., & Vlaminck, I. D. (2020) · Nature · doi:10.1038/s41586-020-2983-4 · Cited by 248 · see citing works
Enterococci and Their Interactions with the Intestinal Microbiome
Dubin, K. A., & Pamer, E. G. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0014-2016 · Cited by 235 · see citing works
Beganovic, M., Luther, M. K., Rice, L. B., Arias, C. A., Rybak, M. J., & LaPlante, K. L. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy064 · Cited by 235 · see citing works
Self-citationTrends in Drug Use–Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017
Schranz, A. J., Fleischauer, A. T., Chu, V. H. Y., Wu, L.-T. T., & Rosen, D. L. (2018) · Annals of Internal Medicine · doi:10.7326/m18-2124 · Cited by 232 · see citing works
Streptococcus Sanguinis Biofilm Formation & Interaction with Oral Pathogens
Zhu, B., Macleod, L. C., Kitten, T. O., & Xu, P. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0043 · Cited by 228 · see citing works
“This matrix is likely responsible for protecting embedded bacteria from phagocytic killing [178] and for the relatively long duration of antibiotic treatment that is required for cure [180].”
BackgroundEgi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 226 · see citing works
Kumar, R. K., Antunes, M. J., Beaton, A., Mirabel, M., Nkomo, V., Okello, E., Regmi, P., Remenyi, B., Sliwa-Hahnle, K., Zühlke, L., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000921 · Cited by 168 · see citing works
Laboratory Diagnosis of Infective Endocarditis
Liesman, R. M., Pritt, B. S., Maleszewski, J. J., & Patel, R. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00635-17 · Cited by 225 · see citing works
Blomström‐Lundqvist, C., TRAYKOV, V. B., Erba, P. A., Burri, H., Nielsen, J. C., Bongiorni, M. G., Poole, J. E., Boriani, G., Costa, R., Deharo, J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa010 · Cited by 223 · see citing works
The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century
Ambrosioni, J., Hernández‐Meneses, M., Téllez, A., Pericàs, J. M., Falces, C., Tolosana, J. M., Vidal, B., Almela, M., Quintana, E., Llopis, J., et al. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0574-9 · Cited by 211 · see citing works
Kaushik, A., Kest, H., Sood, M., Steussy, B. W., Thieman, C., & Gupta, S. (2024) · Pathogens · doi:10.3390/pathogens13010076 · Cited by 214 · see citing works
Infective Endocarditis: A Contemporary Review
Hubers, S. A., DeSimone, D. C., Gersh, B. J., & Anavekar, N. S. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.12.008 · Cited by 208 · see citing works
Treatment of Staphylococcus aureus Infections
David, M. Z., & Daum, R. S. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_42 · Cited by 194 · see citing works
“For empiric or targeted Table 2 Antimicrobial drugs for therapy of S. aureus invasive and noninvasive infections [in part adapted from (Baddour et al. 2015; Liu et al. 2011; Drew 2007)] Drug Typical adult dose* Typical pediatric dose* Comment Oral agents Oral antistaphylococcal b-lactam Varies by…”
BackgroundMethodChamat‐Hedemand, S., Dahl, A., Østergaard, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046723 · Cited by 187 · see citing works
Ayobami, O., Willrich, N., Reuss, A. M., Eckmanns, T., & Markwart, R. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1769500 · Cited by 189 · see citing works
JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis
Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, Ḱ., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0549 · Cited by 180 · see citing works
Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis
Satoskar, A. A., Parikh, S. V., & Nádasdy, T. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0178-8 · Cited by 177 · see citing works
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
Onufrak, N. J., Forrest, A., & González, D. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.06.015 · Cited by 175 · see citing works
Regulation of food intake by oleoylethanolamide
Verme, J. L., Gaetani, S., Fu, J., Oveisi, F., Burton, K. J., & Piomelli, D. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4494-0 · Cited by 169 · see citing works
Management of Staphylococcus aureus Bacteremia
Tong, S. Y. C., Fowler, V. G., Skalla, L. A., & Holland, T. L. (2025) · JAMA · doi:10.1001/jama.2025.4288 · Cited by 192 · see citing works
Self-citationBai, A. D., Steinberg, M., Showler, A., Burry, L. D., Bhatia, R. S., TOMLINSON, G. A., Bell, C. M., & Morris, A. M. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.03.007 · Cited by 170 · see citing works
“Our study findings support the American Heart Association guidelines(3) and European Society of Cardiology guidelines,(4) which recommend TTE as initial imaging of choice in patients without prosthetic valves and TEE for patients with prosthetic valves for suspected IE.(3,4) Our study findings add to existing IE guide…”
BackgroundMethodResultInfluentialWang, T. K. M., Sánchez-Nadales, A., Igbinomwanhia, E., Cremer, P. C., Griffin, B. P., & Xu, B. (2020) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.010600 · Cited by 170 · see citing works
Native-Valve Infective Endocarditis
Chambers, H. F. “., & Bayer, A. S. (2020) · New England Journal of Medicine · doi:10.1056/nejmcp2000400 · Cited by 168 · see citing works
Self-citationLi, M., Kim, J. B., Sastry, B. K. S., & Chen, M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01098-5 · Cited by 175 · see citing works
Infective Endocarditis: Update on Epidemiology, Outcomes, and Management
Vincent, L. L., & Otto, C. M. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1043-2 · Cited by 168 · see citing works
Fabre, V., Sharara, S. L., Salinas, A. B., Carroll, K. C., Desai, S. V., & Cosgrove, S. E. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa039 · Cited by 161 · see citing works
Association of Vegetation Size With Embolic Risk in Patients With Infective Endocarditis
Mohananey, D., Mohadjer, A., Pettersson, G., Navia, J. L., Gordon, S., Shrestha, N. K. M., Grimm, R. A., Rodriguez, L. L., Griffin, B. P., & Desai, M. Y. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.8653 · Cited by 165 · see citing works
Inoculum effect of β-lactam antibiotics
Lenhard, J. R., & Bulman, Z. P. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz226 · Cited by 159 · see citing works
Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention
Dayan, G. H., Mohamed, N., Scully, I. L., Cooper, D., Begier, E. M., Eiden, J., Jansen, K. U., Gurtman, A., & Anderson, A. S. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1179583 · Cited by 156 · see citing works
“tive treatment in patients with native valve endocarditis [258,259].”
BackgroundGranados, U., Fuster, D., Pericàs, J. M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.173690 · Cited by 151 · see citing works
“Early detection and drainage, if required, of embolic complications as well as enlarging the length of antibiotic therapy are crucial for improving immediate and late outcomes of IE, including relapses (7,8).”
BackgroundCoagulation: At the heart of infective endocarditis
Liesenborghs, L., Meyers, S., Vanassche, T., & Verhamme, P. B. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14736 · Cited by 151 · see citing works
Uncovering the Hidden Antibiotic Potential of Cannabis
Farha, M. A., El-Halfawy, O. M., Gale, R. T., MacNair, C. R., Carfrae, L. A., Zhang, X., Jentsch, N. G., Magolan, J., & Brown, E. D. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00419 · Cited by 149 · see citing works
Cephalosporins: A Focus on Side Chains and β-Lactam Cross-Reactivity
Chaudhry, S. B., Veve, M. P., & Wagner, J. L. (2019) · Pharmacy · doi:10.3390/pharmacy7030103 · Cited by 146 · see citing works
“It can also be used as alternative therapy for community-acquired meningitis, and as definitive therapy for vertebral osteomyelitis and culture-negative infective endocarditis [29,36,54].”
Background2022 ACC/AHA guideline for the diagnosis and management of aortic disease
Isselbacher, E. M., Preventza, O. A., Black, J. H., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., et al. (2023) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2023.04.023 · Cited by 148 · see citing works
Self-citationClinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones
Roger, C., Roberts, J. A., & Müller, L. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0601-x · Cited by 140 · see citing works
“Despite promising experimental data, oxazolidinones are not currently indicated for endocarditis related to vancomycin-susceptible strains, especially when daptomycin can be used [127, 128].”
BackgroundMultimodality Imaging in Infective Endocarditis
Erba, P. A., Pizzi, M. N., Roque, A., Salaün, E., Lancellotti, P., Tornos, P., & Habib, G. (2019) · Circulation · doi:10.1161/circulationaha.119.040228 · Cited by 143 · see citing works
Rodger, L., Glockler-Lauf, S. D., Shojaei, E., Sherazi, A., Hallam, B., Koivu, S. L., Gupta, K., Hosseini-Moghaddam, S. M., & Silverman, M. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.5220 · Cited by 138 · see citing works
Long-Term Risk of Infective Endocarditis After Transcatheter Aortic Valve Replacement.
Butt, J., Ihlemann, N., de Backer, O., Søndergaard, L., Havers-Borgersen, E., Gislason, G., Torp-Pedersen, C., Køber, L., & Fosbøl, E. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.078 · Cited by 113 · see citing works
“Both the European and American guidelines consider patients undergoing prosthetic valve replacement to be at high risk of IE (1,24,25).”
BackgroundBaddour, L. M., Weimer, M. B., Wurcel, A. G., McElhinney, D. B., Marks, L. R., Fanucchi, L. C., Garrigos, Z. E., Pettersson, G., & DeSimone, D. C. (2022) · Circulation · doi:10.1161/cir.0000000000001090 · Cited by 135 · see citing works
Self-citationExebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis
Fowler, V. G., Das, A., Lipka, J., Schuch, R., Pomerantz, R. J., Jáuregui-Peredo, L., Bressler, A. M., Evans, D. C., Moran, G. J., Rupp, M. E., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136577 · Cited by 130 · see citing works
“Echocardiography was performed within 3 days of randomization (35).”
MethodSelf-citationHACEK endocarditis: state-of-the-art
Revest, M., Egmann, G., Cattoir, V., & Tattevin, P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2016.1164032 · Cited by 125 · see citing works
“- Fifthly, β-lactamase–producing strains of HACEK may be emerging [19 52], and difficulty in performing antimicrobial susceptibility testing as a result of failure of growth in vitro have led endocarditis experts to recommend that, ‘unless growth is adequate for in vitro screening, then HACEK microorganisms should be…”
BackgroundResultBackes, C. H., Hill, K. D., Shelton, E. L., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025784 · Cited by 126 · see citing works
Weis, S., Kesselmeier, M., Davis, J. S., Morris, A. M., Lee, S., Scherag, A., Hagel, S., & Pletz, M. W. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.010 · Cited by 126 · see citing works
Penicillin skin testing in hospitalized patients with β-lactam allergies
King, E. A., Challa, S., Curtin, P., & Bielory, L. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.04.021 · Cited by 125 · see citing works
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00685-0 · Cited by 119 · see citing works
Prosthetic Valve Endocarditis After TAVR and SAVR
Summers, M. R., Leon, M. B., Smith, C. R., Kodali, S., Thourani, V. H., Herrmann, H. C., Makkar, R., Pîbarot, P., Webb, J. G., Leipsic, J. A., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.041399 · Cited by 119 · see citing works
Muller, A. E., Huttner, B. D., & Huttner, A. C. (2018) · Drugs · doi:10.1007/s40265-018-0880-z · Cited by 120 · see citing works
“Interestingly, the recent US endocarditis guidelines continue to recommend multiple daily administrations in the case of enterococcal endocarditis [85], illustrating that the issue of how best to administer aminoglycosides is far from being resolved.”
BackgroundFungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
Thompson, G. R., Jenks, J. D., Baddley, J. W., Lewis, J. S., Egger, M., Schwartz, I. S., Boyer, J., Patterson, T. F., Chen, S. C. ‐., Pappas, P. G., et al. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-23 · Cited by 128 · see citing works
Hines, K. M., Waalkes, A., Penewit, K. M., Holmes, E. A., Salipante, S. J., Werth, B. J., & Xu, L. (2017) · mSphere · doi:10.1128/msphere.00492-17 · Cited by 114 · see citing works
de Camargo, R. A., Bittencourt, M. S., Meneghetti, J. C., Soares, J., Gonçalves, L. F., Buchpiguel, C. A., Paixão, M. R., Felicio, M. F., Soeiro, A. D. M., Strabelli, T. M. V., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz267 · Cited by 116 · see citing works
Infective Endocarditis After Transcatheter Aortic Valve Replacement
del Val, D., Panagides, V., Mestres, C. A., Miró, J. M., & Rodés‐Cabau, J. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.028 · Cited by 123 · see citing works
Yealy, D. M., Mohr, N. M., Shapiro, N. I., Venkatesh, A. K., Jones, A. E., & Self, W. H. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.02.006 · Cited by 119 · see citing works
How do I manage a patient with enterococcal bacteraemia?
Turco, E. R. D., Bartoletti, M., Dahl, A., Cervera, C., & Pericàs, J. M. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.10.029 · Cited by 113 · see citing works
Straw, S., Baig, M. W., Gillott, R., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz869 · Cited by 111 · see citing works
Wang, S., Ren, H., Zhong, H., Zhao, X., Li, C., Ma, J., Gu, X., Xue, Y., Huang, S., Yang, J., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.2003176 · Cited by 108 · see citing works
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Journal of Intensive Care · doi:10.1186/s40560-017-0270-8 · Cited by 107 · see citing works
“Diagnoses based on transesophageal echocardiography following transthoracic echocardiography is recommended in cases where infective endocarditis is suspected, particularly those involving prosthetic valve replacement, when the clinical criteria indicate a strong possibility of infective endocarditis, or in high-risk…”
BackgroundDental prevention and disease awareness in children with congenital heart disease
Koerdt, S., Hartz, J., Hollatz, S., et al. (2017) · Clinical Oral Investigations · doi:10.1007/s00784-017-2256-2 · Cited by 106 · see citing works
Kimmel, S. D., Walley, A. Y., Li, Y., Linas, B. P., Lodi, S., Bernson, D., Weiss, R. D., Samet, J. H., & Larochelle, M. R. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.16228 · Cited by 104 · see citing works
Lamas, C. D. C., Fournier, P., Zappa, M., Brandão, T. J. D., Januário-da-Silva, C. A., Correia, M. G., Barbosa, G. I. F., Golebiovski, W. F., Weksler, C., Lépidi, H., et al. (2015) · Infection · doi:10.1007/s15010-015-0863-x · Cited by 101 · see citing works
Bland, C. M., Pai, M. P., & Lodise, T. P. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2193 · Cited by 104 · see citing works
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections
Cairns, K. A., Udy, A. A., Peel, T. N., Abbott, I. J., Dooley, M. J., & Peleg, A. Y. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-22 · Cited by 105 · see citing works
Real-world outcomes of surgery for native mitral valve endocarditis
Toyoda, N., Itagaki, S., Egorova, N., et al. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.07.077 · Cited by 103 · see citing works
“Deaths were ascertained from linked state’s vital statistics death records, deceased discharge disposition at any subsequent in-hospital and emergency department and ambulatory surgery visits, and additionally from the Social Security Death Master File; recurrent infective endocarditis was defined as a diagnosis of in…”
MethodTemporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014
Keller, K., von Bardeleben, R. S., Ostad, M. A., Hobohm, L., Münzel, T. F., Konstantinides, S., & Lankeit, M. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.09.035 · Cited by 101 · see citing works
2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease
Gurvitz, M. Z., Krieger, E. V., Fuller, S., Davis, L. L., Kittleson, M. M., Aboulhosn, J., Bradley, E. A., Buber, J., Daniels, C. J., Dimopoulos, K., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.09.006 · Cited by 132 · see citing works
Mathieu, C., Mikaïl, N., Benali, K., Iung, B., Duval, X., Nataf, P., Jondeau, G., Hyafil, F., Le Guludec, D., & Rouzet, F. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005585 · Cited by 102 · see citing works
A Contemporary Picture of Enterococcal Endocarditis
Pericàs, J. M., Llopis, J., Muñoz, P., Gálvez-Acebal, J., Kestler, M., Valerio, M., Hernández-Meneses, M., Goenaga, M. Á., Cobo-Belaustegui, M., Montejo, M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.047 · Cited by 99 · see citing works
Jain, V., Wang, T. K. M., Bansal, A., et al. (2020) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2020.11.008 · Cited by 99 · see citing works
Eichenberger, E. M., de Vries, C. R., Ruffin, F., Sharma‐Kuinkel, B. K., Park, L., Hong, D. K., Scott, E. R., Blair, L. M., Degner, N. R., Hollemon, D. H., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab742 · Cited by 97 · see citing works
Self-citationBest Practices for Imaging Cardiac Device–Related Infections and Endocarditis
Dilsizian, V., Budde, R. P. J., Chen, W., Mankad, S. V., Lindner, J. R., & Nieman, K. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.09.029 · Cited by 100 · see citing works
Zeise, K. D., Woods, R. J., & Huffnagle, G. B. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00323-20 · Cited by 101 · see citing works
- Authors
- Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., Bolger, A. F., Steckelberg, J. M., Baltimore, R. S., Fink, A. M., O’Gara, P., Taubert, K. A., & on behalf of the American Heart Association Committee on Rheumatic Fever, E.
- Affiliations
- American Heart Association (US)
- ORCID
- Venue
- Circulation
- Published
- 2015-10-13
- Volume
- 132
- Issue
- 15
- Pages
- 1435-1486
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1905008412
- Cited by
- 3,232
- References
- 338
- Citations by year
- 2026: 265 · 2025: 337 · 2024: 350 · 2023: 337 · 2022: 348 · 2021: 344 · 2020: 346 · 2019: 301 · 2018: 258 · 2017: 207 · 2016: 120 · 2015: 12 · 2014: 3 · 2013: 1
- FWCI
- 156.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Touro Scholar (Touro College) (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Keywords
- infective endocarditis, adults, diagnosis, antimicrobial therapy, complication management, Staphylococcus aureus, nosocomial infections, treatment guidelines
- MeSH terms
- Adult, Anti-Infective Agents, Anticoagulants, Candidiasis, Diagnostic Techniques, Cardiovascular, Endocarditis, Heart Valve Prosthesis, Humans, Rheumatic Heart Disease, Risk Factors, Staphylococcal Infections, Streptococcal Infections, Prosthesis-Related Infections, Bacteremia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review